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Abstract 
A new family of cationic N-heterocyclic ligand derivatives was prepared and characterised. 
Among these compounds are halide salts of the dications [Y(spacer)Y]2+, each of which 
comprise two N-heterocyclic donor groups (Y = 4,4′-bipy, pyz, apyz, apym) linked by a 
conformationally flexible spacer such as (CH2)n, α,α′-xylylene, 2,6-lutidylene or 
thiabicyclo[3.3.1]nonane-2,6-diyl. The diquaternary halide salts were converted to NO3- and 
PF6- salts, and interaction of these bridging ligands with labile palladium(II) and platinum(II) 
precursors afforded several multinuclear complexes. Bis(4,4′-bipyridinium) dications were 
incorporated into the dinuclear macrocycles [M2(2,2′-bipy)2{4,4′-bipy(CH2)n4,4′-bipy}2]8+ 
(M = Pd, Pt; n = 4, 6), cis-[Pd2Cl4{4,4′-bipy(CH2)34,4′-bipy}2]4+, [Pt2(dppp)2{4,4′-bipy(1,2-
xylylene)4,4′-bipy}2]8+ and cis-[Pt2Cl4{4,4′-bipy(1,2-xylylene)4,4′-bipy}2]4+. While 
bis(pyrazinium) analogues were unreactive towards the palladium(II) and platinum(II) 
precursors, the doubly deprotonated bis(3-aminopyrazinium) and bis(2-aminopyrimidinium) 
derivatives served as charge-neutral quadruply-bridging ligands in the complexes 
[Pt4(2,2′-bipy)4{apyz(CH2)6apyz–2H}2]8+ and [Pt4(2,2′-bipy)4{apym(CH2)5apym–2H}2]8+, 
both of which feature Pt(II)···Pt(II) interactions. Larger species formed when the diamine 
O,O′-bis(2-aminoethyl)octadeca(ethylene glycol) (PEGda) was treated with 
cis-dinitratopalladium(II) and platinum(II) precursors. The resulting complexes 
[M(N,N)(PEGda)]2+
 
(M = Pd, Pt; N,N = 2,2′-bipy, en, tmeda) possessed great size 
(62-membered chelate rings) and aqueous solubility. 
 
DNA-binding studies were conducted with selected complexes in order to investigate the 
types of interactions these species might participate in (see figure). 
+
? ?
 
Equimolar mixtures containing either the 16mer duplex DNA D2 or the single strand D2a 
and palladium(II)/platinum(II) complexes were prepared and analysed by negative-ion 
ESI-MS. Studies of D2/Pd(II) mixtures suggested extensive fragmentation was occuring, 
and the use of [Pd(tmeda)(PEGda)]2+ and [Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ 
resulted in D2 adducts of [Pd(tmeda)]2+ and [4,4′-bipy(CH2)44,4′-bipy]2+, respectively. 
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Decomposition also occurred when D2a was used, although 1 : 1 adducts were observed 
with [Pd(tmeda)(PEGda)]2+, [Pd(2,2′-bipy)(PEGda)]2+ and [Pd2(2,2′-bipy)2{4,4′-
bipy(CH2)44,4′-bipy}2]8+. The low intensities of these adducts indicated that they are 
unstable towards ESI-MS. 
 
Analogous ESI-MS experiments using platinum(II) derivatives were performed and, in 
contrast to those with palladium(II), indicated that the complexes remained largely intact. 
ESI-MS analysis of D2/Pt(II) mixtures allowed for the detection of 1 : 1 D2 adducts of 
[Pt(en)(PEGda)]2+, [Pt(tmeda)(PEGda)]2+ and [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-
bipy}2]8+.  Intensities of the adduct ions suggested the greater charge and aryl surface area 
allow the dinuclear species to bind D2 most strongly. Both [Pt(2,2′-bipy)(Mebipy)2]4+ and 
[Pt(2,2′-bipy)(NH3)2]2+ gave rise to 1 : 2 adducts of D2, although the latter was found to be a 
weaker binder, perhaps owing to its lower charge. Data obtained using 1 : 5 (D2 : complex) 
mixtures were consistent with the results above and suggested that D2 can bind more 
molecules of daunomycin than any of the platinum(II) species. Analyses of D2a/Pt(II) 
mixtures gave results similar to those obtained with D2, although fragmentation was more 
pronounced, indicating that the nucleobases in D2a play more significant roles in mediating 
decomposition than those in D2, in which they are paired in a complementary manner. 
 
Investigations into the effects of selected platinum(II) complexes on the thermal 
denaturation of calf-thymus DNA (CT-DNA) in solution were conducted. Both 
[Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ and [Pt(2,2′-bipy)(Mebipy)2]4+ greatly 
stabilised CT-DNA, most likely by intercalation. In contrast, [Pt(tmeda)(PEGda)]2+ and 
[Pt(en)(PEGda)]2+ (as well as PEGda) caused negligible changes in melting temperature 
(∆Tm), suggesting that these interact weakly with CT-DNA. Data for 
[Pt(2,2′-bipy)(PEGda)]2+ and [Pt(2,2′-bipy)(NH3)2]2+ indicated that these species perhaps 
intercalate CT-DNA, with similar ∆Tm values for both complexes implying that PEGda does 
not play a major role in binding. While findings from ESI-MS experiments were similar to 
those from the thermal denaturation experiments, discrepancies between results from the 
two methods could be found. In particular, fragmentation of cyclic species during ESI-MS 
caused the binding strength of the species to be underestimated when this method was 
employed. 
1 
Chapter One: Introduction 
1.1 Supramolecular chemistry 
Large molecular assemblies are ubiquitous in biochemical systems. Nature has constructed 
innumerable molecular architectures held together by weak interactions, namely H-bonding, 
π–π interactions, hydrophobic interactions, electrostatic interactions and van der Waals 
forces.1 Such assemblies include proteins – Nature’s building blocks – whose structure and 
ability to ‘fold’ and ‘unfold’ are reliant upon H-bonding.2 Supramolecular chemistry, the 
study of (predominantly synthetic) molecular assemblies comprising weakly bound 
components, has been described by Lehn as “the designed chemistry of the intermolecular 
bond.”3 Lehn, along with Cram4 and Pedersen5 shared the 1987 Nobel Prize in Chemistry 
“for their development and use of molecules with structure-specific interactions of high 
selectivity.”6 Their efforts founded an area of chemistry, largely concerned with non-
covalently bound molecular assemblies, which is one of today’s fastest growing areas of 
research and encompasses aspects of many fields spanning biology to materials science.7 
 
1.2 DNA – a natural supramolecule 
Perhaps the most elegant of all supramolecular architectures, either natural or synthetic, are 
those adopted by deoxyribonucleic acid (DNA),8 the biomolecule responsible for the storage 
and transfer of genetic information in biological systems. This entity comprises a large 
number of deoxyribonucleotides, which in turn each consist of an aromatic nucleobase (vide 
infra), a 2-deoxy-D-ribose sugar and a phosphate group.9 While the nucleobases serve to 
carry genetic information, the sugar and phosphate groups perform a structural role, existing 
as the scaffold (or ‘backbone’) of the very long, threadlike molecule. In addition, at 
physiological pH (7.4) DNA molecules bear a large negative charge, owing to the acidity of 
the phosphate groups (pKa < 1).10 
 
The information present in each single strand of DNA (ssDNA) is inherent in the sequence 
of nucleobases appended to each sugar group in the backbone. The four different 
nucleobases present in DNA are: the purines adenine (A) and guanine (G) and the 
pyrimidines thymine (T) and cytosine (C). Each of the nucleobases contains H-bond donor 
and acceptor groups, with stable H-bonded base-pairs forming between adenine and 
thymine, as well as guanine and cytosine (Figure 1.1, right). This is termed Watson-Crick 
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complementary base-pairing, after the researchers who deduced a structure of DNA in 
1953.8 
major groove
minor groove
24 Ǻ
major groove
minor groove
major groove
minor groove
deoxyribose
deoxyribose
deoxyribose
deoxyribose
 
Figure 1.1: The tertiary structure of B-DNA (left) and Watson-Crick H-bonding between nucleobases 
(right). Donor (blue) and acceptor (red) pairs are shown. AT and GC base-pairs are stabilised by two 
and three primary H-bonding interactions, respectively. 
 
Three conformations are commonly adopted by DNA: A-, B- and Z-DNA, of which B-DNA 
predominates under physiological conditions. It comprises two antiparallel DNA strands 
connected by H-bonded bases, with an overall right-handed double helical structure of 
diameter ~23.7 Å. As a result of the complementary H-bonding, the two strands are also 
complementary and, in general, non-equivalent. This causes the DNA double helix to have 
two different grooves – the major and minor grooves.11,12 These are of similar depths11 and 
are formed by base-pairs which sit directly on the helical axis (Figure 1.1, left). 
 
From a supramolecular chemistry viewpoint, the stability of double-stranded DNA (dsDNA) 
arises from three forms of weak interactions: H-bonding, π–π stacking, and hydrophobic 
effects. In particular, the H-bonded bases attached to the DNA backbone are arranged such 
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that π–π interactions are promoted between adjacent bases (whose mean planes are ~3.4 Å 
apart) in each strand.13 Additionally, in aqueous solution hydrophobic effects aid the 
formation of a double helix, in which the relatively hydrophobic core comprising aromatic 
moieties is surrounded by the more hydrophilic sugar-phosphate scaffold. Indeed, this 
scaffold allows for DNA to be strongly hydrated. While the hydrophobic effect may be 
considered less directional than H-bonding and π–π interactions,14 it is clear that it may have 
a marked influence on solution structures. What also becomes evident is that the presence of 
several weak interactions within a supramolecular system may cooperatively aid the 
formation of elaborate structures of remarkable stability. 
 
The findings of Watson and Crick, in particular that the two strands are of a complementary 
nature, immediately suggested that each strand templates the formation of the other in DNA 
replication.15 In other words, the two strands are supramolecular receptors for one another, 
making the double helix an exquisite example of molecular recognition. 
 
1.3 Host-guest systems 
In order for genetic information to be expressed in biological systems, it is essential that 
proteins are able to form stable supramolecular complexes with DNA. To this end, proteins 
must be able to recognise DNA by means of H-bonding, hydrophobic effects and 
electrostatic interactions. These influences form the basis of three general modes of protein 
binding to DNA, typically characterised according to their interaction ‘footprints,’ which 
may be single-headed, double-headed or enveloping in nature.16 The former two modes 
entail binding to the major and/or minor grooves of DNA, with the protein adopting either a 
α-helical or β-sheet secondary structure in order to maximise interactions with base-pairs 
and backbone components. In contrast, the enveloping mode is characterised by positively 
charged amino acid residues interacting electrostatically with the DNA backbone. When 
binding to DNA in such a fashion, proteins incorporate a cleft shape into their overall 
structure. These proteins, which act as ‘hosts’ for DNA ‘guests’, are referred to as being 
toroidal or ring-shaped and are central to several cellular processes. It is no accident that 
proteins involved in DNA metabolism all share similar structural motifs – indeed it has been 
suggested that the structures of these proteins have converged (‘evolved’) to toroidal 
geometries owing to the unique structure of the DNA guest.17 
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Much attention has recently focussed on the toroidal proteins because of their key role in the 
DNA polymerase holoenzyme complex that catalyses DNA replication, repair and 
recombination. The enzymatic polymerisation of several hundreds/thousands of nucleotides 
per second without dissociation from the template DNA is made possible by the mechanical 
association between DNA and a subunit referred to as the DNA “sliding clamp”.17 For 
example, in Escherichia coli, the β-subunit dimer of DNA polymerase III holoenzyme 
performs the role of the sliding clamp. The high processivity of the enzyme results from the 
unhindered motion of the sliding clamp along duplex DNA, the former holding the catalytic 
subunits in close proximity to the primed template; such a situation is demonstrated by the 
X-ray structure of the DNA-protein complex determined by Kong and co-workers 
(Figure 1.2).18 
 
Figure 1.2: X-ray crystal structure of the β-subunit dimer of DNA polymerase III (E. coli) topologically 
associated with B-DNA. 
 
The central cavity of the toroidal protein is approximately 35 Å in diameter, allowing for 
DNA to be accommodated without steric strain. Data from the structure determination, as 
well as theoretical studies, have indicated the presence of an overall positive charge on the 
surface of the central cavity. The electrostatic interactions between this positively-charged 
cavity and the negatively-charged phosphate groups of DNA serve to stabilise the 
supramolecular complex. From a topological viewpoint, the sliding clamp may be 
considered a ‘wheel’, and the encircled DNA an ‘axle’, with the overall arrangement being 
referred to as a pseudorotaxane, namely a [2]pseudorotaxane, as two individual components 
are involved. 
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Examples of topologically-interesting supramolecules are not limited to those occurring in 
natural systems. In particular, the past two decades have seen several reports of synthetic 
interlocked molecular assemblies.19 An example of such an assembly is given in 
Scheme 1.1, which depicts the formation of a [2]pseudorotaxane (1) from a cationic axle 
and a crown ether wheel.20 
 
Scheme 1.1: Formation of a [2]pseudorotaxane (1) from a 1,2-bis(4,4′-bipyridinium)ethane ‘axle’ and a 
dibenzo-24-crown-8 ‘wheel’, and its conversion to a rotaxane (2) with tert-butylbenzyl ‘stoppers’. 
 
The formation of pseudorotaxane 1 is driven by three primary forms of weak interaction. 
H-bonds between methylene protons of the axle and the ether O atoms (shown in red) serve 
to stabilise the complex. These ether O atoms also participate in ion-dipole interactions with 
the quaternised N atoms (shown in blue) of the axle. In addition, aromatic regions within the 
axle (pyridyl rings) and wheel (phenylene groups) are arranged such that π–π stacking can 
occur. While the collective influences of these interactions result in the thermodynamic 
stability of the pseudorotaxane structure, sterically demanding groups can be appended onto 
the ends of the axle in order to confer kinetic stability on the system as well. In such a case 
the wheel would be unable to leave the axle; interlocked structures such as 2 are known as 
[2]rotaxanes. 
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1.4 Metallosupramolecular chemistry 
The subclass of supramolecular chemistry involving the use of metal ions as structurally 
defining elements has been termed metallosupramolecular chemistry (despite metal-ligand 
coordinate bonds often having substantial covalent character).1,21 As such, the 
stereochemical information inherent in individual metal ions, combined with ligand 
directionality, can often be useful in the predictable synthesis of chosen molecular 
architectures. 
 
In the mid-1980s the potential of the above strategy for producing supramolecular structures 
was demonstrated. For example, Sauvage and co-workers were successful in synthesising a 
pair of interlocked molecular rings – a [2]catenane (3) – by means of two elegant chemical 
steps involving the metal-templation procedure illustrated in Scheme 1.2.22 
 
Scheme 1.2: Synthesis of a [2]catenane directed by a tetrahedrally coordinated copper(I) ion. 
 
Their use of copper(I), a metal ion typically exhibiting a tetrahedral coordination geometry, 
allowed for the preorganisation23 of the bound phenanthroline precursor derivatives in a 
mutually perpendicular fashion. The (irreversible) closing of the rings, involving the 
kinetically-controlled alkylation of the phenolic moieties, represented the second and final 
step in the synthesis. 
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Recently, the incorporation of metal ions as members of cyclic structures, sometimes 
referred to as metallocyclic chemistry, has proven to be a particularly useful approach for 
obtaining new cyclic molecular architectures. This is exemplified in the preparation of the 
first metallocyclic square (Scheme 1.3) which was reported in 1990 by Fujita and 
co-workers.24 
 
Scheme 1.3: A metallosupramolecular square incorporating four angular and four linear components. 
 
This product was found to form by ‘self-assembly’, a process defined by Stang as “the 
spontaneous assembly of molecules into structured, stable non-covalently joined 
aggregates”.25 In the above reaction, corner units comprising cis-protected palladium(II) 
centres (defining 90º angles)26 self-assemble in the presence of complementary linear 
4,4´-bipyridine bridging units to give the desired tetranuclear square complex, whose 
connectivity incorporates four palladium(II) ions. The predicted structure (4), based on the 
propensity for palladium(II) to adopt a square-planar coordination geometry and the inherent 
linear directionality of the 4,4´-bipyridine bridging ligand, was obtained in high yield after 
stirring an aqueous suspension of the precursors for ten minutes at room temperature. While 
feasible kinetic pathways to acyclic oligomeric structures also exist, entropy considerations 
(vide infra) and the principle of ‘self-correction’21 apparently make this synthesis (and 
indeed, more generally, many other syntheses in the field of metallosupramolecular 
chemistry) viable. 
 
The phenomenon of ‘self-correction’ is proposed to manifest itself once an equilibrium is 
established between reactants and all possible products. Provided the metal coordination 
bonds are sufficiently labile, such an equilibrium may, for example, entail the 
interconversion of oligomeric species into discrete products. It is claimed that discrete 
products are generally preferred entropically over oligomeric ones on account of their 
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assembly from fewer components.27 In the formation of 4, NMR studies showed that a 
kinetically distributed oligomeric mixture was initially generated, which, by self-correction 
ultimately gave the entropically favoured discrete square species in high yield. It is clear 
that the required interconversion is reliant upon rapid metal-ligand bond formation and 
dissociation. Replacement of palladium(II) with another d8 metal ion, platinum(II), largely 
resulted, under the same reaction conditions, in a reaction mixture containing more 
persistent oligomeric species. This was a result of the increased inertness of platinum(II) 
coordinate bonds28 acting to inhibit the self-correction process, the formation of Pt−N bonds 
in analogous systems being essentially irreversible at room temperature.29 This problem had 
two straightforward solutions: the use of prolonged reaction time at elevated temperature 
(28 days under reflux), or the addition of polar media (NaNO3) to the reaction mixture. The 
latter serves to increase the dielectric constant of the solution, promoting square formation 
due to the induced lability of the Pt−N bonds, the greater influence of hydrophobic 
aggregation, as well as the reduced internuclear repulsion under these conditions. This self-
assembled system falls into the particular class of ‘strict self-assembly’, which refers to 
precursor components assembling into structures that represent the thermodynamic 
product(s) of the system. 
 
Subsequent work demonstrated that in solution a small amount of a triangular analogue also 
forms in equilibrium with the square. It is argued that while this triangular species may be 
entropically favoured (as it assembles from fewer components), it is disfavoured 
enthalpically due to greater angular strain. This, and similar square-triangle equilibria have 
now been well documented30 and, with careful design of reactants and conditions, it is 
possible to isolate either species preferentially.31 
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Since the preparation of the above supramolecular square complexes, many further 
examples of molecular polygons have been reported, several of which incorporate 
cis-protected square-planar metal centres. For example, interaction of cis-[Pd(en)(NO3)2] 
with equimolar 1,4-bis[(4-pyridyl)methyl]benzene under dilute conditions resulted in the 
quantitative formation of an ellipsoid complex (5, Scheme 1.4), incorporating a hydrophobic 
cavity.32 At higher concentrations, however, a second species was found to be in dynamic 
equilibrium with the ellipsoid; this species was found to be a catenated dimer of the form 52. 
In contrast to the permanently interlocked rings of Sauvage et al.,22 this catenane was found 
to form under thermodynamic control. 
 
Scheme 1.4: The formation of a [2]catenane (52) from two identical rings, mediated by π-π interactions. 
 
It was demonstrated that the catenane is stabilised by the presence of π–π stacking 
interactions between the ligands in each ring, as well as the favourable hydrophobic 
association of the two units. The latter was exploited to perturb the equilibrium ratio of 
monomer and dimer by altering the solvent system. This can be rationalised by considering 
the varying propensities of molecules to solvate the dimer structure, as well as their 
dielectric properties1 (as each ring bears a 4+ charge). In particular, polar mixtures (such as 
1.0 M NaNO3 in D2O) were found to favour the catenane, whereas less polar solvents (such 
as 1 : 1 D2O/glycerol) favoured the free metallocycles. Additionally, the presence of 
(4-methoxyphenyl)acetate (a guest molecule capable of complexation with 5 but not 52) also 
favoured the monomer. This is an example of ‘guest-promoted self-assembly’, a 
phenomenon which arises when the formation of a stabilised host-guest complex represents 
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an overwhelmingly favourable state such that species in equilibrium with the host are barely 
observed. 
 
The syntheses of several metallocyclic polygons including ellipsoids,33,34 triangles,35 
squares,36 rectangles,34,37 pentagons38 and hexagons39 have recently been reported. Three 
further examples of two-dimensional supramolecular architectures are given below: a 
triangle incorporating bis(β-diketonato) ligands (6), an alkynylplatinum(II)-derived square 
(7) and a hexagon assembled using both coordination and H-bonding (8).40 
 
Other systems may often be constructed through the designed variation of one or more 
structural elements such that required geometries are generated. For example, in trinuclear 
molecular triangle 6, altering the aryl substitution pattern in the β-diketonato ligands from 
para to meta gives rise to a dinuclear ellipsoid incorporating two such ligands.33 Indeed, 
“supramolecular libraries”41 have been proposed which, in almost a combinatorial fashion, 
summarise the molecular properties required to generate a desired structure. 
 
1.5 Bio-inorganic chemistry of metallosupramolecular 
assemblies 
The last decade of the 20th century saw a dramatic increase in the research output of 
metallosupramolecular chemistry, and several polygonal as well as polyhedral species of 
unprecedented size were reported. At present there is an increasing onus on the functions, 
not solely the (often aesthetically pleasing) structures, of these systems.42 Recently, 
considerable attention has been paid to the study of the bio-inorganic chemistry, in 
particular the DNA-binding properties, of such architectures. Indeed, their large size and 
charge have the potential to allow for modes of DNA-binding and biological activity not 
previously observed with other synthetic molecules. For example, the molecular square 
[Pt4(en)4(4,4′-bipy)4](NO3)8 (the platinum(II) analogue of 4) has the ability to significantly 
affect the secondary and tertiary structures of DNA (for an overview of DNA-binding, see 
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Chapter Four). In addition, the square complex was found to cause apoptosis and displayed 
cytotoxicity comparable to that of cis-diamminedichloridoplatinum(II) (cisplatin) against the 
HL-60 leukaemia cell line.43 More recently, the species has also been found to effectively 
bind a G-quadruplex and inhibit telomerase,44 an enzyme that aids in the protection of 
chromosomes and is particularly active in cancer cells.45 
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A related complex, the platinum(II) ‘metallacalixarene’ 9, has also been the subject of 
biological investigations and binds mononucleotides,46 as well as calf thymus DNA 
(CT-DNA) through non-covalent interactions. At low metallacalixarene concentrations, 
DNA supercoiling is observed, whereas atomic force microscopy imaging suggests the 
DNA uncoils into long rigid structures when more metal complex is present.47 
 
The diiron(II) triple helicate 10 has been shown to bind to natural DNA as well as the 
palindromic hexanucleotide 5′-d(CGTACG)-3′.48 In the latter case, X-ray analysis of single 
crystals obtained from the helicate/oligonucleotide mixture revealed the presence of a three-
way DNA junction 11, rather than the expected duplex DNA. Such junctions are observed 
during DNA replication (the replication fork) but are not well understood. In a beautiful 
example of molecular recognition and guest-promoted self-assembly, the triple helicate 
guest was found in the centre of the DNA host, undoubtedly stabilising the Y-junction 
motif.  
 
As such, the supramolecular chemist is ideally suited to exploit the many opportunities the 
area presents. According to Hannon, the area of DNA-binding is “affording new 
opportunities for supramolecular chemistry, where shape, fit and orientation play a central 
role.”12,13,49 While designing species to interact with the large and chiral structure of DNA 
can often present challenges, genomic and structural information from biology suggests that 
supramolecular DNA recognition is an area of substantial promise. 
9                                                           10                                                     11 
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1.6 DNA nanoshuttles 
The most intricate synthetic assemblies reported to date remain rather primitive compared to 
even the simplest of natural supramolecules. Research in supramolecular chemistry has 
taken many steps towards complex functional molecules. However, while this area of 
chemistry has been developing for half a century,50 living systems have had four billion 
years over which to evolve. Indeed, biology has often served as a source of inspiration in the 
design of synthetic molecular architectures. For example, catenanes comprising DNA are 
widespread in prokaryotic and eukaryotic cells, and both double-51 and single-stranded52 
versions can be prepared stereoselectively. Much attention has also been given to the 
development of bio-hybrid systems, which incorporate both natural and synthetic molecular 
components.53 In terms of the present study, it was of interest to prepare a system 
incorporating both synthetic and natural components held together by weak interactions 
(rather than having them covalently bonded to each other). While several examples of 
purely biomolecular or purely synthetic supramolecular assemblies exist, far fewer hybrid 
systems have been reported. 
 
The preparation of a macrocycle capable of encircling double-stranded linear DNA 
represents a particularly attractive synthetic goal. Such a DNA/macrocycle hybrid 
pseudorotaxane would be unprecedented and perhaps would lead to systems in which the 
macrocycle could be capable of probing DNA structure and function by ‘shuttling’ along the 
biomolecule. Consequently, such synthetic analogues of the aforementioned toroidal 
proteins can be referred to as “DNA nanoshuttles”.54 
 
From the definition above, and upon consideration of the properties of a DNA sliding 
clamp, it becomes evident that candidate molecules must satisfy strict design criteria. The 
most important of these is that the cyclic structure must possess a cavity with the 
appropriate dimensions (i.e. 30 – 40 Å) to accommodate double-stranded DNA. In addition, 
a macrocycle bearing a high positive charge would interact electrostatically with the 
polyanionic backbone of DNA in a favourable manner. It is likely that this would confer 
significant aqueous solubility on such a species, which is necessary for study with DNA 
under biologically relevant conditions. Finally, the macrocycle should maintain its integrity 
in the presence of DNA, that is, be inert to chemical reaction with any component of the 
biomacromolecule. 
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Self-assembled metallocycles, which are often H2O-soluble and highly charged, were 
considered as promising options towards the preparation of DNA nanoshuttles. Previous 
work within the author’s group has resulted in the high-yielding preparation of a 
metallosupramolecular hexagon (12) bearing a 24+ charge.55 
 
This designed synthesis involved the reaction of six linear and six angular (120º) 
components to give the dodecaplatinum(II) complex, which is expected to have a central 
cavity larger than 30 Å. Given the considerable size and charge of 12, as well as its H2O 
solubility, it was considered to satisfy the ‘nanoshuttle’ criteria and DNA-binding 
experiments were conducted with this hexagon using standard molecular biology 
techniques. The incubation of linear pBR322 plasmid DNA with the hexagonal complex 
was undertaken with the aim of forming [n]pseudorotaxanes (linear DNA threaded through 
macrocycles, Figure 1.3). These were not characterised as such, but were treated with T4 
DNA ligase, which served to generate bio-hybrid [n]catenanes, comprising permanently 
interlocked circular DNA and hexagons.* 
 
                                               
*
 The catenanes that formed may have varying numbers of either ring. Acyclic oligomers or larger macrocycles 
of DNA are also potential products. Hexagons which are non-mechanically (electrostatically) bound to the 
DNA are removed by a salting procedure and, in any event, are likely to dissociate during electrophoresis. 
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Agarose gel electrophoresis of the products indicated reduced mobility when higher 
concentrations of platinum complex were employed. Such a result is consistent with an 
increase in mass, as well as charge neutralisation due to the topologically-associated 
cationic (platinum complex) and anionic (DNA) components – indeed this is strong 
evidence for nanoshuttle behaviour. 
DNA ligase
linear DNA DNA/hexagoncatenane
molecular hexagon
Increasing [hexagon]
directio
n
 of
m
o
ve
m
ent
 
Figure 1.3: Formation of interlocked macrocycle-DNA hybrids mediated by DNA ligase. 
 
However, the preparation of hexagon 12 was found to be unreliable, perhaps owing to the 
formation of oligomers† and/or hydration of the ketone groups.56 As one might imagine, the 
synthesis of large macrocycles (either organic or inorganic) is nontrivial; strategies for their 
preparation are presented in the following discussion. 
 
                                               
†
 [Pt6(NH3)12(4,4′-dipyridylketone)6]12+ and trans-[Ptn(NH3)2n(4,4′-bipy)n]2n+ are more likely to be the 
thermodynamic products. The precipitation of material (probably oligomeric in nature) after extended heating 
is consistent with the formation of extended linear species of the latter type. Nevertheless, 12 may 
predominate under kinetic control. 
Chapter One: Introduction 
15 
1.7 Large macrocyclic species 
It is well known that the preparation of macrocycles becomes increasingly difficult with 
larger numbers of ring members.57 While high-dilution conditions (which favour 
intramolecular cyclisation over intermolecular oligomerisation) can be successfully 
employed in such syntheses, often the entropic cost of bringing two ends of a chain together 
is too high. In order to increase the probability of cyclisation, large end groups were 
employed by Fujita and co-workers in their preparation of the palladium(II) complex 132. 
 
The overall cyclic structure incorporates over one hundred atoms, causing this to be termed 
an “ultramacrocycle” that can be considered to border the molecular and nanoscale 
domains.58 Monomeric 13 in DMSO-d6 solution converts to the cyclic dimer upon addition 
of D2O, the driving force for this being hydrophobic catenation (see discussion of species 
52). In particular, the macrocycle has an appropriate diameter for a DNA nanoshuttle 
(~3.0 nm). However, the cavity is largely occupied by the polyaromatic catenated ligands 
and the system lacks the necessary H2O-solubility. 
 
Examples of purely organic ultramacrocycles in the chemical literature also exist. Rothe and 
co-workers reported the cyclooligomerisation of deca-ε-aminocaproic acid to give a cyclic 
oligopeptide mixture containing a 700-membered caprolactam hectamer having a molecular 
weight of 11,315 Da.59 However, while large macrocycles are accessible, the preparation of 
pure monodisperse macrocycles with the desired aqueous solubility and size/charge is far 
from trivial. What is clear is that the assembly of macrocycles under kinetic control, which 
requires high dilution60 or an effective template,61 is typically not as efficient as the 
examples of metallosupramolecular synthesis presented thus far, which, in many cases, give 
a single thermodynamic product in high yield. 
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1.8 The present study - synthesis and DNA-binding of 
metallocyclic architectures 
If a macrocycle with the required ‘nanoshuttle’ features can be prepared, the crucial step 
remains the treatment of (either polymeric of oligomeric) DNA with such a species, and the 
characterisation of any resulting interactions. The two most common strategies for 
pseudorotaxane formation are ‘clipping’62 and ‘threading’;63 these are are illustrated in 
Scheme 1.5. 
 
Scheme 1.5: Pathways for pseudorotaxane formation: ‘clipping’ (top) and ‘threading’ (bottom). 
 
In terms of the target DNA/macrocycle pseudorotaxane, the clipping method would entail 
the use of DNA as a template for macrocycle formation. Two (or more) molecular 
components are required to form the cyclic structure, which might involve the selection of 
the optimal macrocyclic host for the templating DNA guest out of a possible equilibrium 
mixture of species. Such selection or amplification has been referred to by Lehn as 
“Supramolecular Darwinism”64 and may be compared to the evolution of certain proteins 
into a toroidal motif. However, such a strategy would not be conducive to pseudorotaxane 
formation if the precursor components were to react with DNA. For example, metal centres 
with weakly bound ligands (e.g. labile complexes of Pd(II) or Pt(II)) may undergo 
substitution reactions with guanine and adenine nucleobases instead of forming 
metallocyclic complexes incorporating the bridging ligands. 
 
The threading strategy, on the other hand, would involve the pre-formation of the cyclic 
species and subsequent combination of this with DNA. This approach was adopted in the 
present study, the aims of which included the (i) synthesis of large metallocyclic 
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architectures using the supramolecular approaches described thus far, and (ii) 
characterisation of the interactions between these species and DNA (Scheme 1.6). 
+
? ?
 
Scheme 1.6: Interaction of a macrocycle with DNA might result in surface or topological binding. 
 
The preparation of examples of the hitherto unreported class of DNA-macrocycle rotaxanes 
serves as motivation for the present study. This Thesis documents the chemistry towards 
these topologically interesting and unique bio-hybrid species. 
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Chapter Two: Synthesis of N-heterocyclic ligand 
derivatives 
2.1 Design 
As was highlighted in the design aspects described in the previous Chapter, it was of interest 
to prepare metallocyclic products bearing substantial positive charge. One focus of the 
present study was to generate a library of cationic bridging ligand derivatives, from which it 
was hoped that the desired large, multinuclear metal complexes could be synthesised. The 
organocations prepared included a family of ditopic species, each of which incorporate two 
positively charged N-heterocycles, linked by a conformationally flexible spacer unit, as 
outlined in Scheme 2.1. 
 
Scheme 2.1: Diquaternary halide salts were prepared from bis(alkyl halide) (X–spacer–X) and 
N-heterocycle (Y) precursors and could be converted to other salts via anion exchange. 
 
Importantly, these compounds represent a family of ligands which can be engineered in 
terms of their: (i) size – by varying the spacer, (ii) solubility – by varying the counteranion 
(Cl-, Br-, NO3-, ClO4- for H2O-solubility and PF6- for organo-solubility) and (iii) basicity – 
by varying the nature of the donor heterocycle. Four heterocyclic precursors were 
incorporated into dicationic species: 4,4′-bipyridine (4,4′-bipy), pyrazine (pyz), 
aminopyrazine (apyz) and 2-aminopyrimidine (apym). 
 
2.2 Synthesis 
The bridging ligands were conveniently prepared by using adaptations of a procedure 
described by Attalla and co-workers.1 Originally developed for the preparation of 
α,ω-bis(4,4′-bipyridinium)alkane bromide salts, this method can be generalised with respect 
to the N-heterocyclic species, as well as the alkyl halides employed. Briefly, the 
N-nucleophiles displace the halide ions from the substrate in an SN2 manner, a process 
which is undoubtedly favoured by the use of polar aprotic solvents such as DMF and 
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MeCN.2 For the synthesis of dicationic species, the nucleophile is typically used in excess 
(~4 equiv.) in order to promote disubstitution (Scheme 2.2). Despite this, after overnight 
heating and subsequent cooling, the products which had precipitated from solution were 
usually impure. These could be readily crystallised from hot H2O or EtOH/H2O to give 
satisfactory (unoptimised) yields of the halide salts as pure, hygroscopic solids. In general, 
owing to the high aqueous solubility of the halide salts, only small volumes of solvent were 
required for the crystallisations. 
 
Scheme 2.2: Alkylation of N-heterocycles affords organic dications as their halide salts (X = Cl, Br). 
 
The halide ions could be exchanged for NO3-, ClO4- and PF6- in order to generate a suite of 
new ionic compounds. While, as mentioned above, anion exchange has implications in 
terms of ligand solubility, it was performed primarily to eliminate the halide ions, which 
might otherwise compete with the N-donor atoms for metal coordination sites. Typically, a 
halide salt was dissolved in H2O and treated with an aqueous solution of a suitable reagent 
to furnish the new product. For example, reaction of an aqueous halide salt with AgNO3 
solution, followed by removal of AgX by filtration, afforded, upon evaporation of the 
resulting solution, the organic NO3- salt. The ClO4- and PF6- salts were prepared simply by 
treating an aqueous halide salt with saturated aqueous LiClO4 or KPF6, respectively, upon 
which the desired organic ClO4- or PF6- salt precipitated and could be isolated by filtration. 
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The compounds which were prepared in this work are summarised in Table 2.1; new species 
were typically characterised using 1H and 13C{1H} NMR spectroscopy, positive-ion 
electrospray-ionisation mass spectrometry (ESI-MS) and CHN microanalysis. 
 
Table 2.1: The mono-, di- and triquaternary salts prepared in this work. Note: Bn = benzyl, 
tbn = thiabicyclo[3.3.1]nonane, mes(CH2)3 = 2,4,6-tris(methylene)mesitylene. 
 4,4′-bipy pyz apyz apym 
CH3 I- (14), NO3- (15)  
I- (42), NO3- (43), 
PF6- (44) 
I- (56), NO3- (57), 
PF6- (58) 
Bn    
Br- (59), NO3- (60), 
PF6- (61) 
(CH2)2 Br- (16), NO3- (17)   Br- (62) 
(CH2)3 
Br- (18), NO3- (19), 
PF6- (20) 
   
(CH2)4 
Br- (21), NO3- (22), 
PF6- (23) 
Br- (34), PF6- (35)  
Br- (63), NO3- (64), 
PF6- (65) 
(CH2)5  
Br- (36), NO3- (37), 
PF6- (38) 
Br- (45), NO3- (46), 
PF6- (47) 
Br- (66), NO3- (67), 
PF6- (68) 
(CH2)6 
Br- (24), NO3- (25), 
PF6- (26) 
Br- (39), NO3- (40), 
PF6- (41) 
Br- (48), NO3- (49), 
PF6- (50) 
Br- (69), NO3- (70), 
PF6- (71) 
(CH2)8    
Br- (72), NO3- (73), 
PF6- (74), 
1,2-
xylylene 
Br- (27), NO3- (28), 
PF6- (29) 
  
Br- (75), NO3-  (76), 
PF6- (77) 
1,3-
xylylene 
   
Br- (78), NO3- (79), 
PF6- (80) 
1,4-
xylylene 
  Br- (51), PF6- (52) Br- (81), PF6- (82) 
2,6-
lutidylene 
   Cl- (83), NO3- (84) 
(±)-tbn-
2,6-diyl 
Cl- (30), NO3- (31) 
PF6- (32), ClO4- (33) 
   
mes(CH2)3   
Br- (53), NO3- (54), 
PF6- (55) 
Br- (85), NO3- (86), 
PF6- (87) 
 
Indeed, a range of organic spacer components could be incorporated into quaternary salts of 
the four heterocyclic precursors. The spacers shown in Figure 2.1 are ditopic, in that they 
are each able to bear two N-heterocycles. The thiabicyclo[3.3.1]nonane group is a semi-rigid 
bicyclic scaffold, with essentially a fixed angle between substituents (Y) bonded to the C2 
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and C6 atoms. The remaining linkers can be attached to N-heterocycles which are then 
conformationally flexible in terms of the angles between the heterocycles, owing to rotation 
at the methylene junctions. 
 
Figure 2.1: The dications [Y(spacer)Y]2+ prepared incorporated combinations of spacer units and 
heterocyclic species Y. 
 
In addition, monotopic N-methylated and N-benzylated heterocyclic derivatives were also 
prepared as model compounds, representing ‘half’ of a ditopic species. Lastly, the tritopic 
1,3,5-tris(methylene)mesitylene core was also incorporated into new salts. Details, including 
chemical structures of all the compounds of the above type prepared, can be found in the 
Experimental Sections 6.3, 6.6 and 6.7. 
 
2.3 4,4′-Bipyridinium and pyrazinium derivatives 
 
Several ditopic species of the form [4,4′-bipy(CH2)n4,4′-bipy]2+ and [pyz(CH2)npyz]2+ have 
previously been reported, with such cations often featuring in electrochemical3 and 
supramolecular systems.4 Their readily-engineered structure and electron-deficient nature 
allow them to be incorporated into non-covalent charge-transfer complexes with electron-
rich partners. Indeed, they have often served as components in interlocked motifs, such as 
rotaxanes (e.g. 2).5 In addition, there have also been reports on the coordination chemistry of 
these heterocyclic compounds;6 this aspect will be addressed in the next Chapter. 
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The synthesis of the diquaternary 4,4′-bipyridinium salts was carried out according to a 
general procedure, whereby a suitable bis(alkyl halide) was combined with an excess of 
4,4′-bipyridine (4 equiv.) in DMF solution. While this simple method could be employed to 
prepare a range of derivatives, typical 1H NMR spectroscopic analyses of the crude products 
indicated that substantial (~10 – 20%) amounts of impurities were present. While four 
doublets assigned to the 4,4′-bipyridinium groups could be observed, often two further 
doublets were found in the low field region. These doublets were assigned to the symmetric 
species [Br(spacer)4,4′-bipy(spacer)Br]2+ and cyclo-[(4,4′-bipy)2(spacer)2]4+, both of which 
could be removed by recrystallisation from H2O to afford the bis(4,4′-bipyridinium) salts as 
pure solids. 
 
One example of a diquaternary species was structurally characterised. Slow evaporation of 
an aqueous solution containing [4,4′-bipy((±)-tbn-2,6-diyl)4,4′-bipy]Cl2 (30) afforded 
colourless single crystals suitable for an X-ray structure determination. The salt was found 
to crystallise as a racemic twin; the molecular structure of the enantiomer [4,4′-bipy(tbn-
2S,6S-diyl)4,4′-bipy] is given in Figure 2.2. 
N(1)
N(2)
N(3)
N(4)
C(2)
C(1)
C(3)
C(4)
C(5)
C(6) C(7) C(8)
C(9)
C(10)
C(11)
C(12)C(13)
C(14) C(15)
C(16)
C(17)
C(18)
C(19)C(20)
C(21)
C(22)
C(23)C(24)
C(25)
C(26)
C(27)
C(28)
S(1)
Figure 2.2: ORTEP of 30, with ellipsoids at the 50% probability level. H2O solvate molecules and the Cl- 
anions are omitted for clarity. 
 
As expected, the analysis confirmed the substitution at C2 and C6 to afford the chiral 
bis(4,4′-bipyridinium) dication. Importantly, the reaction was found to proceed with the 
retention of stereochemistry, due to the anchimeric assistance of the neighbouring 
nucleophilic S atom.* This results in the mean planes of the two 4,4′-bipy groups being  
approximately 120° apart. A structure for this dication (as its PF6- salt, 32) has previously 
                                               
*
 This occurs by intramolecular SN2 displacement of Cl- by the thioether group to give a sulfenium 
intermediate, which is reactive towards the 4,4′-bipy nucleophile. 
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been reported by Stang and co-workers,7† although 32 was found to crystallise in an achiral 
(Cmcm) space group owing to the disorder present in the dication. 
 
As with the bis(4,4′-bipyridinium) derivatives mentioned above, bis(pyrazinium) species of 
type [pyz(CH2)npyz]2+ (n = 4, 5, 6) could also be prepared as their Br-, NO3- and PF6- salts, 
which were characterised using the techniques mentioned above. In particular, 13C{1H} 
NMR spectra of these species revealed one-bond coupling between adjacent sp2-hybridised 
14N and 13C atoms. This results in a 1 : 1 : 1 triplet 13C resonance (1JC,N ≈ 8 Hz), which was 
not observed in the NMR spectra of bis(4,4′-bipyridinium) salts. Owing to the poor donor 
ability of these ligands towards palladium(II) and platinum(II) (see Chapter Three), only a 
limited number of analogues were prepared during the course of this study. 
 
2.4 3-Aminopyrazinium derivatives 
Species of the formula [apyz(CH2)napyz]2+ have been 
reported previously, their syntheses being analogous to 
those discussed above.8 Such dications result from the 
alkylation of aminopyrazine at N4, which is less 
sterically hindered than N1.‡ Comparatively little 
research has been conducted on these α,ω-bis(3-aminopyrazinium)alkane species, relative to 
[4,4′-bipy(CH2)n4,4′-bipy]2+ and [pyz(CH2)npyz]2+ derivatives. 
 
Several bis(3-aminopyrazinium) species and one tris derivative were prepared and 
characterised in this work. 1H NMR spectroscopic analysis of the Br- and NO3- salts in D2O 
revealed that the amino protons readily exchange with the solvent, although these protons 
can be detected as broad singlets when the PF6- salts are studied in CD3CN. As with the 
bis(pyrazinium) salts, these species exhibited 1JC,N coupling, with the presence of triplets in 
their 13C{1H} NMR spectra.8 
                                               
†
 This ligand could be incorporated into large hexagonal dodecaplatinum(II) complexes similar to 12.7 
‡
 The amino group is less nucleophilic owing to its lone pair being in conjugation with the aromatic π-system. 
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The organic salts prepared in this work, in particular the 
amino derivatives, allowed for the detection of several ions 
using positive-ion ESI-MS. For example, when the 
triquaternary species [mes(CH2apyz)3](PF6)3 (55) was 
subjected to these conditions, a progression of gas phase 
ions, resulting from the loss of PF6- and H+, was detected 
(Figure 2.3). The acidity of the amidine groups conjugated 
to the quaternary centres undoubtedly allows for this 
progression of resonance-stabilised ions to be observed. 
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Figure 2.3: The low resolution positive-ion ESI mass spectrum of [mes(CH2apyz)3](PF6)3. 
 
Interestingly, ions corresponding to the loss of apyz groups were also observed, suggesting 
that fragmentation was occurring. Indeed, MS/MS analysis was performed in this example, 
confirming the decomposition of [55 – PF6-]+ to the daughter ions [55 – apyz – 2PF6- – H+]+ 
and [55 – apyz – 3PF6- – 2H+]+. The fragmentation and resulting loss of heterocycles was 
also observed when apym derivatives were studied by ESI-MS, although no MS/MS 
analyses were conducted for these species. 
 
One aminopyrazinium salt, the simple methylated species [Meapyz]NO3 (43), was 
characterised by an X-ray structure determination. Slow evaporation of an aqueous solution 
containing [Meapyz]NO3 afforded colourless single crystals, crystallographic analysis of 
which resulted in the molecular structure given in Figure 2.4. 
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Figure 2.4: ORTEP of 44, with ellipsoids at the 50% probability level (left) and a diagram depicting the 
solid state packing (right). 
 
The structure of [Meapyz]NO3 is largely unremarkable with, as expected, the amino N atom 
having a trigonal planar geometry (sp2-hybridisation) owing to its conjugation with the 
aromatic π-system. Interestingly however, the distances between the aromatic ring and NO3- 
anion (rcentroid-O(1) = 3.09 Å, rN(2)–N(4) = 3.07 Å) suggest the presence of anion-π interactions 
in the solid state. Interactions of this type have attracted recent attention due to their variable 
nature and their use in the binding of anions.9 The NO3- anions also participate in H-bonding 
interactions with the amino groups, which serve to link the [Meapyz]+ species into a 1-D 
helical polymer along the crystallographic c-axis. 
 
2.5 2-Aminopyrimidinium derivatives 
2.5.1 General 
In contrast to the other three heterocyclic precursors used in the 
present study, of which there are several reported ditopic 
(cationic) derivatives, 2-aminopyrimidine has not, to the best of 
the author’s knowledge, been incorporated into such 
compounds. Diquaternary halide salts could be readily prepared 
by heating DMF solutions containing 2-aminopyrimidine and suitable bis(alkyl halide) 
derivatives, affording the new compounds as pure solids without the need for 
recrystallisation. Although the amino group of 2-aminopyrimidine sterically hinders access 
to the more nucleophilic pyrimidine N atoms, this electron-donating substituent forms part 
of a guanidine moiety which was found to be highly reactive towards the alkyl halides 
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employed. Indeed, the yields observed for these reactions were typically higher than those 
obtained when the other N-heterocyclic nucleophiles were used. 
 
As was the case for the apyz derivatives, one monotopic apym derivative [Bnapym]PF6 (61) 
was characterised in the solid state. Colourless single crystals of this compound formed 
upon slow evaporation of a saturated aqueous KPF6 solution containing the Br- salt. The 
X-ray structure of this representative 2-aminopyrimidinium derivative is given in Figure 2.5. 
 
Figure 2.5: ORTEP of 61, with ellipsoids at the 50% probability level and PF6- omitted for clarity. 
 
As expected, the benzyl group is bound directly to the pyrimidine heterocycle at N(1) rather 
than through the amino N(2) atom. The latter has a trigonal planar geometry, which was also 
the case in [Meapyz]NO3. Inspection of the crystal packing in 61 (Figure 2.6) reveals the 
presence of [Bnapym]+ dimers, each of which is held together by two H-bonds. These 
dimers are linked by H-bonded PF6- anions to form 1-D chains which propagate along the 
crystallographic b-axis.§ 
 
Figure 2.6: The solid state packing of 61, in which [Bnapym]+ cations form dimers linked by N–H···N 
H-bonds.  These dimers bind PF6- anions by electrostatic interactions, as well as C–H···F and N–H···F 
H-bonds to afford 1-D ribbons. Three PF6- anions are omitted for clarity. 
                                               
§
 It is possible that these extensive H-bonding interactions are responsible for the lower solubility of some 
2-aminopyrimidinium derivatives relative to the other quaternary salts. 
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In some cases, including when species incorporating aryl (e.g. xylylene) spacer groups were 
prepared, 2-D NMR techniques, including 1H-1H correlation spectroscopy (COSY), were 
used to aid in the assignment of 1-D NMR spectra. COSY allows for the identification of 
spin systems of coupled nuclei, which are observed as cross-peaks in the 2-D spectra. This 
was particularly useful when information regarding 1H-1H coupling could not be extracted 
due to poor spectral resolution. An example, in the case of [apym(m-xylylene)apym]Br2 
(78), is provided in Figure 2.7. 
 
Figure 2.7: Partial 1H NMR spectrum (left) and 1H-1H COSY spectrum (right) of 
[apym(m-xylylene)apym]2+  recorded in D2O at 300 MHz (residual DMF solvate present). 
 
Crosspeaks (circled) between the pyrimidyl protons H4, H5 and H6 allow for these to be 
correlated and correctly distinguished from the xylylene aryl protons H2′, H4′ and H5′.**  
 
2.5.2 Dimroth rearrangement of 2-aminopyrimidinium species 
Some organic cations derived from 2-aminopyrimidine exhibited interesting reactivity in 
aqueous solution. Crude (~80%) 1,2,4,5-tetrakis[1-(2-aminopyridinium)methyl]benzene 
bromide (88) was prepared from 1,2,4,5-tetrakis(bromomethyl)benzene and 
2-aminopyrimidine. Recrystallisation of the white solid was effected from warm H2O. The 
product which was isolated, rather than being the pure target material, was found to be a 
product of lower symmetry, owing to the greater number of resonances in its 1H NMR 
spectrum. This is most likely a result of two of the 2-aminopyrimidinium groups undergoing 
Dimroth rearrangement10 (Scheme 2.3) to give a mixture of products, including 89. 
                                               
**
 The amino protons of such cations exchange with D2O. Also, the 2-aminopyrimidinium derivatives often 
contained DMF solvate, in some cases even after crystallisation from H2O. 
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Scheme 2.3: Half the apym heterocycles in a tetra- (top) and disubstituted (centre) aryl-linked derivative 
undergo Dimroth rearrangement via hydrolysis and condensation (bottom).10 
 
A similar reaction occurred when [apym(o-xylylene)apym]Br2 (75) was treated with warm 
aqueous AgNO3 with the intention of generating the NO3- salt. Removal of AgBr by 
filtration and concentration of the resulting solution afforded colourless single crystals. 
1H NMR spectroscopic analysis of these suggested the product was of a lower symmetry 
than would be expected for [apym(o-xylylene)apym]2+. A suitable crystal was analysed by 
X-ray diffraction and the molecular structure of the product (90) confirmed (Figure 2.8). 
 
Figure 2.8: ORTEP of 90, with ellipsoids at the 50% probability level. Three H2O solvate molecules and 
the NO3- anion are omitted for clarity. 
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Indeed, it was found that one of the two apym ‘arms’ had undergone rearrangement to 
furnish a monocation in which the pyrimidine rings were non-equivalent. Thus, the 
ortho-xylylene spacer is now attached to the rearranged arm at N(4), which, by virtue of the 
Dimroth reaction, is a secondary amine. The result can be viewed as being equivalent to 
‘half’ of the tetrasubstituted case 89. Further details and a description of the crystal packing 
can be found in the Appendices (Section A.3). 
 
Surprisingly, the presence of AgNO3 was found to be necessary for the o-xylylene 
derivative to rearrange, as the Br- salt does not undergo rearrangement in boiling H2O. This 
can perhaps be attributed to the presence of trace Ag2O acting as a base and catalysing the 
reaction. However, the meta- and para-xylylene, as well as 1,3,5-tris(methylene)mesitylene-
linked analogues, when subjected to the same conditions, did not undergo rearrangement.†† 
Indeed, this reaction occurs in order to relieve steric strain between the 
2-aminopyrimidinium group and a large ortho substituent, and thus does not proceed in 
neutral H2O for other substitution patterns. The rearrangement of the ortho derivative could 
not be reproduced and further synthetic attempts resulted only in the formation of 
[apym(o-xylylene)apym](NO3)2 (76), the intended target of the original procedure. 
 
The Dimroth rearrangement has been known to proceed via a simple hydrolysis and imine 
condensation route, depicted in Scheme 2.3 above. In the case of l,2-dihydro-2-imino-1-
alkylpyrimidines (which are tautomers of 1-alkyl-2-aminopyrimidines), basic conditions are 
required,10 although no added base was used in the cases above. It is likely that this reaction 
is promoted by the presence of either acid or base to activate the neutral l,2-dihydro-2-
imino-1-alkylpyrimidine species toward rearrangement. Consequently, the salts prepared in 
the present study, which are conjugate acids of such species, may spontaneously rearrange 
when heated in aqueous solution. 
 
2.5.3 Rearrangement under basic conditions 
Having fortuitously induced a rearrangement in some 2-aminopyrimidinium compounds, it 
was of interest to effect the conversion in a more efficient and reproducible manner, and 
also induce rearrangement of all the 2-aminopyrimidinium groups, rather than just one of 
two ortho substituents. Selected 2-aminopyrimidinium derivatives were subjected to heating 
under typical Dimroth conditions (1 M NaOH, 60°C) and were found to afford secondary 
                                               
††
 [Bnapym]Br also failed to undergo rearrangement in neutral H2O solution. 
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amine products cleanly. In each case, the precursor salt was suspended in basic solution 
upon which it immediately became yellow. After heating, the product could be isolated by 
centrifugation. As expected, the rate of reaction was found to depend on the steric bulk 
surrounding the 2-aminopyrimidinium centres. Notably, the ortho species 
[apym(o-xylylene)apym]Br2 (75) underwent complete rearrangement to 91 within 2 h,‡‡ 
while in the case of the para analogue [apym(p-xylylene)apym]Br2 (81) the formation of 92 
was incomplete after 2 h (indeed, 24 h was required). A series of secondary amine products 
91 – 96 was prepared under the Dimroth conditions. 
 
In contrast to their charged precursors, these solid compounds are largely insoluble in many 
polar solvents such MeOH and H2O. While it is likely that these species have the propensity 
to form metal complexes, these compounds were not investigated further. 
 
2.6 Larger ligand derivatives 
The simple procedure employed in the synthesis of diquaternary salts can be repeated to 
generate much larger and more positively charged bidentate ligand species. This is 
particularly the case for 4,4′-bipyridinium derivatives, for which it is expected that the 
nucleophilicity of the free N atoms, owing to their remoteness from the quaternised centres, 
                                               
‡‡
 Gondi and co-workers attempted to synthesise this compound directly from 2-aminopyrimidine and 
1,2-bis(bromomethyl)benzene using NaH as the base. However, their conditions were found to result in the 
formation of 2-pyrimidin-2-yl-2,3-dihydro-1H-isoindole, rather than the intended product. In this context, 
1,2-bis(aminomethyl)benzene and 2-chloropyrimidine are probably more logical precursors. 
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is quite substantial. For example, the diquaternary salt 1,1′-bis(4-bromobutyl)-4,4′-
bipyridinium bromide ([Br(CH2)44,4′-bipy(CH2)4Br]Br2, 97) could be prepared from 
4,4′-bipyridine and 1,4-dibromobutane11 (Scheme 2.4; pentylene and hexylene species were 
also prepared in this work). 
 
 
Scheme 2.4: The preparation of tetraquaternary salts via successive N-alkylation reactions. 
 
Another iteration of the alkylation procedure, namely the reaction of this species with 
excess 4,4′-bipyridine, afforded the potential bridging ligand [4,4′-bipy(CH2)44,4′-
bipy(CH2)44,4′-bipy]Br4 (100), from which the Br- ions could be exchanged to furnish the 
NO3- (102) and PF6- salts (103). 
 
The hexylene analogues (n = 6; 101: Br- salt; 104: NO3- salt; 105: PF6- salt) could be 
prepared in much the same way12§§ and, in each case, among other analyses, 1H NMR 
spectroscopy confirmed the structures of the tetraquaternary products. Most diagnostic was 
the presence of six low-field doublet resonances in the range δ 9.2 – 7.9 ppm, each resulting 
from six unique pyridine/pyridinium 1H environments. When ESI-MS analysis of the salts 
was conducted, several cations could be identified in the gas phase. For example, in the case 
of the tetraquaternary salt [4,4′-bipy(CH2)64,4′-bipy(CH2)64,4′-bipy](NO3)4 (103), the ions 
[2M – NO3-]+, [5M – 3NO3-]3+, [3M – 2NO3-]2+, [4M – 3NO3-]3+, [M – NO3-]+ and             
[M – 2NO3-]2+ could all be observed under the ionisation conditions employed. Further 
details of the six compounds 100 – 105 of type [4,4′-bipy(CH2)n4,4′-bipy(CH2)n4,4′-bipy]X4 
(n = 4, 6; X = Br, NO3, PF6) prepared during the course of this study can be found in 
Section 6.6. 
                                               
§§
 Attempts to reproduce the synthesis of the related (larger) dodecylene bromide salt were unsuccessful. 
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The simple quaternisation reactions have been employed by Summers and co-workers to 
generate extremely large structures, such as the decaquaternary salt [4,4′-bipy(CH2)44,4′-
bipy(CH2)44,4′-bipy(CH2)44,4′-bipy(CH2)44,4′-bipy(CH2)44,4′-bipy](ClO4)10 (106).3 This 
compound represents a potentially useful bidentate ligand derivative, and if longer 
oligo(methylene) spacers could be incorporated into the motif then even larger ligands could 
be accessed. 
 
The author’s attempts to prepare these salts found little success even when oligo(methylene) 
spacers of varying lengths were employed. Typically, an intractable mixture of products was 
generated and a clean separation could not be achieved by repeated recrystallisation. It was 
noted that the ClO4- salts which resulted from the syntheses have poor aqueous solubility at 
room temperature, although anion exchange could possibly afford more soluble products if 
the initial syntheses could be achieved. Presumably, this lack of solubility limits the number 
of quaternary centres that can be incorporated into such species. 
 
2.7 Concluding remarks 
The approach adopted in the present study has resulted in the preparation of several new 
flexible, cationic N-heterocyclic derivatives. Four examples were characterised by X-ray 
structure determinations. In the case of the amino derivatives, the analyses revealed 
H-bonding and anion-π interactions in the solid state and, not surprisingly, several 
compounds closely related to these have been shown to be potent anion-binding agents.13 
 
2-Aminopyrimidinium salts were investigated in terms of their potential to undergo Dimroth 
rearrangement. It was found that this can occur in aryl-linked species with two ortho 
1-(2-aminopyrimidinium)methyl groups, even in neutral aqueous solution. The reaction was 
generalised to a wide range of substrates, which, when subjected to basic solution, were all 
found to undergo complete rearrangement. 
Given the family of multidentate N-donor ligands synthesised, it was envisaged that the 
interaction of these species with selected metal ions should give rise to a range of 
multinuclear complexes with varying sizes and solubility properties. Indeed, 
conformationally flexible heterocyclic bridging ligands have been identified as having the 
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potential to afford new classes of metal complexes not available from rigid polyaromatic 
ligands.14 The coordination chemistry of the new ligands described above will be discussed 
in the following Chapter. 
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Chapter Three: Synthesis of palladium(II) and platinum(II) 
complexes  
3.1 Background 
In terms of the present study, it was of interest to integrate cationic N-donor bridging 
ligands into highly-charged multinuclear metal complexes. Ligands possessing 
conformational flexibility are more likely to afford architectures whose structures are 
concentration independent, when compared to their rigid counterparts. Despite this, the use 
of the latter is more widespread in supramolecular chemistry, although employing such 
ligands can often lead to complicated equilibria in which the free energies of several species 
(often of the same empirical formula but of varying nuclearity, e.g. square/triangle systems) 
are similar, owing to the entropic and enthalpic changes having comparable magnitudes.1 
 
It was anticipated that flexible bridging ligands might reliably form multinuclear complexes, 
and that these might be of sufficient size to encircle duplex DNA. With respect to metal 
complexation in aqueous solution, the most relevant of the organic ligands discussed in the 
previous Chapter are the (H2O-soluble) diquaternary NO3- salts. This is because, as 
mentioned earlier, the poor donor ability of NO3- ions causes them to be unlikely to compete 
with the N-donor ligands for metal complexation. In parallel, the coordination chemistry of 
selected PF6- salts was also studied in this work, although these compounds are typically 
only soluble in organic media such as MeCN and Me2CO. 
 
The metal ions chosen for complexation to the heterocyclic cations, palladium(II) and 
platinum(II) (d8), were selected for their propensity to form stable, well-defined square-
planar complexes with N-donor ligands.2 This thermodynamic stability was considered 
necessary to counteract the Coulombic repulsion between the metal ions and cationic 
bridging ligands. The precursors used typically have two coordination sites occupied by 
strongly-bound ligand donor atoms, with the remaining sites featuring two more weakly 
interacting ligands. The latter were to be substituted by the N-donor ligands being studied. 
Often, the weakly-bound ligands take the form of O-donors such as NO3- or OTf- 
(trifluoromethanesulfonate, triflate) anions, which are displaced by pyridine ligands in a 
highly exothermic reaction, with only a small associated entropic penalty (Scheme 3.1). The 
associated binding constants, which are in the order of 106 M-1, imply that the complexation 
is essentially quantitative at typical NMR concentrations (>10 mM).3 
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Scheme 3.1: Successive binding constants for pyridine ligands and cis-ditriflato complexes in CHCl3 
solution.3 
 
Just as both aqueous- and organo-soluble ligands were prepared in this work, a variety of 
labile metal complex precursors were also employed, which exhibited solubility in either of 
these media (Figure 3.1). 
 
Figure 3.1: The metal complex precursors used in the present study. Labile ligands are highlighted in 
red (phen = 1,10-phenanthroline; dppp = 1,3-bis(diphenylphosphino)propane). 
 
Two complexes depicted in Figure 3.1 bear benzonitrile ligands, which are weakly-bound 
owing to the poor donor ability of the sp-hybridised N atoms. It was expected that this 
would cause them to be easily displaced by the sp2-hybridised N atoms of the bridging 
diquaternary N-heterocyclic ligands. 
 
Experiments were carried out by using a number of metal precursor/bridging ligand 
combinations. In each case, characterisation of the product(s) was attempted by using NMR 
spectroscopy. In particular, for platinum(II) complexes, use was also made of 195Pt NMR, a 
technique which can provide valuable information regarding the nature of the coordination 
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environment of 195Pt nuclei (33.8% abundant, I = ½). 195Pt resonances are found over a wide 
chemical shift range (15,000 ppm) and consequently each unique 195Pt environment should 
give rise to a unique signal.4* All reaction products were also subjected to positive-ion 
ESI-MS and, in some cases, characterised by CHN microanalysis and UV-vis spectroscopy. 
 
3.2 Complexes of bis(4,4′-bipyridinium) and bis(pyrazinium) 
derivatives 
In order to assess whether cyclic species might form from bridging ligands of the type 
[4,4′-bipy(CH2)n4,4′-bipy](NO3)2, the coordination of these to [M(2,2′-bipy)(NO3)2] 
(M = Pd, Pt) was investigated (Scheme 3.2). These complexes typically exist as the diaqua 
species [M(2,2′-bipy)(OH2)2]2+ in H2O solution5 and are generally very reactive towards 
N-donor ligands. 
 
Scheme 3.2: The formation of dinuclear [2 + 2] complex species incorporating two [M(2,2′-bipy)]2+ 
fragments and two [4,4′-bipy(CH2)n4,4′-bipy]2+ bridging ligands. 
 
Typically, addition of D2O to an equimolar mixture of the alkyl-bridged 4,4′-bipyridinium 
NO3- salt [4,4′-bipy(CH2)n4,4′-bipy](NO3)2 (n = 4, 6) and [M(2,2′-bipy)(NO3)2] was 
followed by heating at 80°C, which caused dissolution (and reaction) of the dinitrato 
complex. The reaction mixture was monitored by 1H NMR spectroscopy and the spectrum 
exhibited a single set of resonances after 24 h or 48 h heating (for palladium(II) and 
platinum(II), respectively). This is consistent with the formation of a single product 
                                               
*
 For example, resonances for platinum(II) ions existing in a N4 coordination environment typically appear 
between δ –2200 and –2800 ppm, relative to Na2[PtCl6]. 
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possessing high symmetry. The complexes could be isolated as PF6- salts; data for 
[4,4′-bipy(CH2)44,4′-bipy]2+ and its (2,2′-bipyridyl)palladium(II) complex are given in 
Figure 3.2. 
PPM 9.2 9.0 8.8 8.6 8.4 8.2 8.0 7.8 7.6 7.4
 
Figure 3.2: Partial 1H NMR spectra of [4,4′-bipy(CH2)44,4′-bipy](PF6)2 (top) and [Pd2(2,2′-bipy)2{4,4′-
bipy(CH2)44,4′-bipy}2](PF6)8 (bottom) recorded in CD3CN at 300 MHz (assignments supported by 
COSY).  Note the changes in atom numbering between the free ligand and the metal complex. 
 
The protons α- to the non-quaternary N atoms (H2′ in the free ligand, H2 in the complex) 
were found to resonate at lower field upon reaction with palladium(II) (∆δ = 0.48 ppm). This 
is diagnostic of ligation to the electrophilic metal centres and is consistent with, but not 
necessarily indicative of, dinuclear complex formation. Indeed, while NMR analysis can 
often confirm the symmetry of metallosupramolecular species, it provides no evidence 
regarding nuclearity.3 This is often gleaned from ESI-MS data, although ions corresponding 
to intact dinuclear complexes were not observed when the NO3- salts were subjected to such 
analysis, with only smaller cationic fragments being detected.† Samples of each compound 
were converted to PF6- salts with saturated aqueous KPF6 and it was anticipated that MS 
analyses of these salts would be more successful. Typically, PF6- ions associate with 
cationic species more weakly than NO3- ions, allowing for better characterisation. 
Additionally, PF6- salts are soluble in Me2CO or MeCN solvents, which, owing to their 
greater volatility, can be more amenable to MS analysis than H2O or H2O/MeOH. Despite 
this, successful analysis could only be achieved in the case of 
[Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2](PF6)8 (the PF6- salt of 110), for which the intact 
complex ions [110 – 2PF6-]2+ (m/z 1182.153886, calcd 1182.156840) and [110 – 3PF6-]3+ 
(m/z 739.781613, calcd 739.782983) were observed in the ESI-FT-ICR (electrospray 
ionisation Fourier transform ion cyclotron resonance) mass spectrum. This high-resolution 
                                               
†
 For example, in the case of the NO3- salt of 110, ESI-MS: m/z 930.70 [Pt(2,2′-bipy){4,4′-bipy(CH2)64,4′-
bipy}](NO3)3+, 670.47 [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}](NO3)42+. 
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technique can often be used for the unambiguous assignment of multinuclear species6 and 
was used in the present study to confirm low-resolution ESI-MS data of metal complexes, 
when intact species could be observed using this method. It was considered likely that, by 
analogy, complexes of formula [M2(2,2′-bipy)2{4,4′-bipy(CH2)n4,4′-bipy}2](PF6)8 (n = 4, 6; 
M = Pd, Pt), each incorporating two metal ions and two bridging ligands, are the products in 
the remaining three systems. Further details of 107 – 110, which were isolated and 
characterised as their PF6- salts, can be found in the Experimental section. When the 
H2O-soluble NO3- salts were required (e.g. for DNA-binding; see Chapter Four), aqueous 
solutions of the dinuclear complexes, instead of being treated with KPF6, were evaporated to 
dryness to give the desired compounds as glassy yellow solids. 
 
As was mentioned above, the coordination chemistry of the NO3- salts was investigated in 
aqueous solution. In parallel, the organo-soluble PF6- salts of the organocations were also 
combined with complex precursors to see whether related dinuclear species could form. 
Equimolar mixtures of the bridging ligand and a suitable complex precursor (in this case 
either [Pt(dppp)(OTf)2], cis-[Pt(PhCN)2Cl2] or [Pd(PhCN)2Cl2]) were heated in CD3CN. 
The Pd(II)/Pt(II) precursors employed were chosen based on their organo-solubility and it 
was expected than the phosphine and chlorido ligands might labilise the weakly-bound 
ligands trans to these (triflato and benzonitrile, respectively), perhaps resulting in rapid 
formation of the thermodynamic product(s) in each case. The syntheses of three examples of 
dinuclear metallocycles [Pt2(dppp)2{4,4′-bipy(o-xylylene)4,4′-bipy}2](PF6)4(OTf)4 (111), 
cis-[Pt2Cl4{4,4′-bipy(o-xylylene)4,4′-bipy}2](PF6)4 (112) and cis-[Pd2Cl4{4,4′-
bipy(CH2)34,4′-bipy}2](PF6)4 (113) were attempted from [Pt(dppp)(OTf)2], 
cis-[Pt(PhCN)2Cl2] and [Pd(PhCN)2Cl2], respectively. While 111 and 113 could be 
successfully prepared and characterised using 1H NMR spectroscopy, ESI-MS and CHN 
microanalysis, the 1H NMR data for 112 suggest that it is contaminated with a side product 
(~30%) that remains present even after extended heating of a CH3CN solution containing 
cis-[Pt(PhCN)2Cl2] and [4,4′-bipy(o-xylylene)4,4′-bipy](PF6)2. The nature of this side 
product could not be determined, although CHN analytical results for the crude solid 
isolated suggest that it is likely to have the same empirical formula as 112. 
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During the course of this work, Quintela and co-workers reported the preparation of the 
closely-related dinuclear metallocyclic complexes 114 and 115.7 It was found that these 
species could be integrated into catenane topologies, owing to the ability of the metallocycle 
to bind electron-rich organic macrocycles such as dibenzo-24-crown-8 (DB24C8). 
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In contrast to the bis(4,4′-bipyridinium) salts, the bis(pyrazinium) analogues were found to 
be unreactive towards the palladium(II) or platinum(II) complex precursors employed in this 
work. In each case, the combination of bis(pyrazinium) species and metal complex resulted 
in only the starting materials being observed by 1H NMR spectroscopy and ESI-MS. It 
appears that the [pyz(spacer)pyz]2+ species are substantially deactivated relative to their 
analogues incorporating 4,4′-bipy, in which the quaternised N atoms are further removed 
from the Lewis basic N atoms. It is possible that the pyrazinium deriatives are only useful 
for coordination to a metal ion when the resulting complexes exhibit significant 
π-backbonding into unfilled ligand-centred π* orbitals (e.g. pentammineruthenium(II) 
derivative 116)8 and/or where electrostatic interactions might play a key role (e.g. dinuclear 
pentacyanoferrate(II) complex 117).9 
 
Chapter Three: Synthesis of palladium(II) and platinum(II) complexes 
44 
3.3 Complexes of 3-aminopyrazinium derivatives 
It was envisaged that bis(3-aminopyrazinium) derivatives might be incorporated into 
dinuclear platinum(II) complex species in much the same way as the bis(4,4′-bipyridinium) 
ligands described above. While the electron-donating amino substituents positioned ortho to 
the free heterocyclic N atoms undoubtedly increase the basicity of these atoms, it was 
originally believed that the amino groups would not take part in metal complexation (see the 
discussion of [Pt(2,2′-bipy)(2-aminopyridine)2](NO3)2 below). Thus, when equimolar 
amounts of [apyz(spacer)apyz](NO3)2 and [Pt(2,2′-bipy)(NO3)2] were combined in aqueous 
solution, dinuclear complexes of the type [Pt2(2,2′-bipy)2{apyz(spacer)apyz}2]8+ (118) were 
expected to form (Scheme 3.3). 
 
Scheme 3.3: The bis(3-aminopyrazinium) salt 49 did not lead to the formation of a dinuclear [2 + 2] 
metallocycle (top) but rather a tetranuclear complex exhibiting Pt(II)···Pt(II) interactions. 
 
Heating a D2O suspension containing equimolar [apyz(CH2)6apyz](NO3)2 and 
[Pt(2,2′-bipy)(NO3)2] effected dissolution of the starting materials and resulted in a clear 
orange solution, rather than the pale-yellow one expected. The solution became red upon 
further heating, with 1H NMR analysis suggesting a complex mixture of species, including 
free [apyz(CH2)6apyz]2+, was present. ESI-FT-ICR-MS analysis of a solution treated with 
saturated aqueous KPF6 was consistent with the presence of a tetranuclear species 
[Pt4(2,2′-bipy)4{apyzC6H12apyz–2H}2](PF6)8 incorporating two quadruply-bridging 
zwitterionic ligands (m/z 891.768992, calcd 891.768257 [M – 3PF6-]3+). The deprotonation 
of the bis(3-aminopyrazinium) species allows them to bind four platinum(II) ions, each of 
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which are equivalent according to 195Pt NMR spectroscopic data (δ –2361 ppm is consistent 
with an N4 coordination sphere). The binding of each (2,2′-bipyridine)platinum(II) centre to 
a pyrazine N atom as well as an amido N atom is necessary in order to satisfy the identical 
coordination spheres of the platinum(II) ions. 
 
Further evidence for the tetradentate nature of the flexible ligands could be obtained from 
the UV-vis spectrum of this compound, which features an absorption at 428 nm, assigned to 
metal-metal-to-ligand charge transfer (MMLCT).10 The Pt(II)···Pt(II) and π–π interactions 
present in the [Pt2(2,2′-bipy)2]4+ moieties give rise to this absorption (resulting in the deep 
red colour of this complex) and stabilise the octacationic species.‡ Each of the 
[Pt2(2,2′-bipy)2]4+ groups can be referred to as “head-to-tail” dimers because each 
platinum(II) ion is bound to nonequivalent atoms in the bridging ligands. As the formula of 
the tetranuclear complex suggests, it can be prepared using a 2 : 1 (Pt : bridging ligand) 
molar ratio of the precursors, in which case only one set of hexylene signals is observed for 
the reaction mixture (i.e. no free ligand is present). A possible structure for the product is 
pictured above (119) but given the complexity of the 1H NMR spectrum (the low field 
region of which could not be assigned) this could not be confirmed as the identity of the 
complex.§ 
 
Metal-metal interactions of the above type are not uncommon for d8 ions,11 and certain 
arrangements of metal centres, including those involving the stacking of such metallodimers 
in infinite 1-D chains, can give rise to anisotropic materials with unique optical properties.12 
Such interactions have been analysed in terms of molecular orbitals and the overlap of filled 
dz2 orbitals is known to be involved in the interactions.13 
 
The formation of species incorporating [Pt2(2,2′-bipy)2]4+ fragments is well-documented, 
and several reports exist of these bridged structures. For example, Sakai and co-workers 
found that [Pt(2,2′-bipy)(2-aminopyridine)2](NO3)2 (120) could be prepared from 
[Pt(2,2′-bipy)(NO3)2] and 2-aminopyridine (Scheme 3.4).14 However, this species was 
shown to decompose in supercritical H2O to afford the Pt(II)···Pt(II) bonded species 
[Pt2(2,2′-bipy)2(2-aminopyridinato)2](NO3)2 (121) and free 2-aminopyridinium.10 This 
                                               
‡
 No reaction products could be successfully identified when bis(3-aminopyrazinium) salts were treated with 
[Pd(2,2′-bipy)(NO3)2], perhaps suggesting that strong metal-metal interactions are required to stabilise the 
reaction products. Similar results were obtained when bis(2-aminopyrimidinium) salts were used (vide infra). 
§
 Another possible structure satisfying the data is a double helix, which differs to that given (119) by the 
inversion of the chirality at one metal centre (resulting in a ‘twist’ in the bridging ligands). 
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species, owing to the “head-to-tail” arrangement of ligands, is chiral, and it is expected that 
a racemic mixture would form under the conditions employed. 
 
Scheme 3.4: The formation of a head-to-tail diplatinum(II) complex from a simple mononuclear 
derivative in supercritical H2O. 
 
In terms of the present study, the increased acidity of the aminopyrazinium groups, relative 
to 2-aminopyridine, is the likely reason why supercritical conditions are not required when 
these ligands are employed. As a consequence, the facile formation of 119 from the possible 
intermediate 118 hinders the spectroscopic detection of the latter species.** This is in 
contrast to the example reported by Sakai, in which the intermediate could be isolated. 
 
In order to compare the aqueous reactivity of aminopyrazinium ligands to that of 
2-aminopyridine, the chemistry of a simple ligand incorporating one (instead of two) 
heterocycles was studied.  Heating an equimolar suspension of [Pt(2,2′-bipy)(NO3)2] and 
[Meapyz](NO3) (43) in D2O gave rise to a red solution in which the dinuclear  complex 
[Pt2(2,2′-bipy)2(Meapyz–H)2](NO3)4 was the major product (Scheme 3.5). 
 
Scheme 3.5: Formation of a diplatinum(II) complex with the bridging amidinato-like Meapyz-H ligand. 
 
Although parent ions of 122 (or its PF6- salt) could not be observed using ESI-MS, NMR†† 
and UV-vis spectroscopic as well as CHN microanalytical data are consistent with the 
                                               
**
 Heating of the mixture is necessary in order to dissolve [Pt(2,2′-bipy)(NO3)2]. This heating would also cause 
any 118 which might form to convert rapidly to 118. 
††
 A very complex 1H NMR spectrum, similar to that of 119, was obtained. The structure presented for the 
product (122) represents one of the enantiomers that may form. 
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expected structure. Of particular interest are the λMMLCT (Figure 3.3) and δ(195Pt) values for 
the di- and tetranuclear complexes, which are almost identical. 
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Figure 3.3: UV-vis spectra for the platinum(II) complexes 119 and 122. In addition to ligand 
absorptions at ~300 nm, MMLCT bands (which, as expected, have εtetranuclear > εdinuclear) were observed at 
~440 nm. 
 
As with the other ligand types, the coordination chemistry of organo-soluble derivatives was 
also explored, in order to compare their behaviour to that in aqueous solution. However, it 
was found that the PF6- salts of 3-aminopyrazinium ligands were not reactive towards the 
palladium(II) and platinum(II) precursor complexes used in the present study. It was thought 
that the use of a suitable base was necessary in order to induce deprotonation of the amino 
groups and allow complexation of such species. Despite this, the addition of NEt3 to 
mixtures containing the 3-aminopyrazinium salts and metal complex precursors failed to 
promote complex formation. 
 
3.4 Complexes of 2-aminopyrimidinium derivatives 
Given that “head-to-tail” platinum(II) complexes of guanadinato derivatives have been 
reported,12 it was of interest to prepare complexes of bis(2-aminopyrimidinium) nitrate salts. 
The 2-aminopyrimidinium fragments, each of which incorporates a guanadinium moiety, 
were expected to behave in much the same way as the related 3-aminopyrazinium species 
discussed above. 
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Heating a D2O suspension of [apym(CH2)4apym](NO3)2 (64) and [Pt(2,2′-bipy)(NO3)2] 
(2 equiv.) afforded a clear red solution, suggesting that [Pt(2,2′-bipy)(NO3)2] had reacted to 
possibly form a Pt(II)···Pt(II) bonded species (Scheme 3.6). Despite this, NMR and ESI-MS 
data did not conclusively support the formation of a tetranuclear species such as 123. 
Extended heating of the mixtures resulted in the precipitation of an intractable dark-red 
material. 
 
Scheme 3.6: Potential formation of tetranuclear complexes incorporating two bridging ligands, each 
incorporating two guanidinato fragments. 
 
When the above procedure was repeated using the related salt [apym(CH2)5apym](NO3)2 
(67), the reaction product(s) could be identified with greater success. Precipitation of an 
orange solid (using KPF6) gave a product whose ESI-FT-ICR mass spectrum featured an ion 
distribution centred at m/z 1395.61458, which was assigned to [124 – 2PF6-]2+.‡‡ 
Superimposed on this envelope is another ion distribution centred at m/z 1395.11783, 
corresponding to the dinuclear fragment ion [½124 – PF6-]+. In both cases, the difference 
between isotopologue m/z values for each species (~0.5 and ~1, respectively) is consistent 
with the proposed formulae. 1H NMR spectroscopic analysis suggests the presence of one 
major product with trace amounts of another species, possibly a diastereomer of the major 
product, also being present (the dinuclear fragment is not expected to be stable in the 
solution state). A single 195Pt NMR resonance at –2254 ppm was observed, which is 
consistent with a PtN4 core. Despite this, the UV-vis spectrum lacks an absorption at ~450 
nm (the reaction mixture was orange, rather than red) which is often diagnostic of 
Pt(II)···Pt(II) interactions in similar systems. As a consequence, further characterisation of 
this and related species is required. 
 
The reactivity of selected 2-aminopyrimidinium dications towards labile palladium(II) and 
platinum(II) complexes was also investigated in organic solvents. For these purposes, the 
                                               
‡‡
 The product might also take the form of a chiral double helicate, as in the case of 119. 
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organic PF6- salts were combined with metal complex precursors. As with the PF6- salts of 
the 3-aminopyrazinium derivatives, the 2-aminopyrimidinium species were found to be poor 
ligands. The representative species [apym(m-xylylene)apym](PF6)2 (80) was combined with 
an equimolar amount of [Pt(dppp)(OTf)2] in CD3CN (Scheme 3.7). No evidence of any 
reaction could be obtained from NMR or ESI-MS analyses. 
 
Scheme 3.7: 2-Aminopyrimidinium derivatives were found to be unreactive towards the organo-soluble 
complex precursors employed. 
 
Slow evaporation of the solution afforded colourless single crystals, which were 
characterised by an X-ray structure determination. The crystals were found to be a mixed 
OTf-/PF6- salt of the 1,3-bis(1-methyl-2-aminopyrimidinium)benzene dication (80′).§§ As 
was discussed above for the 3-aminopyrazinium salts, deprotonation of the conjugated 
amine (in this case, guanidinium) groups was considered as a method to prepare metal 
complexes. However, the addition of NEt3 to the above mixture failed to induce any 
coordination. 
 
3.5 Larger ligand derivatives 
Despite the cationic nature of many of the N-heterocyclic ligands and metal precursor 
fragments, many new metallocycles could be prepared from combinations of these species. 
The origin of the stability of charged metallo-supramolecular architectures has been the 
subject of an excellent review by Piguet,15 in which theoretical calculations on dinuclear 
ruthenium(II) complexes demonstrated that solvation processes shield what would otherwise 
be strong intramolecular repulsions between positive charges. This shielding is most 
pronounced in H2O, which is a more effective dielectric medium than MeCN.16*** 
 
In general, it was found that all species of type [pyz(spacer)pyz]2+ and the PF6- salts of 
3-aminopyrazinium and 2-aminopyrimidinium derivatives have negligible affinity for the 
                                               
§§
 The solid state structure of this species is largely unremarkable. An ORTEP representation and 
crystallographic details can be found in the Appendices (Section A.3). 
***
 The dielectric constant values εr(H2O) = 80.10 and εr(MeCN) = 38 (εr(vacuum) ≡ 1) suggest that 
electrostatic forces between ions have approximately twice the strength in MeCN, relative to H2O. 
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labile palladium(II) or platinum(II) precursors employed in MeCN solution. However, 
bis(4,4′-bipyridinium) derivatives could be incorporated into new [2 + 2] metallocyclic 
complexes of palladium(II) and platinum(II). The use of bis(3-aminopyrazinium) and 
bis(2-aminopyrimidinium) salts instead gave tetranuclear complexes in which each ligand 
bridges two pairs of platinum(II) ions, each of which is also held together by Pt(II)···Pt(II) 
interactions. In terms of DNA-binding, the species discussed above are of insufficient size 
to encircle double-stranded DNA,††† although single-stranded DNA might be 
accommodated in the cavities of some of the metallocycles. It appears that the formation of 
larger species from the present class of ligands can only be successful if other conditions 
were to be employed, for example, where a suitable templation strategy can be devised. 
 
A simpler and more obvious means of integrating flexible ligands into larger macrocycles 
would be to increase the size of the spacer unit between the donor atoms. While these longer 
ligands may afford mononuclear (in which both ends of the flexible ligand coordinate to the 
same metal ion) instead of dinuclear species, such a compound may be of appropriate size to 
encircle double-stranded DNA, if a sufficiently large bidentate ligand could be prepared 
(Figure 3.4). 
 
Figure 3.4: Di- (left) and mononuclear (right) complexes incorporating flexible N,N-bidentate ligands 
and [Pt(2,2′-bipy)]2+ fragments. The use of intermediate spacer lengths may lead to equilibrium 
mixtures of di- and mononuclear complexes. 
 
Although very large ligands (for example, those containing more than three linked 
4,4′-bipyridinium components) were not prepared during the course of this study, a simple, 
commercially available ligand could be integrated into metal complexes of considerable 
size; its chemistry is described in the following Section. 
                                               
†††
 For example, in the species [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]2+ there exists a 19 Å separation 
between the two Pt centres (Spartan ’04). 
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3.6 PEGda complexes of palladium(II) and platinum(II)  
The diamine O,O′-bis(2-aminoethyl)octadeca(ethylene glycol) (hereafter referred to as 
PEGda) appeared to have the appropriate size, functionality and solubility for the formation 
of large metallocycles in aqueous solution. The reversible metal-complexation process is 
amenable to macrocycle preparation in that simple [1 + 1] macrocycles could form in 
preference to (either linear or cyclic)‡‡‡ oligomeric products on account of entropic 
considerations. 
 
Incorporating PEGda into complexes of palladium(II) and platinum(II) appeared to be a 
straightforward means towards the formation of large cationic macrocycles. The 
complexation of PEGda with cis-protected metal ions has the potential to furnish H2O-
soluble species of the form [M(N,N)(PEGda)]2+ (M = Pd, Pt; N,N = small N,N-chelating 
ligand), featuring impressive 62-membered chelate rings (Scheme 3.8). However, owing to 
the length of PEGda, complexation might also occur in a bridging, rather than a chelating 
manner. It was thought the latter mode would be entropically preferred, and that under 
thermodynamic control, mononuclear species would predominate over oligomeric material. 
As a consequence, solutions of PEGda and suitable metal complex precursors were heated 
for extended periods, over which time it was anticipated that any oligomeric intermediates 
would convert to the desired [1 + 1] macrocycles. Such conditions could also eliminate the 
need for high dilution conditions to be employed. 
 
Scheme 3.8: The incorporation of PEGda into bis(chelate)palladium(II) and platinum(II) complexes. 
 
The compound [Pd(2,2′-bipy)(PEGda)](NO3)2 (125) appeared to be an ideal (and 
disarmingly simple) initial target. Stirring a warm aqueous suspension of 
[Pd(2,2′-bipy)(NO3)2] and PEGda afforded, after 2 h, a clear yellow solution. 1H NMR 
spectroscopic analysis of this solution suggested a product of high symmetry, such as the 
desired species, had formed. This was supported by high resolution ESI-FT-ICR-MS 
                                               
‡‡‡
 These include catenated species which, given the length of PEGda, must come into consideration. 
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characterisation, which confirmed the presence of [Pd(2,2′-bipy)(PEGda)]2+ ions 
(m/z 579.27006, calcd 579.27153). Importantly, no evidence could be found for the 
formation of oligomeric species, which suggests that the moderate lability of Pd–N bonds 
allowed the thermodynamic product to form quickly. However, this lability was thought to 
potentially allow for the integrity of the complex to be compromised in the presence of 
DNA, perhaps by covalent interaction with the nucleobases. It was for this reason that the 
kinetically inert platinum(II) derivative, which was considered more likely to remain intact 
in the presence of DNA, was also prepared in this work. 
 
By analogy with the palladium(II) complex above, the synthesis of 
[Pt(2,2′-bipy)(PEGda)](NO3)2 (126) was attempted by heating an aqueous suspension of 
[Pt(2,2′-bipy)(NO3)2] and PEGda. Dissolution of the platinum(II) precursor occurred, but 
over time the solution developed an orange-red colour and upon cooling a red precipitate 
formed, which was filtered off. Its 1H NMR (D2O) spectrum featured resonances 
exclusively at low field, suggesting that PEGda (either free or coordinated) was not present 
in the material isolated, which was believed to possibly contain the hydroxo-bridged species 
[Pt2(2,2′-bipy)2(µ-OH)2](NO3)2.5 The use of dilute acid (HNO3, 0.01 M aqueous solution) as 
the reaction solvent, in order to suppress the formation of any hydroxo complexes, failed to 
alter this outcome. Instead, it was found that heating a dry DMF solution of the precursors 
(60°C, 48 h)§§§ caused the desired reaction to proceed cleanly. Upon solvent evaporation, 1H 
NMR spectroscopic analysis of the resultant oily yellow solid suggested the desired product 
had formed exclusively. More conclusive evidence could be obtained from the 
accompanying 195Pt NMR spectrum, which exhibited a single resonance at –2661 ppm, 
consistent with the presence of a single platinum(II) environment in which the metal centres 
are each coordinated to four N atoms.4 This was further supported by ESI-FT-ICR-MS 
analysis, which confirmed the presence of [Pt(2,2′-bipy)(PEGda)]2+ ions (m/z 624.29932, 
calcd 624.30133). 
                                               
§§§Heating at temperatures > 70°C caused decomposition, causing the yellow solution to become orange. Note 
also that, unlike [Pt(2,2′-bipy)(NO3)2], the product is highly H2O-soluble. 
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It should be noted that the [Pt(2,2′-bipy)]2+ moiety present in [Pt(2,2′-bipy)(PEGda)]2+ has 
the potential to bind to DNA by intercalation (see Chapter Four),17 a mode which may be 
undesirable in the context of the present study. Consequently, it was of interest to prepare a 
related complex for which intercalation cannot complicate binding; 
[Pt(tmeda)(PEGda)](NO3)2 (127, tmeda = N,N,N′,N′-tetramethyl-1,2-diaminoethane) is one 
such species. Its synthesis was attempted via the labile intermediate [Pt(tmeda)(OD2)2]2+, 
which was generated by stirring a warm suspension of [Pt(tmeda)I2] and AgNO3 in D2O 
(70°C, 48 h). After removal of AgI by filtration, the colourless solution was added to PEGda 
and the mixture heated for a further 2 days, over which time a small amount of white 
precipitate had formed, which was removed by filtration. 1H and 195Pt NMR spectroscopic 
analyses of the filtrate suggested that a mixture of products had formed, the latter indicating 
the presence of three distinct 195Pt environments. A signal at –2675 ppm suggested that a 
platinum(II) product with four N-donor atoms (possibly [Pt(tmeda)(PEGda)]2+) had formed, 
but further resonances at –2421 and –2136 ppm indicated that other platinum(II) species, 
perhaps with N3O coordination spheres, were also present.**** The same result was also 
found to occur when the [Pt(tmeda)(NO3)2] intermediate was isolated and subsequently 
treated with PEGda. 
 
When DMF was used as the solvent in place of H2O, [Pt(tmeda)(PEGda)](NO3)2 could be 
cleanly generated as a sticky solid from [Pt(tmeda)(dmf)2](NO3)2 (prepared in situ from 
[Pt(tmeda)I2] and AgNO3) and PEGda in DMF solution. As with the 2,2′-bipyridine 
analogue, it appears that the ability of DMF to dissolve potentially insoluble reaction 
intermediates and/or the curbing of hydrolysis (which might otherwise occur) allow for the 
reaction to proceed smoothly. Most diagnostic of this is the single NMR resonance observed 
at δ(195Pt) –2695 ppm, which is consistent with the presence of platinum(II) coordinated to 
four N atoms. Further data in support of this could be obtained using 1H NMR spectroscopy 
and ESI-FT-ICR-MS. The analogue [Pt(en)(PEGda)](NO3)2 (128) was prepared and 
characterised in a similar manner, using [Pt(en)I2] as the precursor complex. This analogue, 
as with the other complexes of PEGda, could be isolated as an oily solid.†††† 
 
Relatively few coordination compounds of acyclic diaminopolyethers have been reported to 
date. The short ligand 129 can bind a variety of transition18 (as well as alkaline earth19) 
                                               
****ESI-FT-ICR-MS analysis: m/z calcd for C46H101N4O20Pt+, [Pt(tmeda)(η1-PEGda)(OH)]+: 1225.66073. 
Found: 1225.666247. 
††††
 This precluded their characterisation by CHN microanalysis. 
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metal ions through both the amino and ether electron pairs. For example, the complex 
[Cu(129)]2+ incorporates square-planar, N2O2-coordinated copper(II).20 While the larger 
analogue 130 has been incorporated into dinuclear cobalt(III) complexes,21 there are no 
reports of any metal-containing species with longer aliphatic diaminopolyethers. The related 
aromatic derivatives O,O′-dianilinoethylene glycol (131) and O,O′-dianilinotetra(ethylene 
glycol) (132) have been found to bind metal ions to afford cis-[Pd(131)Cl2]22 and 
[K(132)]+,23 respectively. 
 
The complexes of type [M(N,N)(PEGda)]2+ described above represent a class of very large 
metallocyclic compounds. Owing to their 62-membered chelate rings, they can be referred 
to as ‘gigantocycles’, defined by Vögtle24 as macrocycles having between 50 and 100 atoms 
in their rings. The species prepared in this work obviously bear close resemblance to simple 
aliphatic crown ethers, of which several large examples, including 81-crown-27 (133), have 
been prepared. As its name suggests, 81-crown-27 incorporates 27 ethyleneoxy units 
connected to form an 81-membered ring, and its solid state structure reveals that this 
flexible gigantocycle is twice folded onto itself.25 It is probable that complexes of PEGda 
also exist in similarly folded conformations, which are likely favoured over more open 
‘extended’ states due to entropic and stereoelectronic effects.26‡‡‡‡ More conformationally-
rigid crown ethers can be prepared by the incorporation of aryl rings into macrocycles. One 
such species is the 66-membered tetrabenzocrown 134 which could be synthesised in 11% 
yield, with a smaller, 33-membered species being the major (51%) product.27 This example 
clearly highlights the limitations of macrocycle synthesis using kinetically-controlled 
(organic) chemistry, in this case the [2 + 2] cyclisation of a bis(4-toluenesulfonate) 
precursor with resocinol. In contrast, the palladium(II) and platinum(II) complexes of PEGda 
prepared for the present study form in quantitative yield (by 1H NMR spectroscopy). 
                                               
‡‡‡‡
 18-Crown-6 has been the subject of several theoretical studies. For example, it has been predicted that its 
rearrangement to an open conformation (which is necessary to bind K+) requires ~2.6 kJmol-1. 
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3.7 Concluding remarks 
The diquaternary and PEGda N-donor ligands were found to be useful precursors for the 
preparation of metallocyclic compounds. Indeed, these ligands could be incorporated into 
palladium(II) and platinum(II) complexes of varying size, solubility and nuclearity. 
 
In terms of encircling duplex DNA, many species bearing positive charge and possessing 
high aqueous solubility were prepared during the present study. The most important 
prerequisite for ‘DNA nanoshuttle’ behaviour, namely the presence of a large cavity, is best 
fulfilled by complexes of type [M(N,N)(PEGda)]2+. If the conformationally flexible PEGda 
ligand were to extend to form a roughly circular chelate ring, it is anticipated that this would 
be of considerable size (~3 nm). 
 
The DNA-binding behaviour of selected metallocyclic species, as well as simple acyclic 
analogues, is the central subject of the remainder of this Thesis. 
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Chapter Four: DNA-binding studies 
4.1 Anion binding 
While the study of cation binding by organic ligands is a well-established discipline,1 the 
rational design of agents capable of coordinating anions is a pursuit which has only recently 
gained much attention.2 Indeed, for decades the term “coordination chemistry” was used 
almost exclusively to refer to complexation of metal cations, in particular transition metal 
ions. However, the significant roles anions play in biology3,4 and in the environment5 serve 
to motivate the development of this emerging area of chemistry. 
 
Anions have larger radii than their isoelectronic cations, and their more diffuse electron 
density can cause interactions involving anions to be weak and without directionality.4 
Thus, the use of multiple H-bonding, electrostatic and π–π/hydrophobic interactions is often 
required in order for a successful anion/receptor complex to form. By carefully exploiting 
H-bonding interactions, Crabtree and co-workers were able to demonstrate that a simple, 
non-preorganised (conformationally flexible) diamide (135) can form a stable 1 : 1 complex 
with a single Br- ion.6 The elegant isophthalamide motif, which possesses three H-bond 
donors groups, has been incorporated into several higher order structures, including 
catenanes7 and rotaxanes.8 Indeed, not only can such species act as anion receptors, but very 
often the formation of these interlocked architectures is reliant upon anion templation.9 
 
A more elaborate (chiral) receptor (136) is able to bind 4-nitrobenzoate by means of 
H-bonding, as well as electrostatic and π–π interactions.10 Additionally, the greater affinity 
of 136 for L-N-acetyltryptophan over D-N-acetyltryptophan saw it become the first synthetic 
host capable of binding anions enantioselectively. 
 
4.2 DNA-binding 
The binding of small molecules to DNA, both in terms of fundamental chemistry as well as 
drug design, is a topic of intense research activity. The largely non-covalent interactions 
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involved in the assembly of supramolecular architectures also feature heavily in DNA 
recognition. The 1960s saw the discovery of five modes by which small molecules bind 
B-DNA; these are presented in Figure 4.1. 
 
Figure 4.1: Schematic representation of small molecules (M) binding to DNA (left) and the chemical 
structures of some typical DNA-binding agents (right). 
 
These modes of interaction are: 
o Intercalation – whereby extended aromatic regions of species insert between stacked 
base-pairs in a non-covalent manner.11 The complex [Ru(2,2′-bipy)2(dppz)]2+ (137) 
incorporates such a region in the form of the dipyrido[3,2-a:2′,3′-c]phenazine (dppz) 
ligand, and binding is promoted by electrostatic and π–π interactions.12 
o Major groove binding – which involves molecules recognising the major groove, often 
by sequence-specific H-bonding and hydrophobic/electrostatic interactions. The 
delocalised lipophilic cation methyl green (138) is a major groove binder.13 
o Minor groove binding – a common mode of binding for small molecules (typically those 
containing several aryl groups) in which non-covalent interactions (H-bonding, 
hydrophobic effects) allow for DNA-drug complex formation. The bis(benzimidazole) 
Chapter Four: DNA-binding studies 
59 
Hoechst-33258 (139), which incorporates H-bonding functionality, binds to AT-rich 
regions in the minor groove.14  
o Sugar-phosphate backbone binding – by which cationic molecules bind to the DNA 
backbone, in particular, the phosphodiester groups. The complex trication 
hexamminecobalt(III) (140) binds to the backbone; this is promoted by stabilising 
electrostatic and N–H···Ophosphate H-bonding interactions.15 
o Covalent binding – whence a drug molecule covalently bonds to DNA. Unlike the above 
binding modes involving non-covalent interactions, covalent binding, owing to its 
greater strength, is often irreversible in nature. The anticancer drug cisplatin (141) can 
undergo aquation and subsequently bind in a (coordinate) covalent manner to the N7 
atoms of guanine or adenine nucleobases.16 
 
4.3 Non-covalent DNA-binding of platinum(II) complexes 
While a vast amount of research into platinum(II)-DNA chemistry has focused on covalent 
binders, such as cisplatin and its many analogues,17 square-planar platinum(II) complexes 
have also been demonstrated to bind DNA in a non-covalent manner. In particular, 
complexes incorporating polyaromatic chelating ligands are ideally suited to act as 
metallointercalators. Lippard was the first to investigate the non-covalent interactions 
between such species and DNA, initially studying complexes of the type 
[Pt(2,2′:6′,2′′-terpyridine)X]+ (X = Cl, S(CH2)2OH).18 The labile chlorido complex 142 was 
found to bind DNA covalently, as it can undergo aquation and subsequent nucleobase 
coordination. However, the kinetically inert thiolato derivative 143 does not readily aquate 
and instead intercalates, causing a loss of the regular helical structure of DNA. 
 
Several platinum(II) complexes of N,N-bidentate aromatic ligands have been reported to 
interact non-covalently with DNA. In particular, simple bis(chelate) species such as 
[Pt(phen)(en)]2+ (144),19 by virtue of the high affinity [Pt(phen)]2+ fragments have for 
DNA,20 are potent intercalators. Studies on the in vitro activity of the related complex 
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[Pt(phen)(1S,2S-diaminocyclohexane)]2+ (145) have shown it to be toxic to several cancer 
cell lines, with its mode of action believed to involve DNA intercalation.21 It was found that 
the enantiomer [Pt(phen)(1R,2R-diaminocyclohexane)]2+ had different biological activity to 
145, a fact which is unsurprising given the chiral nature of DNA and the high likelihood of 
the amino groups participating in H-bonding interactions with the macromolecule. 
 
4.4 Complexes employed for DNA-binding 
The study of DNA-binding to metal complexes need not be limited to small mononuclear 
derivatives. As was highlighted in the Introduction to this Thesis (Section 1.5), 
interdisciplinary supramolecular and bio-inorganic chemical research has recently garnered 
several remarkable findings regarding the behaviour of metallosupramolecular species in a 
biological setting, in particular when DNA is involved. Encouraged by these early results, it 
was of interest to investigate the interactions the new types of metallocycles discussed in the 
previous Chapter might have with DNA. 
 
The complexes prepared during the course of this study which were selected for use in 
DNA-binding experiments are presented below. 
 
As was alluded to in Section 3.6, the PEGda complexes [M(2,2′-bipy)(PEGda)](NO3)2 
(125: M = Pd, 126: M = Pt), owing to their [M(2,2′-bipy)]2+ moieties, are potential 
Chapter Four: DNA-binding studies 
61 
metallointercalators, with the palladium(II) and platinum(II) analogues differing in their 
lability. The related (non-intercalating) compounds [Pt(tmeda)(PEGda)](NO3)2 (127) and 
[Pt(en)(PEGda)](NO3)2 (128), which differ in their H-bonding functionality, were also 
employed in the studies. In order to probe the influence that macrocyclic structure might 
have on DNA-binding, the simple acyclic complex [Pt(2,2′-bipy)(NH3)2]2+ was also 
prepared. This complex is known to bind nucleic acids22 and was considered a fragment of 
the complex [Pt(2,2′-bipy)(PEGda)](NO3)2 that could potentially intercalate into DNA, but 
not encircle it. While the Cl- salt [Pt(2,2′-bipy)(NH3)2]Cl2 has been reported previously,23 
for consistency the NO3- salt [Pt(2,2′-bipy)(NH3)2](NO3)2 (146) was prepared and used in 
the present study.* 
 
The dinuclear palladium(II) and platinum(II) complexes 107 – 110 were employed and again 
acyclic analogues of these complexes were also investigated. To this end, two further 
compounds of the form [M(2,2′-bipy)(Mebipy)2](NO3)4 (147: M = Pd, 148: M = Pt; 
Mebipy+ = 1-methyl-4,4′-bipyridinium) were prepared (from [Mebipy]NO3 (15) and 
[M(2,2′-bipy)(NO3)2]) and used in the DNA-binding experiments.† These were prepared as 
model compounds, with each representing roughly one half of the dinuclear derivatives. 
Comparison of the DNA-binding properties of the mononuclear and dinuclear complexes 
would perhaps shed light on how the greater positive charge and cyclic structure of          
107 – 110 might influence DNA-binding. 
 
The importance of successfully characterising the non-covalent interactions between DNA 
and small molecules cannot be understated. This can be achieved using a variety of 
techniques including crystallography, calorimetry, vibrational spectroscopy, NMR 
spectroscopy, circular dichroism, fluorescence, UV-visible spectroscopy and mass 
spectrometry.24 Use was made of the last two techniques in the present study; descriptions 
of these methods and the conclusions drawn from the analyses of DNA mixtures containing 
selected palladium(II) and platinum(II) complexes are presented in the following Sections of 
this Chapter. 
 
                                               
*
 This complex was prepared from aqueous NH3 and [Pt(2,2′-bipy)(NO3)2] (see Experimental Section 6.11). 
†
 A third such compound, the 1,10-phenanthroline complex [Pd(phen)(Mebipy)2](NO3)2 (149) was also 
prepared, although it was not used in any binding experiments. Further details can be found in Section 6.11. 
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4.5 Mass spectrometric analysis of DNA adducts 
4.5.1 Background 
The development of macromolecular ESI-MS analysis by Fenn25‡ has provided scientists 
with an efficient and sensitive technique for the analysis of biomolecules, including DNA.26 
Indeed, ionisation conditions can be sufficiently mild such that non-covalent interactions are 
often preserved,24,27 allowing for information regarding binding strength and stoichiometry 
to be obtained.28 The characterisation of non-covalent DNA/metal complex interactions 
using ESI-MS has recently become an area of great research interest,29,30 no doubt 
motivated by potential applications which might result from this work, such as the design of 
agents capable of repairing31 or probing the structure of DNA.12 
 
Beck and co-workers32 demonstrated that a range of transition metal complexes are able to 
effectively bind 16 base-pair (16mer) duplex oligonucleotides. Their work showed that 
these short DNA sequences, as well as their adducts with small molecules, are very much 
amenable to characterisation using ESI-MS.30 In recent work, the complex [Pt(phen)(en)]2+, 
as well as a number of its analogues in which the phen ligands are methylated, were found 
to have significant affinities for dsDNA, as evidenced by the high abundance of DNA/metal 
complex adduct ions in the mass spectra of these mixtures. The ESI-MS studies showed that 
the position and number of methyl groups has subtle effects on the DNA-binding strength of 
these complexes. In particular, the dimethylated species [Pt(4,7-Me2phen)(en)]2+ was found 
to bind with higher affinity than [Pt(phen)(en)]2+, an observation which might be attributed 
to the greater hydrophobicity of the latter species. Binding experiments were also carried 
out with intercalators of the type [M(phen)2(dppz)]2+ (M = Ni, Ru), with the results 
suggesting that these octahedral complexes, despite their extended aromatic dppz ligands, 
represent weaker intercalators than the square-planar platinum(II) complexes. Indeed, while 
octahedrally coordinated metal ions might bind poorly due to the steric demands of ligands, 
square-planar complexes are not hindered by the presence of axial ligands and are ideally 
suited to insert between DNA base-pairs. Stoichiometry also plays a role in binding and, as 
expected, increasing concentrations of metal complexes resulted in the formation of adducts 
in which more complex species were bound to each DNA molecule. 
 
                                               
‡
 John B. Fenn, along with Koichi Tanaka and Kurt Wüthrich, shared the 2002 Nobel Prize in Chemistry “for 
the development of methods for identification and structure analyses of biological macromolecules.” 
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The following discussion outlines some considerations with respect to experimental design 
for the analysis of oligonucleotides by ESI-MS. 
 
4.5.2 Experimental Approach 
The present study utilised electrospray ionisation time-of-flight mass spectrometry 
(ESI-TOF-MS) for the analysis of DNA and its metal complex adducts. For these purposes, 
two 16mer dsDNA sequences, including that used by Beck and co-workers in the work 
described above (D2), were employed as models for B-DNA. In comparison to the situation 
with polymeric DNA, such as that of calf thymus, the hypothetical threading of synthetic 
molecules might proceed more readily with oligonucleotides, as the DNA termini are more 
accessible than in the polymeric case. Given that such macrocycles might ‘shuttle’ freely 
along duplex DNA, this could also affect the thermodynamic stability of the bio-hybrids. In 
particular, the dissociation (unthreading) of a macrocycle from very short oligonucleotides 
might occur very rapidly, causing observation of the overall interaction to be difficult, 
owing to its transient and weak nature. It was anticipated that the sequence length used 
would be long enough to promote an observable interaction with the complexes of interest. 
 
The dsDNA oligonucleotides D2 and D2′ were used in the present study; their sequences 
are given in Table 4.1. These represent well-studied duplexes each comprising two different 
(i.e. non-self-complementary) strands of different masses.30 This latter aspect is important as 
it allows for more information to be gleaned from MS data than would be the case if the 
individual ssDNA were of equal mass. 
 
Table 4.1: Data for the oligonucleotides used in the present study. Masses are for the protonated form of 
the phosphodiester. 
dsDNA ssDNA sequence (5′ - 3′) M / Da 
D2a CCTCATGGCCATGACC 4802.0 
D2 
D2b GGTCATGGCCATGAGG 4962.5 
D2′a biotin-CCTCATGGCCATGACC 5373.8 
D2′ 
D2′b biotin-GGTCATGGCCATGAGG 5533.6 
 
The study of DNA solutions using ESI-MS can be carried out in either positive- or negative-
ion modes. While mixtures of nucleic acids, particularly those containing DNA bound to 
several cationic drug species, can be successfully characterised using positive-ion analysis,33 
this was not attempted in the present study. It was thought that the complexes employed 
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•   D2 
◦a D2a 
◦b D2b 
 
would bind weakly, and given that they were typically not used in high concentrations, it 
was not expected that many would bind to a single duplex oligonucleotide. Thus, the 
detection of gas phase ions from DNA solutions in the presence and absence of metal 
complexes was carried out in the negative-ion mode. 
 
The present study focused primarily on the interactions of palladium(II) and platinum(II) 
complexes with D2; the mass spectrometric experiments characterising D2 and its adducts 
are presented below. 
 
4.5.3 ESI-MS of D2 
Equimolar amounts of the single-strands D2a and D2b were carefully annealed to afford the 
duplex D2. The negative-ion ESI mass spectra of D2 in (a) H2O and (b) 0.1 M NH4OAc are 
given in Figures 4.2(a) and 4.2(b), respectively. 
(a)
(b)
•
•
•
•
◦a ◦b
◦a ◦b
◦a ◦b
◦a ◦b
◦a
•
•
◦a ◦b
 
Figure 4.2: ESI-MS of D2 in (a) H2O and (b) 0.1 M NH4OAc; • [D2 – nH+]n– (n = 4, 5, 6); ◦a [D2a – nH+]n– 
(n = 3, 4, 5, 6, 8); ◦b [D2b – nH+]n– (n = 3, 4, 5, 6). 
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As expected, the analysis of free D2 allowed for its detection in several charge states. Thus, 
owing to the acidity of the phosphodiester groups (any number of which may be 
deprotonated on a single D2 molecule) a progression of [D2 – nH+]n– ions was observed, 
with the 6–, 5– and 4– anions being the most abundant. Ions assigned to the single strands     
[D2a – nH+]n– and [D2b – nH+]n– were also detected. The relative intensities of ions of 
dsDNA and ssDNA, as well as the charge states they exist in, are highly dependent on the 
conditions employed, both in terms of instrumentation and sample preparation. For 
example, with respect to the former, high cone voltages are known to favour the detection of 
more highly charged species.34 The medium in which the oligonucleotides are dissolved is 
also important. As shown in Figure 4.2(a), the stability of D2 in pure H2O is not particularly 
high, a result evidenced by the high intensities of ions corresponding to D2a and D2b 
(relative to those of D2). However, the duplex form of DNA is stabilised in solutions of 
high ionic strength (i.e. strongly dielectric media)35 and remains largely intact under 
ESI-MS conditions.33 Indeed, as reported by Beck and co-workers (and shown in Figure 
4.2(b)), mass spectra of dsDNA in 0.1 M NH4OAc can often be acquired in which only 
relatively small amounts of ssDNA are detected.36 
 
Aqueous NH4OAc is readily volatilised to NH3 and HOAc (and H2O) during desolvation 
and ionisation processes, typically allowing for the observation of DNA and its metal 
complex adducts without interference from other species. This is a necessary detail, as the 
presence of nonvolatile ionic compounds, such as those containing Na+, would complicate 
spectral interpretation owing to the large number of ion clusters that might form.§ Due to the 
affinity Na+ ions have for the DNA sugar-phosphate backbone,37 the presence of these 
cations would result in several species of formula [D2 + mNa+ – nH+](m–n)– to be detected, 
which may add spectral ambiguity. For example, the major (almost 100% naturally 
abundant) isotopologue of [D2 – 5H+]5– was detected at m/z 1952 with a less intense ‘tail’ 
corresponding to the sodiated progression [D2 + mNa+ – nH+]3–. Such species were 
observed in all D2-containing mixtures and the trace amounts of sodiated ions detected were 
considered to be acceptable. 
 
Mixtures containing selected palladium(II) and platinum(II) complexes and either D2 or D2a 
were prepared. If the metal complexes were to bind these 16mers, it was expected that the 
adducts would be observed as ions having higher m/z values than free DNA. These 
                                               
§
 Such cations can also skew the distribution of charge states observed. 
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•   D2 
◦a D2a 
◦b D2b 
▪   Pd(tmeda)(PEGda)2+ 
▫   PEGda 
▫′  Pd(tmeda)2+ 
 
preliminary experiments typically involved the analysis of freshly prepared mixtures 
containing [complex] = [D2 or D2a] = 10 µM (i.e. a DNA : complex ratio of 1 : 1) in 
0.01 M NH4OAc (pH 7.0).** The results of the ESI-MS analyses are summarised in the 
following Sections of this Chapter. 
 
4.5.4 Interactions of palladium(II) complexes with D2 
The negative-ion ESI-MS analysis of a D2/[Pd(tmeda)(PEGda)]2+ mixture resulted in the 
spectrum given in Figure 4.3, which is presented with a full assignment of all ions. 
◦a ◦b
•
•▪
•▫
•
•▫′
•▫′
•▪
•▫
•▪▫′•▫′▫′
•▪▫′▫′
•▫′▫′
 
Figure 4.3: ESI-MS of D2 with [Pd(tmeda)(PEGda)]2+ (1 : 1 in 0.01 M NH4OAc); • [D2 – nH+]n– 
(n = 5, 6); ◦a [D2a – 3H+]3–; ◦b [D2b – 3H+]3–; •▪ [D2 + Pd(tmeda)(PEGda)2+ – nH+](n–2)– (n = 7, 8); 
•▫ [D2 + PEGda – nH+]n– (n = 5, 6); •▫′ [D2 + Pd(tmeda)2+ – nH+](n–2)– (n = 7, 8); •▫′▫′ [D2 + 2Pd(tmeda)2+  
– nH+](n–4)– (n = 9, 10); •▪▫′ [D2 + Pd(tmeda)(PEGda)2+ + Pd(tmeda)2+ – 9H+]5–; 
•▪▫′▫′ [D2 + Pd(tmeda)(PEGda)2+ + 2Pd(tmeda)2+ – 12H+]6–. 
 
It was found that the most intense ions were those of free D2 in the 6– and 5– charge states, 
with weaker ions, assigned to the single strands D2a and D2b, also being present.†† The 
detection of the adduct [D2 + Pd(tmeda)(PEGda)2+ – nH+](n–2)–, which incorporates one D2 
molecule bound to one (presumably intact) complex, provides evidence of an interaction 
between its constituents in the gas phase. Given the low intensity of these 1 : 1 adduct ions, 
the binding of [Pd(tmeda)(PEGda)]2+ is likely to be weak and/or in competition with other 
processes. In particular, the moderate lability of palladium(II) complexes can result in their 
decomposition during the ionisation process. If the resulting fragments bind DNA then it is 
clear that these side reactions prevent some portion of DNA and complex species 
                                               
**
 In some cases 0.1 M NH4OAc (pH 7.4) was used. ††
 Notation: • D2; ◦a D2a; ◦b D2b; ▪ intact complexes; ▫ 4,4′-bipy(CH2)n4,4′-bipy2+ (n = 4, 6), Mebipy+ or 
PEGda; ▫′ [M(N,N)]2+ (M = Pd, Pt; N,N = 2,2′-bipy, en, tmeda). In general, circles denote DNA, and squares 
metal complexes; black symbols denote intact species, and white symbols denote fragments thereof. 
Juxtapositions of symbols refer to adducts incorporating the relevant components with, in all cases, loss of 
nH+, where n determines the overall charge, e.g. •▪ [D2 + Pd(tmeda)(PEGda)2+ – nH+](n–2)– (n = 7, 8) refers to a 
1 : 1 adduct present as 6– and 5– ions. 
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participating in what might already be a very weak mode of interaction. In the present 
example, ions corresponding to the binding of the individual fragments PEGda and 
[Pd(tmeda)]2+ to D2 were also observed. The diamine PEGda is dibasic (doubly protonated 
at pH 7.0 or 7.4) and PEGdaH22+ might bind non-covalently to the sugar-phosphate 
backbone of D2 through H-bonding and electrostatic interactions. The fragment 
[Pd(tmeda)]2+, on the other hand, is likely to bind D2 in a coordinate covalent manner by 
virtue of its two reactive coordination sites. This interaction is likely to be moderately strong 
– indeed, ions assigned to D2 binding two [Pd(tmeda)]2+ fragments were detected, as well as 
D2 adducts of [Pd(tmeda)(PEGda)]2+ with up to two additional [Pd(tmeda)]2+ fragments. 
 
It should be noted that most of the species observed by ESI-MS were present in two charge 
states, with the respective ions differing in composition by a single H+. The detection of ion 
progressions in multiple charge states undoubtedly aids the unambiguous assignment of ESI 
mass spectra of oligonucleotides. 
 
For the purposes of comparison, the binding experiment was also performed in the absence 
of NH4OAc. Analysis of an aqueous mixture of D2 and [Pd(tmeda)(PEGda)]2+ allowed for a 
similar spectrum to be obtained (see Appendices, Section A.4.1, Figure A.21(b)). As 
expected, ions corresponding to D2a and D2b had greater intensities (relative to D2) when 
H2O was used in place of 0.01 M NH4OAc. Additionally, 1 : 1 adducts of these single 
strands with [Pd(tmeda)]2+ were observed. It is clear that, although the use of a weaker 
dielectric medium would strengthen interactions between dsDNA and complex cations, the 
stability of the former is markedly reduced under these conditions, and the relative 
intensities of ions assigned to adducts of dsDNA decrease as a result. 
 
The analysis of a 0.01 M NH4OAc solution containing D2 and [Pd2(2,2′-bipy)2{4,4′-
bipy(CH2)44,4′-bipy}2]8+ was carried out in much the same way as in the previous example. 
The resulting ESI mass spectrum (Figure 4.4) featured ions assigned to free D2 (and D2a, 
D2b), along with weaker ions corresponding to several DNA adducts, none of which 
contained intact octacationic complexes. Ions were observed for D2, D2a and D2b adducts 
of [4,4′-bipy(CH2)44,4′-bipy]2+, a species whose large aromatic surface area and positive 
charge were thought to allow it to interact with DNA. As was found when using 
[Pd(tmeda)(PEGda)]2+, palladium(II) chelate fragments, in this case [Pd(2,2′-bipy)]2+, were 
observed to interact with D2. The binding of [M(2,2′-bipy)]2+ fragments (M = Pd, Pt) to 
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•   D2 
◦a D2a 
◦b D2b 
▪   Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}28+ 
▫   4,4′-bipy(CH2)44,4′-bipy2+ 
▫′  Pd(2,2′-bipy)2+ 
 
DNA is well understood, and these have been shown to bind by a non-intercalative mode 
involving reversible coordination to nucleobases.38  
◦b
•▫
•
•▫′
•▫▫′
•▫▫′▫′
•▫▫
◦a▫
•
•▫
•▫▫
•▫′
•▫▫′
◦a
◦b▫
•▫▫▫′
•▫▫▫′
 
Figure 4.4: ESI-MS of D2 with [Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ (1 : 1 in 0.01 M NH4OAc); 
• [D2 – nH+]n– (n = 5, 6); ◦a [D2a – 3H+]3–; ◦b [D2b – 3H+]3–; •▫ [D2 + 4,4′-bipy(CH2)44,4′-bipy2+ – nH+](n–2)– 
(n = 7, 8); •▫▫ [D2 + 2{4,4′-bipy(CH2)44,4′-bipy}2+ – nH+](n–4)– (n = 9, 10); •▫′ [D2 + Pd(2,2′-bipy)2+              
– nH+](n–2)– (n = 7, 8); •▫▫′ [D2 + Pd(2,2′-bipy){4,4′-bipy(CH2)44,4′-bipy}4+ – nH+](n–4)– (n = 9, 10); 
•▫▫▫′ [D2 + Pd(2,2′-bipy){4,4′-bipy(CH2)44,4′-bipy}26+ – nH+](n–6)– (n = 11, 12); •▫▫′▫′ [D2 + Pd2(2,2′-
bipy)2{4,4′-bipy(CH2)44,4′-bipy}6+ – 12H+]6–; ◦a▫ [D2a + 4,4′-bipy(CH2)44,4′-bipy2+ – 5H+]3–; 
◦b▫ [D2b + 4,4′-bipy(CH2)44,4′-bipy2+ – 5H+]3–. 
 
The D2 adducts of larger and more positively charged fragments (including 
[Pd(2,2′-bipy){4,4′-bipy(CH2)44,4′-bipy}2]6+) could also be identified, although such ions 
were of lower intensity than the adducts of the simpler fragments mentioned above. It was 
thought that the binding of [Pd(2,2′-bipy){4,4′-bipy(CH2)44,4′-bipy}2]6+ might involve 
intercalation, whereas the related hexacation [Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}]6+, 
which was also found to bind D2, has the possibility of interacting covalently through its 
two vacant coordination sites. Overall, given the cationic nature of the [Pd(2,2′-bipy)]2+ and 
[4,4′-bipy(CH2)44,4′-bipy]2+ species which make up the dinuclear complex, it is not 
surprising that it fragments under the ESI-MS conditions and, furthermore, that these 
fragments bind D2. 
 
Having investigated the reactivity of [Pd(tmeda)(PEGda)]2+ and [Pd2(2,2′-bipy)2{4,4′-
bipy(CH2)44,4′-bipy}2]8+ towards D2, it also was of interest to conduct experiments with the 
ssDNA D2a. 
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◦a D2a 
▪   Pd(tmeda)(PEGda)2+ 
▫   PEGda 
▫′  Pd(tmeda)2+ 
♦    unidentified ion 
 
4.5.5 Interactions of palladium(II) complexes with D2a 
The experimental procedure described above for D2 was also performed using D2a; its ESI 
mass spectrum is given in Figure 4.5(a). 
(a)
(b)
◦a
◦a
◦a
♦
◦a▪
◦a
◦a▫′
◦a
◦a
◦a▫′
◦a▫′◦a▫′▫′
◦a▫′▫′ ♦◦a▫
 
Figure 4.5: ESI-MS of D2a (a) alone and (b) with equimolar [Pd(tmeda)(PEGda)]2+ 
(in 0.01 M NH4OAc); ◦a [D2a – nH+]n– (n = 3, 4, 5); ◦a▪ [D2a + Pd(tmeda)(PEGda)2+ – 6H+]4–; 
◦a▫ [D2a + PEGda – 4H+]4–; ◦a▫′ [D2a + Pd(tmeda)2+ – nH+](n–2)– (n = 5, 6, 7); ◦a▫′▫′ [D2a + 2Pd(tmeda)2+    
– nH+](n–4)– (n = 8, 9); ♦ unidentified ion. 
 
As was observed with D2, a progression of ions could be detected, with the composition of 
these differing only in the number of protons bound to the phosphodiester backbone. The 
most intense ions were assigned to [D2a – 5H+]5–, [D2a – 4H+]4– and [D2a – 3H+]3–. A 
weak ion was also observed at m/z 1919, although its identity could not be established. It 
was often observed when mixtures containing D2a were analysed and it is most likely due 
to the presence of a trace impurity. 
 
A 0.01 M NH4OAc solution containing equimolar D2a and [Pd(tmeda)(PEGda)]2+ was 
prepared and subjected to ESI-MS. Ions corresponding to D2a were the most intense in the 
resulting spectrum (Figure 4.5(b)), which was, however, quite different to that of D2a alone. 
A weak ion detected at m/z 1479 was consistent with the formula for 
[D2a + Pd(tmeda)(PEGda)2+ – 6H+]4–, an ion which, assuming the palladium(II) complex is 
intact, would represent a 1 : 1 species held together by non-covalent interactions. The 
observation of intense ions for 1 : 1 and 1 : 2 D2a adducts of [Pd(tmeda)]2+, along with an 
ion corresponding to the binding of PEGdaH22+, suggests that [Pd(tmeda)(PEGda)]2+ 
fragments under the conditions employed, as discussed in the previous Section. Given the 
‘availability’ of the nucleobases in D2a (relative to those in D2, which would participate in 
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◦a D2a 
▪   Pd(2,2′-bipy)(PEGda)2+ 
▫   PEGda 
▫′  Pd(2,2′-bipy)2+ 
♦    unidentified ion 
Watson-Crick base-pairing) it is not unexpected that such covalent adducts can readily form 
owing to the greater number of accessible Lewis basic sites. 
 
It is likely that electrostatic and H-bonding interactions between [D2a – nH+]n– and 
[Pd(tmeda)(PEGda)]2+ cause these ions to come into close proximity with one another, 
whence ligand substitution might occur, affording [Pd(tmeda)(η2-D2a – nH+)](n–2)–.‡‡ 
A parallel conclusion was drawn by Beck and co-workers in experiments concerning the 
interactions of nickel(II) complexes with the quadruplex (TTGGGGGT)4 (Q1).32 It was 
observed that Q1 formed adducts of [Ni(phen)2(dppz)]2+ and [Ni(phen)3]2+, however in both 
cases with the loss of a phen ligand. These results were consistent with the initial formation 
of non-covalent complexes of Q1 and the nickel(II) species, followed by ligand dissociation. 
Thus, the observation of metal complex fragments (rather than intact species) binding DNA 
does not necessarily suggest that the binding of intact complexes does not occur, but rather 
that if it does, the resulting DNA adducts are unstable to ESI-MS analysis. 
 
Results similar to those using [Pd(tmeda)(PEGda)]2+ were obtained when a related PEGda 
complex, [Pd(2,2′-bipy)(PEGda)]2+, was employed in the analysis (Figure 4.6). This 
complex was also found to undergo decomposition, with ions representing D2a adducts of 
[Pd(2,2′-bipy)]2+ and PEGdaH22+ (in addition to very weak ions of 
[D2a + Pd(tmeda)(PEGda)2+ – 6H+]4–) being observed. 
◦a▫
◦a
◦a
◦a
◦a▫′
◦a▪
◦a▫′◦a▫′▫′
◦a▫′▫′
◦a▫′ ♦
 
Figure 4.6: ESI-MS of D2a with [Pd(2,2′-bipy)(PEGda)]2+ (1 : 1 in 0.01 M NH4OAc);                                 
◦a [D2a – nH+]n– (n = 3, 4, 5); ◦a▪ [D2a + Pd(2,2′-bipy)(PEGda)2+ – 6H+]4–; ◦a▫ [D2a + PEGda – 4H+]4–; 
◦a▫′ [D2a + Pd(2,2′-bipy)2+ – nH+](n–2)– (n = 5, 6, 7); ◦a▫′▫′ [D2a + 2Pd(2,2′-bipy)2+ – nH+](n–4)– (n = 8, 9). 
 
The interactions of the metallocycle [Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ with 
D2a were studied in much the same way as those described for D2. Importantly, while this 
dinuclear complex was not expected to be of a sufficient size to encircle dsDNA, its cavity 
might be large enough to host ssDNA. The mass spectrum of a mixture containing D2a and 
[Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ (1 : 1) is given in Figure 4.7. 
                                               
‡‡
 The other possible explanation is that [Pd(tmeda)(PEGda)]2+ first fragments, and only then binds to D2a. 
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◦a D2a 
▪   Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}28+ 
▫   4,4′-bipy(CH2)44,4′-bipy2+ 
▫′  Pd(2,2′-bipy)2+ 
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Figure 4.7: ESI-MS of D2a with [Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ (1 : 1 in 0.01 M NH4OAc). 
Intensities of ions in the ranges m/z 1500 – 1522 and 1980 – 2022 are magnified ×10; ◦a [D2a – nH+]n– 
(n = 3, 4); ◦a▪ [D2a + Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}28+ – nH+](n–8)– (n = 11, 12); 
◦a▫ [D2a + 4,4′-bipy(CH2)44,4′-bipy2+ – nH+](n–2)– (n = 5, 6); ◦a▫▫ [D2a + 2{4,4′-bipy(CH2)44,4′-bipy}2+         
– 8H+]4–; ◦a▫′ [D2a + Pd(2,2′-bipy)2+ – nH+](n–2)– (n = 5, 6); ◦a▫′▫′ [D2a + 2Pd(2,2′-bipy)2+ – nH+](n–4)– (n = 7, 
8); ◦a▫′▫′▫′ [D2a + 3Pd(2,2′-bipy)2+ – nH+](n–6)– (n = 9, 10); ◦a▫′▫′▫′▫′ [D2a + 4Pd(2,2′-bipy)2+ – 12H+]4–; 
◦a▫▫′ [D2a + Pd(2,2′-bipy){4,4′-bipy(CH2)44,4′-bipy}4+ – nH+](n–4)– (n = 7, 8); ◦a▫▫▫′ [D2a + Pd(2,2′-
bipy){4,4′-bipy(CH2)44,4′-bipy}26+ – 10H+]4–; ◦a▫▫′▫′ [D2a + Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}6+     
– nH+](n–6)– (n = 9, 10); ◦a▫▫′▫′▫′ [D2a + Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}6+ + Pd(2,2′-bipy)2+           
– 11H+]3–. 
 
The complex [Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ was found to fragment to a 
large extent when D2a was present, this being evidenced by the observation of several 
combinations of the individual components binding D2a. Nevertheless, the results are 
significantly different to those obtained with D2. The single-stranded D2a molecules appear 
to have a particularly high affinity for [Pd(2,2′-bipy)]2+ moieties, with the most intense ion 
in the spectrum being assigned to [D2a + Pd(2,2′-bipy)2+ – 6H+]4–. Indeed, ions containing 
D2a and up to four [Pd(2,2′-bipy)]2+ fragments were observed, highlighting the ability of 
ssDNA to form covalent adducts with compounds of the present type. While the binding of 
larger fragments of the dinuclear complexes to D2a was detected, it was also found that D2a 
adducts of intact [Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ (1 : 1) were formed. This is 
in contrast to the situation with D2, to which no intact metallocycles were found to bind. 
 
The tetracation [Pd(2,2′-bipy)(Mebipy)2]4+, a mononuclear analogue of the dipalladium(II) 
complex above, was treated with D2a in order to compare its binding with that of the 
dinuclear complex. ESI-MS analysis confirmed the presence of adducts containing the 
fragments Mebipy+, [Pd(2,2′-bipy)]2+ and [Pd(2,2′-bipy)(Mebipy)]3+ bound to D2a 
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◦a D2a 
▫   Mebipy+ 
▫′  Pd(2,2′-bipy)2+ 
♦    unidentified ion 
(Figure 4.8). It is likely that coordination of nucleobases to palladium(II) is involved in the 
binding of the latter two fragments. 
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Figure 4.8: ESI-MS of D2a with [Pd(2,2′-bipy)(Mebipy)2]4+ (1 : 1 in 0.01 M NH4OAc); ◦a [D2a – nH+]n– 
(n = 3, 4, 5); ◦a▫ [D2a + Mebipy+ – 5H+]4–; ◦a▫′ [D2a + Pd(2,2′-bipy)2+ – nH+](n–2)– (n = 5, 6, 7); 
◦a▫▫′ [D2a + Mebipy+ + Pd(2,2′-bipy)2+ – 7H+]4–, ◦a▫′▫′ [D2a + 2Pd(2,2′-bipy)2+ – nH+](n–4)– (n = 7, 8); 
♦ unidentified ion. 
 
In contrast to the situation with the dinuclear complex, no ions corresponding to D2a 
adducts of intact [Pd(2,2′-bipy)(Mebipy)2]4+ could be observed. This might be ascribed to 
the lower affinity these less cationic complexes have for D2a, or perhaps the rapid 
dissociation of Mebipy+ ligands from the palladium(II) ions during the ionisation process.§§ 
 
4.5.6 Interaction of platinum(II) complexes with D2 
Owing to the propensity of the palladium(II) complexes to fragment in the presence of D2 
and D2a, it was anticipated that similar experiments using analogous platinum(II) species 
might provide more valuable information regarding the DNA-binding of (intact) 
metallocycles. The use of the more kinetically inert platinum(II) derivatives would most 
likely result in DNA-binding, rather than fragmentation, being the dominant process. This 
Section describes ESI-MS studies of the interactions beween the platinum(II) compounds  
108, 110, 126 – 128, 146, 148 and D2. 
 
                                               
§§
 As will become clear in the next Section, in the discussion of D2 binding of [Pt(2,2′-bipy)(Mebipy)2]4+, the 
latter reason appears much more feasible. 
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•   D2 
◦a D2a 
◦b D2b 
▪   Pt(tmeda)(PEGda)2+ 
▫   PEGda 
▫′  Pt(tmeda)2+ 
 
The complex [Pt(tmeda)(PEGda)]2+ was treated with D2 in anticipation of observing strong 
ions corresponding to D2 adducts of intact PEGda macrocycles. The ESI mass spectrum of a 
solution containing equimolar quantities of the two components is presented in Figure 4.9. 
•
◦a ◦b
•
•▪
•▫ •▪▫′
•▪
 
Figure 4.9: ESI-MS of D2 with [Pt(tmeda)(PEGda)]2+ (1 : 1 in 0.01 M NH4OAc). Intensities of ions in the 
ranges m/z 1800 – 1850 and 2100 – 2300 are magnified ×10; • [D2 – nH+]n– (n = 5, 6); ◦a [D2a – 3H+]3–; 
◦b [D2b – 3H+]3–; •▪ [D2 + Pt(tmeda)(PEGda)2+ – nH+](n–2)– (n = 7, 8); •▫ [D2 + PEGda – 5H+]5–; 
•▪▫′ [D2 + Pt(tmeda)(PEGda)2+ + Pt(tmeda) 2+ – 9H+]5–. 
 
In a similar result to that obtained with the palladium(II) analogue, the high intensity of free 
D2 ([D2 – nH+]n– n = 5, 6) relative to other ions, indicated that the binding of D2 to 
[Pt(tmeda)(PEGda)]2+ is very weak. While the intensities of adduct ions were very low 
(these regions are expanded in Figure 4.9 to allow for them to be viewed), the species 
[D2 + Pt(tmeda)(PEGda)2+ – nH+](n–2)– (n = 7, 8) could indeed be detected in the gas phase. 
While decomposition of [Pt(tmeda)(PEGda)]2+ was found to occur (D2 was observed to 
bind the fragments [Pt(tmeda)]2+ and PEGdaH22+), this complex is much more stable to MS 
analysis than the palladium(II) analogue, in which ions incorporating the respective 
fragments and D2 were of greater intensity, relative to free D2. 
 
The use of [Pt(en)(PEGda)]2+ in place of [Pt(tmeda)(PEGda)]2+ allowed for a spectrum to be 
collected (see Appendices, Section A.4.1, Figure A.22) which was comparable to that 
presented above, a result which was not unexpected, considering the structural similarity of 
the two complexes. Given the strength with which [Pt(tmeda)]2+ and [Pt(en)]2+ are expected 
to bind D2, it is likely that intense ions corresponding to D2 adducts of these chelates would 
be observed if the fragments were to be present in significant quantities. This appears not to 
be the case in the present example, and consequently it can be inferred that 
[Pt(tmeda)(PEGda)]2+ can survive the ionisation process intact and that its gas phase 
interactions with D2 are genuinely very weak. No D2 adducts of any form could be 
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identified when the related complex [Pt(2,2′-bipy)(PEGda)]2+ was employed. In this case, 
the only ions observed (see Appendices, Section A.4.1, Figure A.23) were those of free D2; 
at present it is not known why the results obtained using [Pt(2,2′-bipy)(PEGda)]2+ are 
different to those for the other PEGda complexes discussed above. Interestingly, the simple 
diammine complex [Pt(2,2′-bipy)(NH3)2]2+, an acyclic analogue of 
[Pt(2,2′-bipy)(PEGda)]2+, was found to have significant affinity for D2. At a 1 : 1 molar 
ratio, two of these dications could bind each duplex, with up to four complexes interacting 
with a single D2 when a 1 : 5 molar ratio is used (Figure 4.10). 
•
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•▪▪▪
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Figure 4.10: ESI-MS of D2 with [Pt(2,2′-bipy)(NH3)2]2+ (1 : 5 in 0.1 M NH4OAc); • [D2 – nH+]n– (n = 4, 5, 
6); ◦a [D2a – 3H+]3–; ◦b [D2b – 3H+]3–; •▪ [D2 + Pt(2,2′-bipy)(NH3)22+ – nH+](n–2)– (n = 6, 7, 8); 
•▪▪ [D2 + 2Pt(2,2′-bipy)(NH3)22+ – nH+](n–4)– (n = 8, 9, 10); •▪▪▪ [D2 + 3Pt(2,2′-bipy)(NH3)22+ – nH+](n–6)– 
(n = 11, 12); •▪▪▪▪ [D2 + 4Pt(2,2′-bipy)(NH3)22+ – 13H+]5–. 
 
The most intense adduct ions observed are assigned to 1 : 1 species, with ions corresponding 
to the binding of two, three and four diammine complexes being successively weaker. While 
both [Pt(2,2′-bipy)(NH3)2]2+ and [Pt(2,2′-bipy)(PEGda)]2+ can potentially intercalate into 
D2, it appears that the former has a much higher propensity to form adducts detectable by 
ESI-MS. This disparity was considered to perhaps arise from the PEGda complex being less 
stable than its acyclic analogue,*** or the PEGda ligand somehow hindering intercalation (as 
well as not participating in a topological interaction with DNA). 
 
ESI-MS analysis of a mixture containing equimolar amounts of the diplatinum(II) complex 
[Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ and D2 was performed. The results obtained 
(Figure 4.11), in addition to confirming the presence of ions from free DNA (D2, D2a and 
                                               
***
 It is unlikely that decomposition, if it is occuring, involves reaction with NH4OAc. [Pt(2,2′-bipy)(NH3)2]2+ 
and [Pt(2,2′-bipy)(OAc)2] are likely products of this process, species which would be expected to give 
detectable adducts of D2. 
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D2b), also revealed the formation of 1 : 1 D2 adducts of the metallocycle. No ions 
indicating the binding of D2 to fragments of the octacation were detected,††† suggesting that 
the latter is somewhat stable to the ionisation process. This can be contrasted to the situation 
with the related (but more labile) dipalladium(II) species, in which no D2 adducts of intact 
species could be detected, although several fragments of the complex were found to bind 
D2. 
◦a
•
•▪
•▪◦b
•
 
Figure 4.11: ESI-MS of D2 with [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ (1 : 1 in 0.01 M NH4OAc); 
• [D2 – nH+]n– (n = 5, 6); ◦a [D2a – 3H+]3–; ◦b [D2b – 3H+]3–; •▪ [D2 + Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-
bipy}28+ – nH+](n–8)– (n = 13, 14). 
 
Interestingly, when either positive or negative-ion ESI-MS analysis of the dinuclear 
platinum(II) species alone (as its NO3- salt) was performed, no ions corresponding to intact 
complexes could be detected. The fact that D2 could be observed to bind the intact 
[Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ metallocycles suggests that the presence of 
[D2 – nH+]n– polyanions might stabilise the platinum(II) complex. It is possible that the 
binding of these duplexes to the metallocycle allows for strong electrostatic interactions to 
hold the complex together. When DNA is absent, however, the species dissociates into its 
(mutually repulsive) cationic components.  
 
In order to better understand the effects that size and charge of complex species have on 
DNA-binding, the interactions of D2 were also studied with the mononuclear derivative 
[Pt(2,2′-bipy)(Mebipy)2]4+. This complex, which represents approximately one half of the 
species [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+, was combined with equimolar D2 
and the resulting mixture subjected to ESI-MS (Figure 4.12). The spectrum features intense 
6– ions arising from free D2 and its 1 : 1 adduct with [Pt(2,2′-bipy)(Mebipy)2]4+, with ions 
                                               
†††
 When 2.5 molar equivalents of the related complex [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ were 
used, ions assigned to two of these binding D2 were detected (see Appendices, Section A.4.2, Figure A.35). 
However, the higher concentration also allowed for D2 adducts of fragment ions to be observed. 
Chapter Four: DNA-binding studies 
76 
•  D2 
◦a D2a 
◦b D2b 
▪   Pt(2,2′-bipy)(Mebipy)24+ 
 
of these species in the 5– charge state also being prominent. Additionally, small amounts of 
the single strands D2a and D2b were also detected, some of which could be observed to 
bind [Pt(2,2′-bipy)(Mebipy)2]4+. 
•▪
•▪
•▪▪
•▪▪
•
•
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◦a▪
◦b▪◦
b
 
Figure 4.12: ESI-MS of D2 with [Pt(2,2′-bipy)(Mebipy)2]4+ (1 : 1 in 0.01 M NH4OAc); • [D2 – nH+]n– 
(n = 4, 5, 6); ◦a [D2a – 3H+]3–; ◦b [D2b – 3H+]3–; •▪ [D2 + Pt(2,2′-bipy)(Mebipy)24+ – nH+](n–4)– (n = 9, 10); 
•▪▪ [D2 + 2Pt(2,2′-bipy)(Mebipy)24+ – nH+](n–8)– (n = 13, 14); ◦a▪ [D2a + Pt(2,2′-bipy)(Mebipy)24+ – 7H+]3–; 
◦b▪ [D2b + Pt(2,2′-bipy)(Mebipy)24+ – 7H+]3–. 
 
Perhaps the most important aspect of the analysis is the presence of weak, but detectable 
ions with m/z values higher than [D2 + Pt(2,2′-bipy)(Mebipy)24+ – nH+](n–4)–. These are 
assigned to a 1 : 2 adduct, present as both 6– and 5– anions. It is possible that the lower 
charge of the mononuclear complex relative to the dinuclear complex has an effect on why 
this adduct is observed in this case, but not when the dinuclear complex is employed. In 
particular, the charge neutralisation of D2 upon binding the dinuclear octacation is likely to 
cause the DNA-binding of a second complex moiety to be less favourable. This might not 
be so pronounced when the complex bears only a 4+ charge, although other effects, such as 
the size of the complexes, as well as their binding sites, are also likely to influence the 
binding. With respect to the latter, the size of the binding site of the mononuclear complex 
is almost certainly smaller than that of the dinuclear species, allowing for more of the 
mononuclear complexes to be accommodated on a given length of DNA. 
 
As was the case with the palladium(II) complexes, the platinum(II) analogues were also 
studied with D2a. The results of these ssDNA-binding experiments are presented in the 
following Section. 
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4.5.7 Interaction of platinum(II) complexes with D2a 
ESI-MS analysis of a equimolar mixture of D2a and [Pt(tmeda)(PEGda)]2+ in 0.01 M 
NH4OAc afforded the spectrum presented in Figure 4.13. 
◦a▪
◦a
 
Figure 4.13: ESI-MS of D2a with [Pt(tmeda)(PEGda)]2+ (1 : 1 in 0.01 M NH4OAc). Intensities of ions in 
the range m/z 1450 – 1650 are magnified ×10; ◦a [D2a – 3H+]3–; ◦a▪ [D2a + Pt(tmeda)(PEGda)2+ – 5H+]3–. 
 
The most intense ions detected were those assigned to free D2a (here [D2a – 3H+]3–). The 
only other ion observed was at m/z 1501, a value consistent with the presence of the adduct 
[D2a + Pt(tmeda)(PEGda)2+ – 5H+]3–. The low intensity of this ion (relative to that of free 
D2a) suggests that [Pt(tmeda)(PEGda)]2+ has negligible affinity for D2a, comparable to, if 
not lower, than that for D2. While the exact nature of the binding is not clear, it is possible 
that the reduced charge of D2a (compared to D2) may be a cause of this weaker binding.‡‡‡ 
 
It was anticipated that the bipyridinium complex [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-
bipy}2]8+, owing to its greater charge and aryl surface area compared to 
[Pt(tmeda)(PEGda)]2+, would allow it to bind D2a more strongly than the latter species. 
Indeed, it was found that when a solution containing D2a and [Pt2(2,2′-bipy)2{4,4′-
bipy(CH2)44,4′-bipy}2]8+ was subjected to ESI-MS, the most intense ion in the resulting 
spectrum was not of free D2a, but rather D2a bound to one dinuclear complex 
(Figure 4.14(a)).§§§ 
                                               
‡‡‡
 In the absence of complexes, the 16mers (as 10 µM solutions in 0.01 M NH4OAc) were analysed under 
identical conditions and the most abundant charge state for D2 was 6–, while that for D2a was 4–. 
§§§
 A 1 : 1 adduct was also observed when [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ was used 
(Appendices Section A.4.1, Figure A.24). 
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Figure 4.14: ESI-MS of D2a with equimolar (a) [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ or 
(b) [Pt(2,2′-bipy)(Mebipy)2]4+ (in 0.01 M NH4OAc); ◦a [D2a – nH+]n– (n = 3, 4, 5); 
◦a▪ [D2a + Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}28+ – nH+](n–8)– (n = 11, 12); ◦a▫▫′ [D2a + Pt(2,2′-
bipy){4,4′-bipy(CH2)44,4′-bipy}4+ – nH+](n–4)– (n = 7, 8); ◦a▫▫′▫′ [D2a + Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-
bipy}6+ – nH+](n–6)– (n = 9, 10); ◦a▪′ [D2a + Pt(2,2′-bipy)(Mebipy)24+ – nH+](n–4)– (n = 7, 8, 9); 
◦a▪′▪′ [D2a + 2Pt(2,2′-bipy)(Mebipy)24+ – 11H+]3–; ◦a▫′ [D2a + Pt(2,2′-bipy)2+ – nH+](n–2)– (n = 5, 7); 
◦a▪′▫′ [D2a + Pt(2,2′-bipy)(Mebipy)24+ + Pt(2,2′-bipy)2+ – 9H+]3–; ◦a▪′▪′▫′ [D2a + 2Pt(2,2′-bipy)(Mebipy)24+ 
+ Pt(2,2′-bipy)2+ – 13H+]3–; ◦a▫′′▫′ [D2a + Pt(2,2′-bipy)(Mebipy)3+– 7H+]4–. 
 
Two further species, each present in the 4– and 3– charge states, were identified as the D2a 
adducts of the fragments [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}]6+ and 
[Pt(2,2′-bipy){4,4′-bipy(CH2)44,4′-bipy}]4+, both of which might bind D2a covalently. 
Notably, when D2 was treated with the metallocycle, these fragments were not found to 
bind D2, although similar decomposition did occur when D2a was combined with the 
palladium(II) analogue. This difference in stability of the complex in the presence of either 
D2 or D2a again suggests that the latter, because of its unpaired nucleobases, has a higher 
propensity to mediate the decomposition of metal complexes, resulting in the subsequent 
formation of covalently-bound adducts. 
 
As was performed with D2, the analysis of D2a was also conducted in the presence of 
[Pt(2,2′-bipy)(Mebipy)2]4+, the mononuclear analogue of [Pt2(2,2′-bipy)2{4,4′-
bipy(CH2)44,4′-bipy}2]8+ (Figure 4.14(b)). Several adduct species could be identified, and 
up to two intact complexes were found to bind a single molecule of D2a. This is in contrast 
to the situation with the dinuclear complex, in which 1 : 2 adducts were not observed. This 
is likely a result of the difference in charge between the mono- and dinuclear complexes 
discussed in the previous Section. As such, the binding of two mononuclear complexes 
might be considered as being ‘equivalent’ to the binding of a single dinuclear species. 
 
The analysis allowed for the detection of other adduct species, including those containing 
the fragments [Pt(2,2′-bipy)]2+ and [Pt(2,2′-bipy)(Mebipy)]3+, suggesting that 
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[Pt(2,2′-bipy)(Mebipy)2]4+ decomposes under the ESI conditions employed. Such 
fragmentation, not observed in the analysis of D2/[Pt(2,2′-bipy)(Mebipy)2]4+ mixtures, may 
be due to the increased reactivity of the nucleobases in D2a relative to D2 resulting in the 
displacement of Mebipy+ ligands. 
 
4.5.8 Comparison of D2-binding affinities of platinum(II) complexes  
In order to compare the relative DNA-binding strengths of selected platinum(II) complexes, 
further ESI-MS experiments were conducted under identical conditions, from which 
important additional information could be obtained. This was made possible because of the 
moderate stability and affinity for D2 that the complexes showed under the ionisation 
conditions. Four complexes were chosen for this study: [Pt(2,2′-bipy)(Mebipy)2]4+, 
[Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+, [Pt(2,2′-bipy)(NH3)2]2+ and 
[Pt(en)(PEGda)]2+. The PEGda complex, owing to its large cavity (which might potentially 
encircle D2), was considered to be an important species in the analysis. However, as 
described in the previous Section, its affinity for D2 was found to be low. As a consequence, 
a 1 : 5 ([D2] = 10 µM, [complex] = 50 µM) molar ratio was used for each of the mixtures, 
except for the dinuclear complex, for which a 1 : 2.5 ratio was employed. Higher 
concentrations of this complex caused an unidentified white material to precipitate from 
solution. It is possible that this solid might take the form of a [Pt2(2,2′-bipy)2{4,4′-
bipy(CH2)64,4′-bipy}2]8+ salt of D2, given the high charge of both species. If this were the 
case, it could in itself be evidence of strong binding. In any event, owing to the different 
ratio used for the dinuclear complex, the results for this species cannot strictly be compared 
to those of the other complexes, although some definite conclusions can be drawn 
(vide infra). 
 
Previous work has demonstrated that a convenient way of comparing DNA-binding is to 
consider the relative abundances of different DNA/drug adducts.30 Thus, solutions 
containing DNA and each compound were prepared in 0.1 M NH4OAc and subjected to 
ESI-MS analysis (using cone voltage = 70 V),**** from which the data of interest could be 
obtained. This was achieved for each adduct by summing the intensities of 6– and 5– ions 
assigned to this species and dividing by the total intensity of all 6– and 5– ions containing 
D2 (either free or bound). These two charge states were selected as these ions were typically 
                                               
****
 All experiments were also repeated at cone voltages of 90 V, 110 V, 130 V and 150 V. 
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found to be the most intense in the spectra acquired. The analysis is illustrated below in the 
case of [Pt(2,2′-bipy)(Mebipy)2]4+, with the ESI mass spectrum given in Figure 4.15. 
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Figure 4.15: ESI-MS of D2 with [Pt(2,2′-bipy)(Mebipy)2]4+ (1 : 5 in 0.1 M NH4OAc); 
•▪ [D2 + Pt(2,2′-bipy)(Mebipy)24+ – nH+](n–4)– (n = 9, 10); •▪▪ [D2 + 2Pt(2,2′-bipy)(Mebipy)24+ – nH+](n–8)– 
(n = 13, 14); •▪▪▪ [D2 + 3Pt(2,2′-bipy)(Mebipy)24+ – nH+](n–12)– (n = 17, 18); 
•▪▪▪▪ [D2 + 4Pt(2,2′-bipy)(Mebipy)24+ – nH+](n–16)– (n = 21, 22). 
 
Two progressions of 6– and 5– ions could be detected, with each ion corresponding to a D2 
molecule bound to between one and four complexes (c.f. Figure 4.12, in which the use of a 
1 : 1 molar ratio resulted in binding of up to two complexes). The relative abundance of, for 
example, the 1 : 2 adduct, is determined by adding the intensities of the 6– and 5– ions of 
this species (31 and 28 at m/z 1857 and 2228, respectively) and dividing by the total 
intensity of all 6– and 5– ions (156), to give a relative abundance = 59/156 × 100% = 38%. 
This was repeated for all ions of D2 (and its adducts) for each mixture, with the relevant 
spectra and analyses, including those acquired using other cone voltages, being provided in 
the Appendices (Section A.4.2, Figures A.25-A.36). 
 
The DNA-binding of the four platinum(II) complexes was compared to two well-studied 
DNA-binding agents, distamycin A (150, hereafter referred to simply as distamycin) and 
daunomycin (151), which were subjected to the same ESI-MS analysis described above. 
The compounds represent two monobasic (monoprotonated at pH 7.4) organic drugs whose 
interactions with DNA are known in detail, in particular by means of extensive mass 
spectrometric investigations.39 
 
The naturally-occuring tripeptide distamycin (150) is a minor groove binder and ESI-MS 
studies (both positive- and negative-ion) on its interactions with DNA have shown it to 
possess selectivity for AT base-pairs.33,39,40 In addition to electrostatic forces, the amide 
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groups of this antibiotic serve as H-bond donors to N3adenine and O2thymine.41 In contrast, the 
chemotherapeutic agent daunomycin (151) contains an intercalating anthraquinone 
fragment, as well as a minor groove-binding aminosugar (daunosamine) moiety.42 
Daunomycin, because of its delocalised, polarisable electronic structure and electron-
deficient nature, can bind DNA strongly, showing preference for GC base-pairs.43 Mass 
spectra acquired using distamycin and daunomycin are presented below in Figures 4.16(a) 
and 4.16(b), respectively. 
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Figure 4.16: ESI-MS of D2 with (a) distamycin or (b) daunomycin (1 : 5 in 0.1 M NH4OAc);                    
◦a [D2a – 3H+]3–; ◦b [D2b – 3H+]3–; •▪▪ [D2 + 2distamycin – nH+]n– (n = 5, 6); •▪▪▪ [D2 + 3distamycin           
– nH+]n– (n = 5, 6); •▪▪▪▪ [D2 + 4distamycin – nH+]n– (n = 5, 6); ◦a▪ [D2a + distamycin – 3H+]3–; 
◦b▪ [D2b + distamycin – 3H+]3–; •▪′ [D2 + daunomycin – 6H+]6–; •▪′▪′ [D2 + 2daunomycin – nH+]n– 
(n =  5, 6); •▪′▪′▪′ [D2 + 3daunomycin – nH+]n– (n = 5, 6); •▪′▪′▪′▪′ [D2 + 4daunomycin – nH+]n– (n = 5, 6); 
•▪′▪′▪′▪′▪′ [D2 + 5daunomycin – nH+]n– (n = 5, 6); ◦a▪′ [D2a + daunomycin – 3H+]3–; 
◦b▪′ [D2b + daunomycin – 3H+]3–; ◦b▪′▪′ [D2b + 2daunomycin – 3H+]3–. 
 
As expected, distamycin was found to have a high affinity towards D2, a fact evidenced by 
the high intensities of the ions assigned to 1 : 2 and 1 : 4 adducts and the absence of free D2. 
The binding of distamycin in pairs suggests cooperative interactions are involved which, for 
example, would cause the binding of a second molecule to D2 to be more favourable than 
the first. Indeed, it has been reported that the expansion of the DNA minor groove allows 
for the accommodation of two distamycin molecules.44 A similar result to that documented 
here was reported by Beck and co-workers,28 in which a 1 : 3 D2/distamycin mixture 
(in 0.1 M NH4OAc) afforded exclusively 1 : 2 adducts in the negative-ion ESI mass 
spectrum. No 1 : 4 adducts could be detected in their analysis, a result most likely related to 
the lower molar ratio of distamycin used in their study. 
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Daunomycin also exhibited strong binding to D2 with adducts containing up to five such 
intercalator species being detected. The distribution of the relevant intensities is very similar 
to previous studies with other 16mer duplexes, and is quite feasible given that the average 
size of a DNA-binding site of daunomycin is two base-pairs.29,45†††† 
 
With the analysis of the four complexes and two organic drugs complete, a plot of the 
relative abundances of DNA/drug adducts for each agent could be generated (Figure 4.17). 
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Figure 4.17: Plot of relative abundance of DNA/drug adducts ([DNA] : [compound] = 1 : 5 in 0.1 M 
NH4OAc, cone = 70 V). 
 
As was expected given the results presented in Section 4.5.6, [Pt(en)(PEGda)]2+ was found 
to be a weak D2-binder, with 1 : 1 adducts being present at 5% relative abundance. Indeed, 
most of the intensity assigned to ions containing D2 (95%) could be attributed to free D2. 
The complex [Pt(2,2′-bipy)(NH3)2]2+ afforded adducts containing up to four of these species 
bound to D2, with a much lower relative abundance of free D2 being observed (21%). As a 
consequence, it can be concluded that [Pt(en)(PEGda)]2+ binds D2 with lesser strength than 
does [Pt(2,2′-bipy)(NH3)2]2+. Another complex which could bind D2 at a 1 : 4 ratio was 
[Pt(2,2′-bipy)(Mebipy)2]4+. When these tetracations were used, no free D2 could be 
detected, which suggested the bipyridinium compound to bind more strongly than 
                                               
††††
 Saturation of a 16 base-pair dsDNA sequence typically occurs once eight daunomycin molecules are 
bound.29 
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•  D2 
◦a D2a 
◦b D2b 
▪   Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}28+ 
▫   4,4′-bipy(CH2)64,4′-bipy2+ 
▫′  Pt(2,2′-bipy)2+ 
 
[Pt(2,2′-bipy)(NH3)2]2+. This conclusion was also supported by the 1 : 2 and 1 : 3 adducts 
having greater relative intensities in the case of the bipyridinium complex. It was considered 
likely that the high charge and aryl surface area of [Pt(2,2′-bipy)(Mebipy)2]4+ contribute to 
this high affinity for D2. 
 
The binding profile of daunomycin is similar to that for [Pt(2,2′-bipy)(Mebipy)2]4+, although 
it is shifted to a greater number of species being bound to D2. Considering that ions 
incorporating up to five daunomycin molecules could be detected, and taking into account 
the relative intensities of 1 : 4 adducts (36% and 10% for daunomycin and 
[Pt(2,2′-bipy)(Mebipy)2]4+, respectively), it is clear that daunomycin possesses a higher 
affinity for D2 than does the tetracation. It is possible that this is due to the interaction of D2 
with [Pt(2,2′-bipy)(Mebipy)2]4+ being weaker than that with daunomycin, although other 
influences, including the charge differences and the size of the binding site must also be 
considered. For example, the DNA-binding site of the tetracation might be larger than that 
of daunomycin, and thus it is feasible that the D2-binding of the complex could be stronger 
than that of daunomycin. In this case the larger binding site of the tetracation indicates that 
fewer species can be accommodated on a single D2 molecule, relative to daunomycin. 
 
As with the other species, the binding curve for [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-
bipy}2]8+ is also given, although, as mentioned above, the lower concentration at which it 
was used prevents a close analysis. Nevertheless, the presence of this complex at 25 µM 
(with 10 µM D2) allowed for adducts containing two dinuclear species bound to D2 to be 
observed, the relevant spectrum being presented in Figure 4.18. 
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Figure 4.18: ESI-MS of D2 with [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ (1 : 2.5 in 0.1 M NH4OAc); 
• [D2 – nH+]n– (n = 5, 6); ◦a [D2a – 3H+]3–; ◦b [D2b – 3H+]3–; •▪ [D2 + Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-
bipy}28+ – nH+](n–8)– (n = 13, 14); •▪▪ [D2 + 2[Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ – nH+](n–16)– 
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(n = 21, 22); •▫▫′ [D2 + Pt(2,2′-bipy){4,4′-bipy(CH2)64,4′-bipy}4+ – nH+](n–4)– (n = 9, 10); 
•▫▫▫′ [D2 + Pt(2,2′-bipy){4,4′-bipy(CH2)64,4′-bipy}26+ – nH+](n–6)– (n = 11, 12); 
•▫▫′▫′ [D2 + Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}6+ – nH+](n–6)– (n = 11, 12); •▪▫▫′ [D2 + Pt2(2,2′-
bipy)2{4,4′-bipy(CH2)64,4′-bipy}28+ + Pt(2,2′-bipy){4,4′-bipy(CH2)64,4′-bipy}4+ – nH+](n–12)– (n = 17, 18); 
•▪▫▫▫′ [D2 + Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}28+ + Pt(2,2′-bipy){4,4′-bipy(CH2)64,4′-bipy}26+          
– nH+](n–14)– (n = 19, 20); •▪▫▫′▫′ [D2 + Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}28+ + Pt2(2,2′-bipy)2{4,4′-
bipy(CH2)64,4′-bipy}6+ – nH+](n–14)– (n = 19, 20). 
 
When a 1 : 1 molar ratio of the related butylene derivative was used, the complex did not 
undergo fragmentation, with the only adducts that could be observed being of a 1 : 1 
stoichiometry (Figure 4.11, vide supra). In contrast, the use 25 µM complex allows for 
decomposition of this species to be observed, as evidenced by the detection of several weak 
adduct ions incorporating fragments of the metallocycle. Thus, the lower concentration of 
[Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ used, in addition to fragmentation processes 
competing with the D2-binding of intact octacations, does not allow much information to be 
gleaned from the analysis. Despite this, it is clear that [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-
bipy}2]8+ has a much higher propensity than [Pt(en)(PEGda)]2+ to form D2 adducts, a result 
which is probably due to the charge and extended π-systems of the former. 
 
Despite the complexes of PEGda being weak binders of D2, further ESI-MS studies of the 
interactions these species have with DNA were nevertheless undertaken. This work is 
described in the following Section. 
 
4.5.9 Interaction of PEGda complexes with D2′ 
In addition to the studies presented above concerning the binding of D2, preliminary 
experiments were also conducted using the related sequence D2′. This 16mer has a 
sequence of nucleobases identical to D2, but is biotinylated at each 5′ terminus. It could be 
prepared by annealing equimolar amounts of the biotinylated single strands D2′a and D2′b; 
the ESI mass spectra of the two individual strands, as well as the duplex D2′ are provided in 
the Appendices (Section A.4.3, Figures A.37-A.39). 
 
The biotin groups present in D2′ allow it to bind two avidin proteins, one at either end of the 
duplex. It was thought that if PEGda macrocycles of the type [Pt(N,N)(PEGda)]2+ were to 
thread D2′, then these pseudorotaxanes might be converted to rotaxanes by using 
streptavidin (dstreptavidin ≈ 4.6 nm)46 as a stopper (Scheme 4.1). While the strong non-covalent 
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•′   D2′ 
◦′a D2′a 
◦′b D2′b 
▪   Pt(tmeda)(PEGda)2+ 
▫   PEGda 
▫′  Pt(tmeda)2+ 
 
biotin-avidin interaction (KD ≈ 10-15 M)47 has recently been employed in the generation of 
pseudorotaxanes,48 as mentioned in the Introduction to this Thesis, the use of DNA as the 
thread in a synthetic rotaxane would be without precedent. 
 
5′-CCTCATGGCCATGACC-3′
3′-GGAGTACCGGTACTGG-5′
2 ×
+
5′-CCTCATGGCCATGACC-3′
3′-GGAGTACCGGTACTGG-5′
 
Scheme 4.1: Proposed synthesis of a [2]rotaxane comprising D2′, a macrocycle and two avidin 
molecules, all of which are held together by non-covalent interactions. In principle, any number of 
macrocycles might thread D2′, with [n]rotaxanes being the general description of the final product(s). 
 
If unambiguous characterisation of the resultant product(s) could be achieved, then 
conclusions could be drawn regarding whether or not the interactions of D2 with 
[Pt(N,N)(PEGda)]2+ are of a topological nature. For example, if threading does not occur, the 
macrocyclic ‘wheel’ and stoppered ‘axle’ would not be interlocked, although the two 
components might nevertheless remain weakly associated with each other. The use of, for 
example, ESI-MS might allow for this situation to be distinguished from that depicted in 
Scheme 4.1. 
 
The first and most crucial step in the synthesis involves the characterisation of a mixture 
possibly containing D2′-based pseudorotaxanes. The complexes of PEGda were considered 
the most likely candidates for this purpose and the binding of these to D2′ was investigated 
with two such macrocycles, [Pt(tmeda)(PEGda)]2+ and [Pt(2,2′-bipy)(PEGda)]2+. The ESI 
mass spectrum of D2′ in the presence of the former (at a 1 : 5 ratio in 0.1 M NH4OAc) is 
given below (Figure 4.19). 
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Figure 4.19: ESI-MS of D2′ with [Pt(tmeda)(PEGda)]2+ (1 : 5 in 0.01 M NH4OAc); •′ [D2′ – nH+]n– 
(n = 5, 6); ◦′a [D2′a – 3H+]3–; ◦′b [D2′b – 3H+]3–; •′▪ [D2′ + Pt(tmeda)(PEGda)2+ – nH+](n–2)– (n = 7, 8); 
•▫ [D2′ + PEGda – 6H+]6–; •′▪▫′ [D2′ + Pt(tmeda)(PEGda)2+ + Pt(tmeda)2+ – 9H+]5–. 
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•′   D2′ 
◦′a D2′a 
◦′b D2′b 
▪   Pt(2,2′-bipy)(PEGda)2+ 
▫   PEGda 
▫′  Pt(2,2′-bipy)2+ 
 
While the most intense ions in the spectrum are assigned to free D2′ (m/z 1817 and 2180 are 
assigned to the 6– and 5– charge states, respectively), the detection of other ions could be 
attributed to the formation of new species. In particular, the presence of the 1 : 1 adduct 
[D2′ + Pt(tmeda)(PEGda)2+ – nH+](n–2)– (n = 7, 8) could be confirmed, although the low 
intensity of its ions relative to those of D2′ indicate that the binding is of a weak nature. 
Adducts incorporating the individual fragments PEGda and [Pt(tmeda)]2+ were also 
observed, suggesting that decomposition was occuring under the conditions employed. 
Apart from differences in m/z values resulting from biotinylation, the spectrum in Figure 
4.19 is remarkably similar to that presented in Figure 4.9, obtained using D2. Thus, it is 
highly likely that the biotin groups do not play a major role in the binding of D2′ by 
[Pt(tmeda)(PEGda)]2+. 
 
The ESI-MS analysis was repeated for [Pt(2,2′-bipy)(PEGda)]2+, with the spectrum 
presented in Figure 4.20. This complex was found to bind D2′ with some strength, as 
indicated by the detection of ions consistent with the interaction of up to four macrocycles 
with a single duplex oligonucleotide. Two progressions of 6– and 5– ions with increasing 
m/z values were observed, these representing D2′ binding to successive 
[Pt(2,2′-bipy)(PEGda)]2+ complexes.‡‡‡‡ Apart from the observation of ions corresponding 
to D2′ and its single strands D2′a and D2′b, evidence could also be obtained for the 
fragmentation of [Pt(2,2′-bipy)(PEGda)]2+, as well as its interaction with D2′a. 
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Figure 4.20: ESI-MS of D2′ with [Pt(2,2′-bipy)(PEGda)]2+ (1 : 5 in 0.01 M NH4OAc); •′ [D2′ – nH+]n– 
(n = 6, 8); ◦′a [D2′a – nH+]n– (n = 3, 4); ◦′b [D2′b – 4H+]4–; •′▪ [D2′ + Pt(2,2′-bipy)(PEGda)2+ – nH+](n–2)– 
(n = 7, 8); •′▪▪ [D2′ + 2Pt(2,2′-bipy)(PEGda)2+ – nH+](n–4)– (n = 9, 10); •′▪▪▪ [D2′ + 3Pt(2,2′-bipy)(PEGda)2+ 
– 12H+]6–; •′▪▪▪▪ [D2′ + 4Pt(2,2′-bipy)(PEGda)2+ – 14H+]6–; •′▫ [D2′ + PEGda – 6H+]6–; •′▪▫′ [D2′ + Pt(2,2′-
bipy)(PEGda)2+ + Pt(2,2′-bipy)2+ – nH+](n–4)– (n = 9, 10); •′▪▪▫′ [D2′ + 2Pt(2,2′-bipy)(PEGda)2+ + Pt(2,2′-
bipy)2+ – nH+](n–6)– (n = 11, 12); •′▪▪▪▫′ [D2′ + 3Pt(2,2′-bipy)(PEGda)2+ + Pt(2,2′-bipy)2+ – 14H+]6–; 
•′▪▪▪▪▫′ [D2′ + 4Pt(2,2′-bipy)(PEGda)2+ + Pt(2,2′-bipy)2+ – 16H+]6–; ◦′a▪ [D2′a + Pt(2,2′-bipy)(PEGda)2+      
– 6H+]4–; ◦′a▪▫′ [D2′a + Pt(2,2′-bipy)(PEGda)2+ + Pt(2,2′-bipy)2+ – 8H+]4–. 
                                               
‡‡‡‡
 The analysis may suggest that more than four complexes can bind a single D2′ duplex, although the poor 
resolution in the range m/z > 2900 prevents any further assignment of the spectrum. 
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The observation that [Pt(2,2′-bipy)(PEGda)]2+ possesses moderate affinity for D2′ came as a 
very surprising result, especially considering that no adduct ions could be detected when the 
non-biotinylated dsDNA D2 was used instead (see Appendices, Section A.4.1, Figure A.23). 
Given the contrast in binding it seems probable that the biotin groups present in D2′ interact 
in some fashion with [Pt(2,2′-bipy)(PEGda)]2+, although details of this binding, which may 
involve the thioether group, are not well understood. Treatment of the 
D2′/[Pt(2,2′-bipy)(PEGda)]2+ mixture with excess streptavidin (5 equiv. in 0.1 mM 
NH4OAc) was performed, with the aim of determining whether or not interlocked species 
might be formed. However, ESI-MS analysis failed to indicate the presence of any D2′ 
(either free or bound to streptavidin), and the characterisation of this system has so far 
proven to be intractable. It is possible that further optimisation of the conditions, including 
pH, is required to facilitate a clean reaction. 
 
4.5.10  Discussion 
It must be noted that the mass spectrometric observation of ions assigned to a non-
covalently bound aggregate alone gives no information regarding the interactions holding 
the species together. Indeed, such species might result from the components participating in 
either non-specific gas-phase interactions or binding of a more particular nature. With 
respect to dsDNA, both experimental49 and theoretical evidence50 has confirmed the latter to 
be true – i.e. Watson-Crick base-pairing can be conserved during the ionisation of 
oligonucleotides. Hence, ions with m/z values consistent with the presence of dsDNA can be 
genuinely assigned to the double-helical structures one would expect to be prevalent in 
solution. However, questions remain as to the nature of the DNA adducts, and the 
interactions holding these together. For example, the mode of binding present in ions of the 
type [D2 + M(N,N)(PEGda)2+ – nH+](n–2)– is not known, and it is presently unclear whether 
these can be assigned to [2]pseudorotaxanes or if they are products featuring 
M(N,N)(PEGda)2+ bound to the surface of D2. 
 
An aspect of the characterisation not mentioned in this Thesis until now is the effect 
ESI-MS analysis might have on the molecules present in reaction mixtures. Importantly, the 
distribution of species detected by mass spectrometry need not be reflective of the 
equilibrium state in solution.33 Moreover, the ionisation process may lead to the formation 
of new species not present in solution, and, conversely, species present in solution may 
undergo fragmentation before they can be detected in the gas phase. This latter aspect 
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appeared to be particularly significant when the labile palladium(II) complexes were 
employed. As a consequence, efforts were made to characterise the behaviour of the 
macrocycles and their DNA adducts in solution, rather than in the gas phase. The solution 
experiments were performed using the platinum(II) complexes, as since their relative 
affinities for DNA had already been investigated using ESI-MS, it was anticipated that 
comparisons might be drawn from the separate studies. 
 
4.6 Thermal denaturation experiments 
4.6.1 Background 
Thermal denaturation refers to the heat-induced dissociation of DNA into its constituent 
strands. In the case of dsDNA, this involves the breaking of H-bonds between AT and GC 
base-pairs at elevated temperatures. This reversible, endothermic process is often referred to 
as DNA ‘melting’, and the temperature at which one half of the DNA strands exist as 
dsDNA is known as the melting temperature (Tm).51 As one would expect, this temperature 
is dependent on the DNA sequence employed, with longer DNA and DNA incorporating a 
high proportion of GC base-pairs typically having higher melting temperatures than shorter 
or AT-rich DNA. 
 
The stacked arrangement of nucleobases in dsDNA results in a decrease in UV absorptivity, 
relative to free ssDNA.52 As a result, thermal denaturation can be conveniently studied in 
solution by monitoring the absorbance at 260 nm of a given solution while the temperature 
is varied. If the melting process is monophasic, plots of absorbance versus temperature are 
of a sigmoidal shape, with the point of inflexion corresponding to Tm. As a result, data can 
be fitted to sigmoidal equations, with differentiation allowing for accurate estimation of Tm, 
which, for CT-DNA, was found to be 60.0ºC (Figure 4.21).§§§§ 
                                               
§§§§
 This is estimated from the x-intercept of the 2nd derivative, which gives the point of inflexion of the 
melting profile. 
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Figure 4.21: Melting profile for CT-DNA fitted to a sigmoidal function (top) and the 1st and 2nd 
derivatives of the fitted data (bottom). 
 
The binding of small molecules to a given dsDNA sequence can perturb the melting of the 
system, resulting in a change in the melting profile. In particular, measuring and comparing 
the melting temperature both in the presence (Tmc) and absence of these molecules (Tmo) 
represents a sensitive means of gathering information regarding the interactions at play. The 
difference between these values (∆Tm = Tmc – Tmo), while not directly implicating a 
particular interaction, can provide evidence that is consistent with certain modes of binding 
(which might be confirmed by other means). For example, it has been reported that the 
covalent binding of dsDNA to drugs such as cisplatin destabilises the double helix, resulting 
in negative ∆Tm values.53 Conversely, compounds that intercalate or bind to either of the 
DNA grooves typically stabilise duplex DNA, leading to positive ∆Tm values being 
recorded.54 As it was thought that some of the compounds prepared in the present study 
(those with 2,2′-bipy ligands) might intercalate DNA, it was expected that the latter effect, 
in which DNA is stabilised, would be observed. It was also believed that a compound 
encircling DNA might potentially cause the melting temperature to increase, as the 
dissociation of the two strands would be hindered by this topological interaction. 
 
4.6.2 Experimental approach and results 
The thermal denaturation of DNA in the presence of platinum(II) complexes was studied 
using a procedure similar to that described by Cusumano and co-workers.20 Mixtures of 
CT-DNA and complexes ([base-pairs]/[complex] = 10) were prepared in phosphate-buffered 
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saline solution (pH 7.4) and their thermal denaturation monitored spectrophotometrically 
over the temperature range 37 – 100ºC with the solutions being held at 37ºC for 30 min 
prior to heating. Data were fitted to sigmoidal plots using Origin 7.0®, with the maxima of 
the first derivatives occuring at Tmc. Examples of such derivative plots are given below both 
for CT-DNA and a CT-DNA mixture containing [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-
bipy}2](NO3)8 (110) (Figure 4.22). 
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Figure 4.22: Comparison of the 1st derivates of melting data for CT-DNA alone and in the presence of 
the complex [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+. 
 
The data acquired for CT-DNA in the absence of metal complex (Tmo) was subtracted from 
these to obtain ∆Tm. Measurements were also taken for all complexes in the absence of 
DNA and in each case it was found that these solutions had absorbances which were 
temperature invariant. This is consistent with the complexes having significant stability in 
the buffer solution used and allowed for reliable measurement of ∆Tm. 
 
The compounds employed in the study, along with the associated ∆Tm values, are given in 
Table 4.2 (sample melting curves for each compound are given in the Appendices, Section 
A.5). The known intercalator ethidium bromide (EtdBr, 152)55 was also used, in order to 
validate the study and allow for comparison with previously reported results obtained under 
different conditions. 
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Table 4.2: Changes in the melting temperature of CT-DNA in the presence of selected compounds. 
Compound ∆Tm / ºC 
PEGda -0.7 
[Pt(en)(PEGda)](NO3)2 (128) 0.6 
[Pt(tmeda)(PEGda)](NO3)2 (127) 0.8 
[Pt(2,2′-bipy)(NH3)2](NO3)2 (146) 5.4 
[Pt(2,2′-bipy)(PEGda)](NO3)2 (126) 5.8 
[Pt(2,2′-bipy)(Mebipy)2](NO3)4 (148) 11.3 
EtdBr (152) 12.6 
[Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2](NO3)8 (110) 25.5 
 
4.6.3 Discussion 
The free ligand PEGda and its complexes [Pt(tmeda)(PEGda)]2+ and [Pt(en)(PEGda)]2+ 
were each found to have a negligible effect on the melting of CT-DNA. This is consistent 
with these compounds interacting only very weakly (perhaps by electrostatic means) with 
DNA, at the concentrations used. The related complex [Pt(2,2′-bipy)(PEGda)]2+, was found 
to stabilise dsDNA, as evidenced by the associated ∆Tm of 5.8°C. This value is suggestive of 
intercalation, a binding mode made possible by the 2,2′-bipy co-ligand. When instead the 
related 2,2′-bipy complex [Pt(2,2′-bipy)(NH3)2]2+ was employed, a comparable increase in 
the DNA melting temperature (5.2°C) was observed.55***** The slight difference can be 
attributed to the polyether chain of PEGda, with the presence of this group potentially 
allowing for several weak interactions with DNA that lead to its stabilisation. Apart from 
participating in non-specific van der Waals forces (which are non-trivial when large species 
are concerned), the PEGda O atoms can act as H-bond acceptors with nucleobases 
(Nexocyclic–H···O), and this binding might take place in the major (with A and C bases) and/or 
minor grooves (with G). It was thought that if dsDNA was being encircled by the 
macrocycle, a high ∆Tm would be observed, owing to the two strands being mechanically 
held together. In view of the above melting results it seems unlikely that this is occurring in 
the present system, a result which is unsurprising given the conformational flexibility of the 
[Pt(2,2′-bipy)(PEGda)]2+ macrocycle and, more importantly, the length of CT-DNA 
(>20,000 base-pairs).††††† This latter aspect most likely causes threading to be a very slow 
                                               
*****
 Using similar conditions to those employed in the present study, Cusumano and co-workers found that the 
complex [Pt(2,2′-bipy)(en)]2+ had a similar ∆Tm value to that for EtdBr. Surprisingly, the melting studies in 
this work suggest that the analogue [Pt(2,2′-bipy)(NH3)2]2+ has a much lower affinity for DNA.  
†††††
 As specified by Sigma-Aldrich, from which CT-DNA was purchased. 
Chapter Four: DNA-binding studies 
92 
process‡‡‡‡‡ and, in any case, intercalation may still be a more favourable interaction (these 
two modes of interaction might be mutually exclusive). 
 
In contrast to the complexes of PEGda, the dinuclear metallocycle 
[Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ was found to cause a marked increase in the 
stability of dsDNA (∆Tm = 25.5°C). As mentioned above, while ∆Tm values do not confirm 
or rule out a mode of DNA-binding, when these values are high it is often the case that 
intercalative interactions are at play.20 It is possible that this compound behaves as a 
bis(intercalator), in which both [Pt(2,2′-bipy)]2+ fragments bind the same (or separate) DNA 
molecule. The high charge of the dinuclear complex, as well as its large aromatic surface 
area undoubtedly allow for this strong binding to occur. 
 
The tetracation [Pt(2,2′-bipy)(Mebipy)2]4+ was also found to stabilise dsDNA 
(∆Tm = 11.3°C), albeit to a lesser extent than the dinuclear species [Pt2(2,2′-bipy)2{4,4′-
bipy(CH2)64,4′-bipy}2]8+, of which it represents roughly half. Its reduced size and charge, 
relative to the dinuclear complex, most likely cause its interactions with DNA to be 
weaker.56§§§§§ Nevertheless, [Pt(2,2′-bipy)(Mebipy)2]4+ appears to bind DNA with a strength 
comparable to that of Etd+ (∆Tm = 12.6°C) and it is likely that this binding involves 
intercalation.  
 
4.7 Concluding remarks 
The conclusions drawn from both ESI-MS and thermal denaturation studies of DNA/metal 
complex mixtures were found to be largely in agreement. More specifically, both methods 
suggest that the platinum(II) complexes of PEGda have only very low affinities for nucleic 
acids. In contrast, the bipyridinium complexes [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ 
and [Pt(2,2′-bipy)(Mebipy)2]4+ interact strongly with DNA, a result attributed to their 
greater number of aryl groups and positive charge. Nevertheless, some differences between 
ESI-MS and thermal denaturation data were observed. In particular, mass spectrometric 
analyses indicated [Pt(2,2′-bipy)(NH3)2]2+ binds more strongly to DNA than do either of the 
metallocycles [Pt(2,2′-bipy)(PEGda)]2+ or [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+. 
                                               
‡‡‡‡‡
 Results with complexes of PEGda do not differ greatly when longer incubation times (60 min instead of 
30 min) were used. The use of even longer times was not investigated, owing to the possible degradation of 
DNA. 
§§§§§
 Indeed, the size of ∆Tm can be interpreted in terms of the extent of intercalation. In conjunction with other 
data, thermodynamic parameters, such as enthalpies of binding, can be obtained, although no such analyses 
were carried out in the present study. 
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However, melting data suggest the cyclic complexes bind DNA with equal or greater 
affinity. This was rationalised in terms of the fragmentation of the cyclic species during 
ESI-MS, which resulted in the lower intensities of ions assigned to intact complexes binding 
DNA. In general, however, the above results are consistent with previous comparisons 
between ESI-MS and UV-vis DNA-binding studies.34 Indeed, it has recently been shown 
that the relative binding strengths of metal complexes using these gas and solution phase 
techniques are comparable, although absolute binding affinities, if they can be determined, 
might not be.34 
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Chapter Five: Conclusions and future directions 
5.1 Synthesis of bridging ligands and their metal complexes 
The present study required the preparation of positively-charged macrocycles of 
considerable size. With this aim in mind, a new family of conformationally flexible, cationic 
N-heterocyclic derivatives was prepared and fully characterised, in five examples by an 
X-ray structure determination. Using a generalised alkylation protocol, the heterocycles 
4,4′-bipy, pyz, apyz and apym could be incorporated into halide salts of organocations, from 
which further compounds were prepared by anion exchange. The straightforward syntheses 
allowed for the generation of a large number of analogues, which were engineered in terms 
of their size, solubility and donor ability. Given the ease with which these salts can be tuned, 
it is hardly surprising that such compounds are extremely versatile, with related species 
having been shown to possess interesting anion binding, supramolecular and metal ion 
coordination chemistry. This final aspect was investigated with the potentially bridging 
diquaternary salts. 
 
The combination of labile palladium(II) and platinum(II) precursors with diquaternary salts 
resulted in the synthesis of several new multinuclear derivatives. Bis(4,4′-bipyridinium) 
dications were incorporated into dinuclear [2 + 2] metallocycles of formula 
[M2(2,2′-bipy)2{4,4′-bipy(CH2)n4,4′-bipy}2]8+ (M = Pd, Pt; n = 4, 6), 
cis-[Pd2Cl4{4,4′-bipy(CH2)34,4′-bipy}2]4+, [Pt2(dppp)2{4,4′-bipy(1,2-xylylene)4,4′-bipy}2]8+ 
and cis-[Pt2Cl4{4,4′-bipy(1,2-xylylene)4,4′-bipy}2]4+. While the bis(pyrazinium) analogues 
were found to be largely unreactive towards the palladium(II) and platinum(II) precursors 
used in the study, the doubly deprotonated bis(3-aminopyrazinium) and 
bis(2-aminopyrimidinium) derivatives, in contrast,  served as charge-neutral quadruply-
bridging ligands when interacted with [Pt(2,2′-bipy)(NO3)2]. The tetranuclear complexes 
[Pt4(2,2′-bipy)4{apyz(CH2)6apyz–2H}2]8+ and [Pt4(2,2′-bipy)4{apym(CH2)5apym–2H}2]8+ 
that resulted both incorporated Pt(II)···Pt(II) interactions in their bonding. 
 
Larger complexes could be prepared when the conformationally flexible diamine PEGda 
was interacted with cis-labile palladium(II) and platinum(II) precursors. The mononuclear 
dications [M(N,N)(PEGda)]2+
 
that resulted were found to possess high aqueous solubility, 
and their 62-membered chelate rings, if in an ‘open’ conformation, were thought to be of a 
size that might accommodate duplex DNA. 
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5.2 DNA-binding 
Having synthesised a series of large cationic metal complexes, DNA-binding studies were 
conducted using selected candidates in order to investigate the behaviour of these in the 
presence of nucleic acids.  
 
Solutions containing either the duplex D2 or free D2a and equimolar amounts of selected 
palladium(II) complexes were prepared and subjected to ESI-MS analysis. Results from 
studies of D2/Pd(II) mixtures suggested that extensive fragmentation was occuring under 
these conditions. In particular, the use of [Pd(tmeda)(PEGda)]2+ and [Pd2(2,2′-bipy)2{4,4′-
bipy(CH2)44,4′-bipy}2]8+ resulted in the detection of DNA adducts containing, for example, 
[Pd(tmeda)]2+ and [4,4′-bipy(CH2)44,4′-bipy]2+, respectively. Similar decomposition was 
observed with the binding of the single strand D2a, although 1 : 1 adducts of intact 
complexes could be observed when [Pd(tmeda)(PEGda)]2+, [Pd(2,2′-bipy)(PEGda)]2+ or 
[Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ was used. However, the relative intensities of 
these ions were invariably very low, indicating that such adducts are unstable under the 
ESI-MS conditions employed. 
 
Analogous experiments using platinum(II) derivatives were also performed, and in contrast 
to those with palladium(II), indicated that the complexes stay intact to a large degree. The 
ESI-MS analysis of D2/Pt(II) mixtures allowed for the detection of 1 : 1 D2 adducts when 
either [Pt(tmeda)(PEGda)]2+ or [Pt(en)(PEGda)]2+ was used. The highly-charged 
bipyridinium derivative [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2]8+ also gave rise to 1 : 1 
species, although these were of greater relative intensity than in the previous two examples. 
The difference in binding strength could be ascribed to the greater charge and aryl surface 
area of the dinuclear species relative to complexes of type [M(N,N)(PEGda)]2+. Indeed, it is 
anticipated that these PEGda complexes would require topological interactions to be at play 
in order to show any sort of affinity towards DNA. Such interactions, as suggested by MS 
studies, are either non-existent or of a highly transient nature, no doubt resulting from the 
conformational flexibility of PEGda. This aspect might cause DNA encirclement to be 
entropically disfavoured with enthalpic contributions (e.g. electrostatic interactions, 
H-bonding) not compensating for this. When the mononuclear complex 
[Pt(2,2′-bipy)(Mebipy)2]4+ was employed, an ion containing D2 bound to two tetracations 
could be observed, consistent with the complex representing ‘half’ of the dinuclear complex 
mentioned above. A 1 : 2 adduct of D2 could also be observed with [Pt(2,2′-bipy)(NH3)2]2+, 
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although it was found to be a weaker binder than the tetracationic complex, a result perhaps 
of its lower charge. Additional investigations using 1 : 5 (D2 : complex) mixtures afforded 
results consistent with the above observations and, furthermore, suggested that D2 is 
capable of binding more molecules of daunomycin than any of the platinum(II) species 
studied. It is thought that this is in some way due to the higher positive charge of the 
complexes (and also potentially their larger binding sites) hindering the binding of large 
numbers of the complexes to D2. The results of binding experiments using D2a and the 
platinum(II) complexes garnered results not dissimilar to those obtained with D2. However, 
it was noticed that ions containing D2a bound to fragmented complexes were more 
noticeable, indicating that the nucleobases in D2a could play more significant roles in 
mediating decomposition than in the case of the duplex D2, in which the bases participate in 
Watson-Crick pairing. 
 
In addition to the comprehensive study using D2, experiments were also conducted with the 
biotinylated analogue D2′, allowing for adducts to be observed with [Pt(tmeda)(PEGda)]2+ 
and [Pt(2,2′-bipy)(PEGda)]2+. In the latter case, up to four macrocycles were found to bind a 
single duplex, and it is believed that the biotin groups could be involved in binding. 
However, no products could be detected when this mixture was treated with streptavidin, 
suggesting that further optimisation of the reaction is necessary. Nevertheless, the work 
described here represents the first mass spectrometric investigation of the interactions 
between macrocyclic palladium(II) and/or platinum(II) complexes and oligonucleotides. 
 
A spectrophotometric investigation into the effects platinum(II) complexes have on the 
thermal denaturation of CT-DNA was also conducted in order to study interactions in the 
solution phase. The complex [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ and its 
mononuclear analogue [Pt(2,2′-bipy)(Mebipy)2]4+ were found to stabilise CT-DNA 
considerably, with the associated ∆Tm values being consistent with intercalative interactions 
being present. In contrast, [Pt(tmeda)(PEGda)]2+ and [Pt(en)(PEGda)]2+ (as well as the 
parent compound PEGda) caused negligible changes in Tm suggesting that these compounds 
interact only weakly with CT-DNA. The results for the related metallocycle 
[Pt(2,2′-bipy)(PEGda)]2+ suggested that it interacts moderately with DNA, possibly by 
intercalation of the [Pt(2,2′-bipy)]2+ fragment. This was supported by the analysis with 
[Pt(2,2′-bipy)(NH3)2]2+, for which a similar ∆Tm value was obtained, and indicates that the 
PEGda ligand is unlikely to play a major role in DNA-binding. 
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While the findings from ESI-MS experiments were largely in agreement with those from 
thermal denaturation, some discrepancies between results from the two methods could be 
found. For example, when comparing the binding of [Pt(2,2′-bipy)(NH3)2]2+ and 
[Pt(2,2′-bipy)(PEGda)]2+, ESI-MS analyses suggested that the former had a greater affinity 
for DNA, while the thermal denaturation studies suggested their interactions with DNA to 
be of comparable strengths. In such cases it was considered likely that the fragmentation of 
complex species under ESI-MS conditions caused the binding strength of some species 
(in this case [Pt(2,2′-bipy)(PEGda)]2+) to be underestimated. 
 
As such, it is clear that both the further development of macrocycle synthesis and the 
strategic use of characterisation methods are necessary in order to gain detailed information 
regarding binding and perhaps to identify species capable of encircling dsDNA. 
 
5.3 Future work 
The design and synthesis of large metallocyclic architectures with the H2O-solubility, size 
and charge required for encircling dsDNA is not a straightforward matter. Ideally, it would 
be desirable to have access to structures possessing the high positive charge of the dinuclear 
bipyridinium complexes with the size and solubility properties of the PEGda complexes. 
Lastly, it is also necessary that these species exhibit some degree of conformational rigidity, 
analogous to the toroidal proteins, whose preorganised structures no doubt contribute to 
them being effective hosts for linear dsDNA. Two future synthetic targets, both of which are 
platinum(II) complexes of bidentate bipyridinium-based ligands, are given below. 
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Molecular hexagon 152 incorporates six trans-diammineplatinum(II) fragments bridged by 
six 2,6-bis(4,4′-bipyridinium)-9-thiabicyclo[3.3.1]nonane ligands. Such a compound might 
be prepared from (±)-2,6-bis(4,4′-bipyridinium)-9-thiabicyclo[3.3.1]nonane nitrate and 
trans-[Pt(NH3)2(NO3)2], provided no trans → cis isomerism of the platinum(II) centres 
occurs. Indeed, as mentioned in Chapter Two, Stang and co-workers have prepared similar 
(although lipophilic) self-assembled hexagonal complexes from the very same bridging 
ligand. In contrast, a different strategy, namely the cyclisation of a large, somewhat flexible 
bidentate ligand might also afford a potential ‘nanoshuttle’. This approach was employed in 
the present study to afford complexes of PEGda and might be exploited for the formation of 
a highly charged metallocycle such as 153. The synthesis of such a macrocycle would first 
require the (non-trivial) preparation of a suitably large decaquaternary NO3- salt similar to 
106, which could afford 153 upon treatment with [Pt(en)(NO3)2]. 
 
Given candidate macrocycles amenable to ‘nanoshuttle’ behaviour, the unambiguous 
characterisation of non-covalent DNA/metal complex adducts that might result remains a 
challenge. The incubation of a suitable complex, such as [Pt(2,2′-bipy)(PEGda)]2+ (or even 
152/153) with biotinylated dsDNA D2′, followed by treatment with streptavidin remains an 
interesting prospect, although, as mentioned above, this approach is not without 
complications. Such a synthesis would result in the formation of interlocked and/or non-
interlocked products, depending on the extent to which the threading of D2′ occurs. The 
resulting species could then be subjected to ESI-MS (run at different cone voltages) or 
tandem MS/MS analyses, in order to gauge how easily the macrocyclic ‘wheel’ dissociates 
from the protein/DNA ‘axle’, thus providing information regarding the presence of 
topological interactions. Contrasting these results to those obtained when the reaction with 
streptavidin is performed before incubation with the metallocycle (a sequence which should 
not generate rotaxanes) might also shed light on the processes involved. 
 
A related method of generating permanently interlocked species is the T4 DNA ligase-
mediated cyclisation of linear DNA in the presence of macrocyclic species, which might 
give rise to [n]catenanes, as described in Chapter One. An interesting prospect would be to 
study the effect of macrocycle concentration on the number of macrocycles potentially 
threaded onto the longer DNA duplexes that would be used for this approach. 
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More generally, analysing the interactions of metallocyclic platinum(II) derivatives with a 
wider variety of duplexes would afford further evidence regarding the nature of DNA-
binding and reveal any inherent sequence selectivity. The complexes prepared in this work 
could be used for such screening and concrete thermodynamic and kinetic data could be 
obtained from isothermal titration calorimetric studies. 
 
As has been documented in this Thesis, the results of the synthetic and DNA-binding 
experiments carried out in the present study have allowed for several conclusions to be 
drawn regarding the chemistry of metallocyclic species. Despite this, many questions 
remain unanswered and it is anticipated that further synthesis and DNA work (i.e. more 
iterations of the design and testing processes) will go some way to addressing these matters. 
With a view to the future, the successful development of DNA ‘nanoshuttles’ might give 
rise to functional species that may serve as topological probes of DNA structure and 
function or novel medicinal agents with unprecedented modes of action. Such prospects will 
undoubtedly serve as powerful motivations for research in the exciting area of 
supramolecular DNA recognition to flourish for many years to come. 
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Chapter Six: Experimental 
6.1 Instrumentation 
Low resolution ESI-MS data were collected using a Finnigan LCQ detector. High resolution 
ESI-FT-ICR-MS data were collected using either a Bruker 7.0T or a Bruker Apex 4.7T 
spectrometer. Solutions containing oligonucleotides were analysed using a Waters 
Micromass Q-ToF2 Ultima spectrometer (see Section 6.12). 
 
NMR spectra were recorded at 300 K using a Bruker Avance DPX200, DPX300 or DPX400 
spectrometer. Unless otherwise stated: chemical shifts (δ) are reported relative to Me4Si and 
were referenced to residual solvent signals;1 data for 1H, 13C{1H} and 195Pt (relative to 
external Na2[PtCl4] at –1628 ppm) nuclei were recorded at 300, 75 and 85 MHz, 
respectively; 2-D spectra were acquired with 1H and 13C channels at 400 and 100 MHz, 
respectively. 
 
UV-vis data were recorded using a Varian Cary 1E spectrophotometer, except for thermal 
denaturation experiments, for which a Cary 500 spectrophotometer (equipped with a Cary 
temperature controller) was used. 
 
Elemental analyses were performed at the Campbell Microanalytical Laboratory, University 
of Otago, New Zealand. 
 
Single-crystal X-ray diffraction data were collected at the University of Sydney using either 
a Bruker APEXII-FR591 or a Bruker SMART 1000 CCD diffractometer and processed by 
either Dr Paul Jensen (30) or Dr Jack Clegg (43, 61, 80′, 90). The procedures used, as well as 
selected crystallographic details, are given in the Appendices (Section A.3). 
 
6.2 Materials 
Unless otherwise stated, all chemicals used were obtained from commercial sources,* are of 
reagent grade and were used without further purification. Solutions containing Na2[PdCl4] 
or PdCl2 were filtered prior to use. Many organic compounds used were hygroscopic and all 
                                               
*
 The author gratefully acknowledges Johnson-Matthey for the generous loan of K2[PtCl4]. 
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solid materials were dried (P2O5) under vacuum for at least 24 h prior to use. The compound 
PEGda (Fluka, oligomeric purity) contained trace impurities, as evidenced by ESI-MS.† 
 
The 16mers D2a, D2b, D2′a and D2′b (Geneworks, HPLC grade) were purified using 
HPLC (aqueous NH4OAc→MeCN gradient) as reported previously.2 In each case, 
equimolar quantities3‡ of appropriate strands (both dissolved in 0.1 M NH4OAc, pH 7.4) 
were combined to give a mixture in which the concentration of each of these constituents 
was 1 mM. This solution was heated at (Tm + 20)ºC and cooled slowly to room temperature 
to afford a stock solution of the annealed dsDNA, which was used without further 
purification.§ CT-DNA (sodium salt, highly polymerised) was resuspended in phosphate-
buffered saline solution (1 mM phosphate, 2 mM NaCl, pH 7.4) and its concentration 
determined spectrophotometrically.4** 
 
THF was dried over Na/benzophenone ketyl.5 DMF (peptide grade) was stored over 4 Å 
molecular sieves. MilliQTM H2O was used for all experiments requiring H2O. 
 
Cellulose microfilters (0.2 µm) were used when small volumes of aqueous solutions 
required filtration. When larger volumes required filtration and no acidic species (e.g. those 
containing aminopyrimidinium and aminopyrazinium groups) were present, solids were 
removed by filtration through Celite. 
 
6.3 Synthesis of quaternary halide salts 
The syntheses of ligands of the type [Y(spacer)Y]X2 (Y = 4,4′-bipy, pyz, apyz, apym; 
X = Cl, Br) were performed using adaptations of the procedure described by Atalla et al.6 
Unless otherwise specified, the N-heterocyclic nucleophile (12 mmol) and bis(alkyl halide) 
derivative (3 mmol) were stirred overnight in DMF (10 mL) at 70°C, over which time an 
off-white precipitate formed. After cooling to room temperature, this was isolated by 
filtration, washed with DMF (2 mL) and Et2O (5 mL) and crystallised from a small volume 
                                               
†
 O,O′-Bis(aminoethyl)heptadeca(ethylene glycol) could be detected (m/z 854 [M + H+]+). 
‡
 Values for [ssDNA] were estimated by measurement of UV absorbance at 260 nm using ε260 values for A, G, 
C and T of 15200, 12010, 7050 and 8400 M−1cm−1, respectively.3 
§
 The purification and annealing of D2a and D2b to give D2 was performed by Dr Thitima Urathamakul at the 
University of Wollongong. 
**
 CT-DNA concentration, quantified as [base-pairs], was estimated using ε260 = 13100 Mbase-pairs−1cm−1.4 
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of hot H2O to afford the desired product. Derivatives of 2-aminopyrimidine did not require 
crystallisation. 
 
(±)-2,6-Bis(4,4′-bipyridinium)-9-thiabicyclo[3.3.1]nonane chloride (30) 
The title compound was prepared 
from 4,4′-bipyridine and (±)-2,6-
dichloro-9-thiabicyclo[3.3.1]nonane 
(60%, off-white powder). A similar method (using MeCN rather than DMF) has been 
reported by Sharpless.7 However, in this preparation the title compound is not 
purified/characterised, but rather converted directly to the PF6- salt using excess NaPF6. 
Slow evaporation of an aqueous solution of the title compound afforded single crystals 
suitable for X-ray crystallographic analysis, details of which are given in the Appendices 
(Section A.3). 
1H NMR (D2O) δ 9.24 (d, 4H, 3JH,H = 6.58 Hz, H2), 8.84 (d, 4H, 3JH,H = 5.05 Hz, H2′), 8.56 
(d, 4H, 3JH,H = 6.58 Hz, H3), 7.99 (d, 4H, 3JH,H = 5.05 Hz, H3′), 5.84 (m, 2H, Haliphatic), 3.46 
(m, 2H, Haliphatic), 3.25 (m, 2H, Haliphatic), 2.55 (m, 6H, Haliphatic) ppm. ESI-MS: m/z 487.13 
[M – Cl-]+, 226.07 [M – 2Cl-]2+. Anal. calcd for C28H28N4Cl2S·4H2O: C, 56.47; H, 6.09; 
N, 9.41. Found: C, 56.25; H, 6.11; N, 9.19. 
 
1,6-Bis(3-aminopyrazinium)hexane bromide (48) 
The title compound was prepared from aminopyrazine and 
1,6-dibromohexane (56%, yellow powder). 
1H NMR (D2O) δ 8.59 (m, 3H, H5), 8.16 (m, 3H, H6), 7.96 
(s, 3H, H2), 4.49 (t, 4H, 3JH,H = 7.5 Hz, Hhexyleneα), 2.04 (m, 4H, Hhexyleneβ), 1.46 (m, 4H, 
Hhexyleneγ) ppm. 13C{1H} NMR (D2O) δ 159.06, 149.38, 125.52, 123.58 (t, 1JC,N = 8.0 Hz), 
62.64, 30.24, 25.20 ppm. ESI-MS: m/z 353.20 [M – Br-]+, 273.20 [M – H – 2Br-]+, 137.20 
[M – 2Br-]2+. Anal. calcd for C14H22N6Br2: C, 38.73; H, 5.11; N, 19.36. Found: C, 38.89; 
H, 5.39; N, 19.16. 
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1,3,5-Tris(3-aminopyraziniummethyl)-2,4,6-trimethylbenzene bromide 
monohydrate (53) 
Aminopyrazine (350 mg, 3.68 mmol) and 
1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene (147 mg, 
0.368 mmol) were stirred overnight in DMF (2 mL) at 70°C. 
After cooling to room temperature, the solid was isolated by 
filtration, washed with DMF (0.5 mL) and Et2O (1 mL) and 
crystallised from EtOH/H2O to afford the title compound as a 
colourless crystals (139 mg, 54%). 
1H NMR (D2O, relative to residual EtOH) δ 8.64 (m, 3H, H5), 8.12 (m, 3H, H6), 7.94 
(s, 3H, H2), 6.02 (s, 6H, CH2), 2.40 (s, 9H, CH3) ppm. 13C{1H} NMR (D2O) δ 159.63, 
150.1, 145.71, 127.91, 124.40, 122.96, 60.02, 17.13 ppm. ESI-MS: m/z 603.67 [M – Br-]+. 
Anal. calcd for C24H30N9Br3·H2O: C, 41.05; H, 4.59; N, 17.95. Found: C, 41.18; H, 4.60; 
N, 17.34. 
 
1,2-Bis(2-aminopyrimidinium)ethane bromide (62) 
The title compound was prepared from 2-aminopyrimidine and 
1,2-dibromoethane (71%, off-white powder). 
1H NMR (D2O) δ 8.76 (m, 2H, H4), 8.54 (m, 2H, H6), 7.04 
(m, 2H, H5), 4.10 (t, 4H, 3JH,H = 9.14 Hz, CH2) ppm. ESI-MS: m/z 216.87 [M – 2Br- – H+]+, 
122.2 [M – 2Br- – apym – H+]+. 
 
1,4-Bis(2-aminopyrimidinium)butane bromide (63) 
The title compound was prepared from 2-aminopyrimidine and 
1,4-dibromobutane (76%, white powder). 
1H NMR (400 MHz, D2O) δ 8.82 (dd, 2H, 3JH,H = 4.4 Hz, 
4JH,H = 2.0 Hz, H4), 8.40 (dd, 2H, 3JH,H = 6.4 Hz, 4JH,H = 2.0 Hz, H6), 7.14 (dd, 2H, 
3JH,H = 6.4 Hz, 3JH,H = 4.4 Hz, H5), 4.28 (m, 4H, Hbutyleneα), 2.04 (m, 4H, Hbutyleneβ) ppm. 
13C{1H} NMR (100 MHz, D2O) δ 166.3, 155.5, 149.8, 111.5, 53.8, 23.1 ppm. ESI-MS: 
m/z 245.07 [M – 2Br- – H+]+, 123.07 [M – 2Br-]2+. Anal. calcd for C12H18N6Br2·3H2O: 
C, 31.32; H, 4.73; N, 18.26. Found: C, 31.00; H, 5.12; N, 17.81. 
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1,5-Bis(2-aminopyrimidinium)pentane bromide (66) 
The title compound was prepared from 2-aminopyrimidine and 
1,5-dibromopentane (22%, colourless crystals). Significant loss of 
yield was due to crystallisation from H2O. 
1H NMR (300 MHz, D2O) δ 8.85 (m, 2H, H4), 8.43 (m, 2H, H6), 7.17 (m, 2H, H5), 4.25 
(t, 4H, 3JH,H = 6.9 Hz, Hpentyleneα), 2.02 (m, 4H, Hpentyleneβ), 1.56 (m, 2H, Hpentyleneγ) ppm. 
13C{1H} NMR (D2O) δ 166.52, 155.94, 150.26, 111.83, 54.71, 26.24, 22.60 ppm. ESI-MS: 
m/z 758.73 [2M – Br-]+, 678.67 [2M – 2Br- – H+]+, 598.67 [2M – 3Br- – 2H+]+, 520.00 
[2M – 4Br- – 3H+]+, 340.80 [M – Br-]+, 259.13 [M – 2Br- – H+]+, 130.27 [M – 2Br-]2+. Anal. 
calcd for C13H20N6Br2·2H2O: C, 34.69; H, 5.22; N, 18.67. Found: C, 34.72; H, 5.36; 
N, 18.61. 
 
1,6-Bis(2-aminopyrimidinium)hexane bromide (69) 
The title compound was prepared from 2-aminopyrimidine and 
1,6-dibromohexane (66%, off-white powder). 
1H NMR (400 MHz, D2O) δ 8.79 (dd, 2H, 3JH,H = 4.4 Hz, 
4JH,H = 2.0 Hz, H4), 8.38 (dd, 2H, 3JH,H = 6.8 Hz, 4JH,H = 2.0 Hz, H6), 7.11 (dd, 2H, 
3JH,H = 6.8 Hz, 3JH,H = 4.4 Hz, H5), 4.19 (t, 4H, 3JH,H = 7.2 Hz, Hhexyleneα), 1.91 (m, 4H, 
Hhexyleneβ), 1.47 (m, 4H, Hhexyleneγ) ppm. 13C{1H} NMR (100 MHz, D2O) δ 166.0, 155.5, 
149.9, 111.4, 54.6, 26.0, 25.0 ppm. ESI-MS: m/z 273.13 [M – 2Br- – H+]+, 137.07          
[M – 2Br-]2+. Anal. calcd for C14H22N6Br2: C, 38.73; H, 5.11; N, 19.36. Found: C, 38.50; 
H, 5.12; N, 19.10. 
 
1,8-Bis(2-aminopyrimidinium)octane bromide (72) 
The title compound was prepared from 2-aminopyrimidine and 
1,8-dibromooctane (73%, white powder). 
1H NMR (D2O) δ 8.76 (dd, 2H, 3JH,H = 4.44 Hz, 4JH,H = 1.87 Hz, 
H4), 8.33 (dd, 2H, 3JH,H = 6.65 Hz, 4JH,H = 1.97 Hz, H6), 7.07 (dd, 2H, 3JH,H = 6.65 Hz, 
3JH,H = 4.44 Hz, H5), 4.14 (t, 4H, 3JH,H = 7.60 Hz, Hoctyleneα), 1.86 (m, 4H, Hoctyleneβ), 1.35 
(m, 8H, Hoctyleneγ,δ) ppm. 13C{1H} NMR (D2O) δ 166.25, 155.86, 150.31, 111.64, 55.12, 
28.40, 26.45, 25.56 ppm. ESI-MS: m/z 380.93 [M – Br-]+, 301.27 [M – 2Br- – H+]+, 151.93         
[M – 2Br-]2+. Anal. calcd for C16H26N6Br2·H2O: C, 40.02; H, 5.88; N, 17.50. Found: 
C, 40.05; H, 5.51; N, 17.28. 
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1,2-Bis(1-methyl-2-aminopyrimidinium)benzene bromide (75) 
The title compound was prepared from 2-aminopyrimidine and 
1,2-bis(bromomethyl)benzene (67%, white powder). 
1H NMR (400 MHz, D2O, relative to DMF) δ 8.92 
(dd, 2H, 3JH,H = 4.1 Hz, 4JH,H = 1.9 Hz, H4), 8.26 (dd, 2H, 
3JH,H = 6.2 Hz, 4JH,H = 2.0 Hz, H6), 7.47 (m, 2H, H3xylyl), 7.23 (br, s, 4H, NH2), 7.09 
(m, 2H, H4xylyl), 7.03 (dd, 2H, 3JH,H = 6.4 Hz, 3JH,H = 4.4 Hz, H5), 5.08 (s, 4H, CH2) ppm. 
13C{1H} NMR (100 MHz, D2O, relative to DMF) δ 167.5, 156.7, 149.7, 130.9, 129.5, 128.7, 
112.4, 54.9 ppm. ESI-MS: m/z 293.07 [M – 2Br- – H+]+, 198.27 [M – 2Br- – apym – H+]+. 
Anal. calcd for C16H18N6Br2: C, 42.31; H, 3.99; N, 18.50. Found: C, 42.42; H, 4.00; 
N, 18.60. 
 
1,3-Bis(1-methyl-2-aminopyrimidinium)benzene bromide (78) 
The title compound was prepared from 2-aminopyrimidine 
and 1,3-bis(bromomethyl)benzene (69%, white powder). 
1H NMR (D2O) δ 8.88 (m, 2H, H4apym), 8.63 (m, 2H, H6apym), 
7.63 (t, 1H, 3JH,H = 7.58 Hz, H5xylylene), 7.47 (d, 4H, 3JH,H = 7.58 Hz, H4xylylene), 7.23 (s, 1H, 
H2xylylene), 7.17 (m, 2H, H5apym), 5.47 (s, 4H, CH2) ppm. Traces of DMF present. 
13C{1H} NMR (D2O) δ 167.2 (C4apym), 156.5 (C2apym), 150.2 (C6apym), 132.5 (C1xylylene), 
131.3 (C5xylylene), 129.7 (C4xylylene), 127.9 (C2xylylene), 112.3 (C5apym), 57.3 (CH2) ppm. For 
2-D COSY and HSQC, see Section A.1. ESI-MS: m/z 827.00 [2M – Br-]+, 746.67           
[2M – 2Br- – H+]+, 666.67 [2M – 3Br- – 2H+]+, 584.87 [2M – 4Br- – 3H+]+, 293.13            
[M – 2Br- – H+]+, 198.20 [M – apym – 2Br- – H+]+, 147.20 [M – 2Br-]2+. Anal. calcd for 
C16H18Br2N6: C, 42.31; H, 3.99; N, 18.50. Found: C, 42.13; H, 3.97; N, 18.42. 
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2,6-Bis(1-methyl-2-aminopyrimidinium)pyridine chloride (83) 
2,6-Bis(chloromethyl)pyridine (0.447 g, 2.54 mmol) and 
2-aminopyrimidine (1.21 g, 12.7 mmol) were dissolved in 
DMF (2 mL) and the mixture stirred overnight at 70°C. The 
precipitate was isolated by filtration and washed with DMF (1 mL) and Et2O (1 mL). The 
crude solid was dissolved in H2O (5 mL) and the solution was allowed to evaporate slowly, 
affording the product as colourless needles (0.411 g, 44%).  
1H NMR (D2O) δ 8.88 (dd, 2H, 3JH,H = 4.40 Hz, 4JH,H = 2.03 Hz, H4) 8.30 
(dd, 2H, 3JH,H = 6.61 Hz, 4JH,H = 2.03 Hz, H6) 8.04 (t, 1H, 3JH,H = 7.81 Hz, H4lut) 7.59 
(d, 2H, 3JH,H = 7.81 Hz, H3lut) 7.12 (dd, 2H, 3JH,H = 6.61 Hz, 4JH,H = 4.40 Hz, H5) 5.58 
(s, 4H, CH2) ppm. Traces of DMF present. 13C{1H} NMR (D2O) δ 167.08, 156.48, 151.25, 
150.76, 139.32, 122.65, 111.57, 57.54 ppm. ESI-MS: m/z 294.13 [M – 2Cl- – H+]+, 199.27            
[M – 2Cl- – H+ – apym]+, 147.60 [M – 2Cl-]2+. Anal. calcd for C15H17Cl2N7·1.25H2O: 
C, 46.34; H, 5.06; N, 25.22. Found: C, 46.19; H, 4.99; N, 25.05. 
 
1,3,5-Tris[1-(2-aminopyrimidiniummethyl)]-2,4,6-trimethylbenzene 
bromide (85) 
The title compound was prepared analogously to 
1,3,5-tris(3-aminopyraziniummethyl)-2,4,6-trimethylbenzene 
monohydrate (53), using 2-aminopyrimidine instead of 
aminopyrazine (73%, white powder). 
1H NMR (D2O) δ 8.87 (m, 3H, H4), 7.96 (m, 3H, H6), 7.10 
(m, 3H, H5), 5.40 (s, 6H, CH2), 2.31 (s, 9H, CH3) ppm. Traces 
of DMF present. 13C{1H} NMR (100 MHz, D2O) δ 165.8, 156.3, 145.6, 144.6, 127.0, 112.0, 
51.7, 16.3 ppm. ESI-MS: m/z 442.00 [M – 3Br-]+, 347.13 [M – 3Br- – 2H+ – apym]+, 252.07 
[M – 3Br- – 2H+ – 2apym]+, 221.53 [M – 3Br- – H+]2+, 174.07 [M – 3Br- – H+ – apym]2+. 
Anal. calcd for C24H30N9Br3·4H2O: C, 38.11; H, 5.06; N, 16.67. Found: C, 38.21; H, 4.96; 
N, 16.61. 
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1,2,4,5-Tetrakis[1-(2-aminopyrimidiniummethyl)]benzene bromide (88) 
2-Aminopyrimidine (475 mg, 5.00 mmol) and 
1,2,4,5-tetrakis(bromomethyl)benzene (225 mg, 
0.500 mmol) were stirred in DMF (2 mL) for 48 h at 70°C. 
After cooling to room temperature, this was isolated by 
filtration, washed with DMF (0.5 mL) and Et2O (1 mL) and 
dried in vacuo to afford the crude product as a white powder 
(87 mg, 21%). 
1H NMR (D2O) δ 8.87 (m, 4H, H4), 8.34 (m, 4H, H6), 7.19 (m, 4H, H5), 6.00 (s, 2H, CH), 
5.59 (s, 8H, CH2), 2.31 (s, 9H, CH3) ppm. Traces of DMF and Et2O present. 
ESI-MS: m/z 668.53 [M – 3Br- – 2H+]+, 507.13 [M – 4Br- – 3H+]+, 293.80 [M – 3Br-           
– H+]2+, 254.07 [M – 4Br- – 2H+]2+. 
 
6.4 Synthesis of bis(bromoalkyl) diquaternary Br- salts 
The syntheses of ligands of type [Br(CH2)n4,4′-bipy(CH2)nBr]Br2 (97: n = 4; 98: n = 5; 
99: n = 6) were performed using adaptations of a procedure reported for the dodecyl 
derivative (n = 12).8 A mixture of α,ω-dibromoalkane (50 mmol), 4,4′-bipyridine (10 mmol) 
and DMF (30 mL) was stirred for 48 h at 70°C, over which time a precipitate formed. After 
cooling to room temperature, this was isolated by filtration, washed with DMF (20 mL) and 
Me2CO (20 mL) and dried in vacuo to give the desired product as a crude solid.†† 
 
1,1′-Bis(4-bromobutyl)-4,4′-bipyridinium bromide (97) 
A synthesis of the title compound has 
been reported previously, but it resulted 
in a inseparable mixture containing this 
compound.9 It was prepared from 1,4-dibromobutane and 4,4′-bipyridine (90%, yellow 
powder). 
1H NMR (D2O) δ 9.17 (d, 4H, 3JH,H = 6.4 Hz, H2′), 8.59 (d, 4H, 3JH,H = 6.2 Hz, H3′), 
4.84 (obscured by HOD peak, 4H, H4), 3.58 (t, 4H, 3JH,H = 6.4 Hz, H1), 2.29 (m, 4H, H3), 
2.01 (m, 4H, H2) ppm. ESI-MS: m/z 508.67 [M – Br-]+. 
                                               
††
 The solid products were found to contain trace amounts of [4,4′-bipy(CH2)n4,4′-bipy]Br2 as well DMF and 
Me2CO solvate. They were used without further purification. 
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1,1′-Bis(5-bromopentyl)-4,4′-bipyridinium bromide (98) 
The title compound was prepared from 
1,5-dibromopentane and 4,4′-bipyridine 
(87%, yellow powder). 
1H NMR (D2O) δ 9.19 (d, 4H, 
3JH,H = 6.7 Hz, H2′), 8.62 (d, 4H, 3JH,H = 5.9 Hz, H3′), 4.83 (obscured by HOD peak, 4H, 
H5), 3.57 (t, 4H, 3JH,H = 6.5 Hz, H1), 2.16 (m, 4H, H4), 1.99 (m, 4H, H2), 1.59 
(m, 4H, H3) ppm. ESI-MS: m/z 536.47 [M – Br-]+, 228.00 [M – 2Br-]2+. 
 
1,1′-Bis(6-bromohexyl)-4,4′-bipyridinium bromide (99) 
The title compound was prepared 
from 1,6-dibromohexane and 
4,4′-bipyridine (81%, yellow 
powder). 
1H NMR (D2O) δ 9.17 (d, 4H, 3JH,H = 6.5 Hz, H2′), 8.60 (d, 4H, 3JH,H = 6.2 Hz, H3′), 
4.78 (obscured by HOD peak, 4H, H6), 3.54 (t, 4H, 3JH,H = 6.6 Hz, H1), 2.16 (m, 4H, H5), 
1.90 (m, 4H, H2), 1.60-1.40 (m, 8H, H3,4) ppm. ESI-MS: m/z 564.80 [M – Br-]+, 
242.13 [M – 2Br-]2+. 
 
6.5 Synthesis of tetraquaternary Br- salts 
The compounds 100 and 101 were synthesised using a procedure similar to that previously 
described for the dodecyl derivative.8 A mixture of the 1,1′-bis(ω-bromoalkyl)-4,4′-
bipyridinium bromide (3.40 mmol) and 4,4′-bipyridine (5.74 g, 34.0 mmol) in DMF/MeOH 
(2 : 1, 100 mL) was stirred at reflux for 48 h. The mixture was allowed to cool, and MeOH 
was removed in vacuo. The precipitate was isolated by filtration, washed with DMF (5 mL), 
Et2O (10 mL) and crystallised from H2O to give the tetraquaternary salt as a pure solid. 
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1,1′-Bis[4-(4,4′-bipyridinium)butyl]-4,4′-bipyridinium bromide (100) 
 
The title compound was prepared from 1,1′-bis(4-bromobutyl)-4,4′-bipyridinium bromide 
(97) (27%, tan fibres).  
1H NMR (D2O) δ 9.20 (d, 4H, 3JH,H = 6.7 Hz, H2′′), 9.05 (d, 4H, 3JH,H = 6.7 Hz, H2′′′), 8.80 
(d, 4H, 3JH,H = 6.0 Hz, H2′), 8.62 (d, 4H, 3JH,H = 6.6 Hz, H3′′), 8.46 (d, 4H, 3JH,H = 6.7 Hz, 
H3′′′), 7.95 (d, 4H, 3JH,H = 6.0 Hz, H3′), 4.88 (m, 4H, H1), 4.81 (obscured by HOD peak, 
4H, H4), 2.29 (m, 8H, H2,3) ppm. 13C{1H} NMR (D2O) δ 154.49, 150.67, 150.42, 145.96, 
145.24, 142.90, 127.70, 126.67, 122.92, 61.52, 60.90, 27.80, 27.75 ppm. For 2-D COSY, 
see Section A.1. ESI-MS: m/z 820.93 [M – Br-]+, 370.00 [M – 2Br-]2+. Anal. calcd for 
C38H40Br4N6·3.5H2O: C, 47.37; H, 4.92; N, 8.72. Found: C, 47.41; H, 4.95; N, 8.68. 
 
1,1′-Bis[6-(4,4′-bipyridinium)hexyl]-4,4′-bipyridinium bromide (101) 
 
The title compound was prepared from 1,1′-bis(6-bromohexyl)-4,4′-bipyridinium bromide 
(99) (19%, yellow powder). 
1H NMR (D2O) δ 9.16 (d, 4H, 3JH,H = 6.5 Hz, H2′′), 9.00 (d, 4H, 3JH,H = 6.5 Hz, H2′′′), 8.78 
(d, 4H, 3JH,H = 5.3 Hz, H2′), 8.58 (d, 4H, 3JH,H = 6.4 Hz, H3′′), 8.43 (d, 4H, 3JH,H = 6.4 Hz, 
H3′′′), 7.93 (d, 4H, 3JH,H = 5.8 Hz, H3′), 4.75 – 4.69 (obscured by HOD peak, 8H, H1,6), 
2.14 (m, 8H, H2,5), 1.52 (m, 8H, H3,4) ppm. 13C{1H} NMR (D2O) δ 154.13, 150.43, 
149.90, 145.88, 145.18, 142.98, 127.48, 126.49, 122.91, 62.44, 61.86, 30.82, 30.73, 25.30 
(2 superimposed resonances) ppm. ESI-MS: m/z 876.80 [M – Br-]+, 397.93 [M – 2Br-]2+, 
238.87 [M – 3Br-]3+. Anal. calcd for C42H48Br4N6·7H2O: C, 46.60; H, 5.77; N, 7.76. Found: 
C, 46.58; H, 5.80; N, 7.68. 
 
6.6 Synthesis of NO3- salts 
Typically, the halide salt (1 mmol) was dissolved in the minimum amount of warm H2O, 
and treated with AgNO3 (1 mmol/mmolhalide ion) in H2O (5 mL). The mixture was filtered, 
and concentrated to ~3 mL on a hotplate, filtering through cellulose if necessary. The 
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solvent was removed and, if required, the solid could be crystallised from H2O to give the 
pure NO3- salt. 
 
1-Methyl-4,4′-bipyridinium nitrate (15) 
The title compound was prepared from 
1-methyl-4,4′-bipyridinium iodide (14)10‡‡ (31%, colourless 
crystals). 
1H NMR (D2O) δ 8.92 (d, 2H, 3JH,H = 6.76 Hz, H2), 8.72 (d, 2H, 3JH,H = 4.43 Hz, H2′), 8.36 
(d, 2H, 3JH,H = 6.76 Hz, H3), 7.87 (d, 2H, 3JH,H = 6.76 Hz, H3′), 4.47 (s, 3H, CH3) ppm. 
13C{1H} NMR (D2O) δ 153.72, 150.37, 146.02, 142.86, 126.04, 122.79, 48.23 ppm. 
ESI-MS: m/z 171.00 [M – NO3-]+. Anal. calcd for C11H11N3O3: C, 56.65; H, 4.75; N, 18.02. 
Found: C, 56.94; H, 4.99; N, 18.30. 
 
1,2-Bis(4,4′-bipyridinium)ethane nitrate (17) 
The title compound was prepared from 
1,2-bis(4,4′-bipyridinium)ethane 
bromide (16)11 (95%, colourless crystals) 
1H NMR (D2O) δ 9.03 (d, 4H, 3JH,H = 6.6 Hz, H2), 8.81 (d, 4H, 3JH,H = 5.5 Hz, H2′), 8.52 
(d, 4H, 3JH,H = 6.6 Hz, H3), 7.95 (d, 4H, 3JH,H = 5.5 Hz, H3′), 5.38 (s, 4H, CH2) ppm. 
13C{1H} NMR (D2O) δ 156.00, 150.40, 145.68, 142.60, 127.28, 122.99, 60.11 ppm. 
ESI-MS: m/z 401.87 [M – NO3-]+, 170.27 [M – 2NO3-]2+. Anal. calcd for C22H20N6O6: 
C, 56.89; H, 4.34; N, 18.10. Found: C, 56.51; H, 4.41; N, 17.94. 
 
1,3-Bis(4,4′-bipyridinium)propane nitrate (19) 
The title compound was prepared from 
1,3-bis(4,4′-bipyridinium)propylene 
bromide (18)6 (51%, off-white powder). The crude product was purified by dissolution in 
warm EtOH/H2O (1 : 1) and precipitation with Me2CO, resulting in the lower yield. 
1H NMR (D2O) δ 9.08 (d, 4H, 3JH,H = 5.96 Hz, H2), 8.76 (d, 4H, 3JH,H = 4.33 Hz, H2′), 8.46 
(d, 4H, 3JH,H = 5.96 Hz, H3), 7.91 (d, 4H, 3JH,H = 4.33 Hz, H3′), 4.96 (t, 4H, 3JH,H = 7.31 Hz, 
Hpropyleneα), 2.96 (q, 2H, 3JH,H = 7.31 Hz, Hpropyleneβ) ppm. 13C{1H} NMR (D2O) δ 154.71, 
                                               
‡‡
 This compound contained traces of 1,1′-dimethyl-4,4′-bipyridinium iodide and could not be purified by 
repeated crystallisation from EtOH or H2O. 
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150.65, 145.41, 142.76, 126.76, 122.92, 58.41, 31.96 ppm. ESI-MS: m/z 415.00                
[M – NO3-]+, 177.27 [M – 2NO3-]2+. Anal. calcd for C38H40Br4N6·H2O: C, 55.64; H, 4.87; 
N, 16.93. Found: C, 55.46; H, 4.90; N, 16.93. 
 
1,4-Bis(4,4′-bipyridinium)butane nitrate (22) 
The title compound was prepared from 
1,4-bis(4,4′-bipyridinium)butylene 
bromide (21)6 (51%, colourless crystals). 
1H NMR (200 MHz, D2O) δ 9.01 (d, 4H, 3JH,H = 6.0 Hz, H2), 8.79 (d, 4H, 3JH,H = 4.3 Hz, 
H2′), 8.46 (d, 4H, 3JH,H = 6.0 Hz, H3), 7.85 (d, 4H, 3JH,H = 4.3 Hz, H3′), 4.79 (obscured 
by HOD peak, m, 4H, Hbutyleneα), 2.96 (m, 4H, Hbutyleneβ) ppm. ESI-MS: m/z 430.0              
[M – NO3-]+, 184.2 [M – 2NO3-]2+. 
 
1,6-Bis(4,4′-bipyridinium)hexane nitrate (25) 
The title compound was prepared from 
1,6-bis(4,4′-bipyridinium)hexane 
bromide (24)11 (53%, colourless crystals). 
1H NMR (D2O) δ 8.98 (d, 4H, 3JH,H = 6.76 Hz, H2), 8.76 (d, 4H, 3JH,H = 5.37 Hz, H2′), 8.40 
(d, 4H, 3JH,H = 6.76 Hz, H3), 7.89 (d, 4H, 3JH,H = 5.37 Hz, H3′), 4.70 (t, 4H, 3JH,H = 7.20 Hz, 
Hhexyleneα), 2.12 (m, 4H, Hhexyleneβ), 1.49 (m, 4H, Hhexyleneγ) ppm. 13C{1H} NMR (D2O) 
δ 154.24, 150.47, 125.15, 142.92, 126.41, 122.83, 61.922, 30.61, 25.33 ppm. 
ESI-MS: m/z 457.67 [M – NO3-]+, 197.67 [M – 2NO3-]2+. Anal. calcd for C26H26O6N6: 
C, 59.99; H, 5.42; N, 16.14. Found: C, 59.79; H, 5.44; N, 16.02. 
 
1,2-Bis(4,4′-bipyridiniummethyl)benzene nitrate (28) 
The title compound was prepared 
from 1,2-bis(4,4′-
bipyridiniummethyl)benzene bromide 
(27)11 (90%, yellow powder). 
1H NMR (D2O) δ 8.79 (d, 4H, 3JH,H = 6.7 Hz, H2), 8.58 (d, 4H, 3JH,H = 6.1 Hz, H2′), 8.25 
(d, 4H, 3JH,H = 6.7 Hz, H3), 7.84 (m, 2H, H4xylyl), 7.77 (m, 2H, H3xylyl), 7.66 (d, 4H, 
3JH,H = 6.1 Hz, H3′), 6.13 (s, 4H, CH2) ppm. 13C{1H} NMR (D2O) δ 155.48, 151.38, 145.91, 
142.45, 135.41, 133.55, 132.09, 127.33, 123.47, 62.81 ppm. ESI-MS: m/z 478.13              
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[M – NO3-]+, 208.20 [M – 2NO3-]2+. Anal. calcd for C28H24N6O6·0.5H2O: C, 61.18; H, 4.59; 
N, 15.30. Found: C, 61.20; H, 4.64; N, 15.22. 
 
(±)-2,6-Bis(4,4′-bipyridinium)-9-thiabicyclo[3.3.1]nonane nitrate (31) 
The title compound was prepared 
from (±)-2,6-bis(4,4′-bipyridinium)-
9-thiabicyclo[3.3.1]nonane chloride (30) (93%, white powder). 
1H NMR (D2O) δ 9.23 (d, 4H, 3JH,H = 6.36 Hz, H2), 8.85 (d, 4H, 3JH,H = 4.60 Hz, H2′), 
8.56 (d, 4H, 3JH,H = 6.36 Hz, H3), 7.97 (d, 4H, 3JH,H = 4.60 Hz, H3′), 5.83 (m, 2H, Haliphatic), 
3.45 (m, 2H, Haliphatic), 3.21 (m, 2H, Haliphatic), 2.52 (m, 6H, Haliphatic) ppm. Traces of DMF 
present. 13C{1H} NMR (relative to residual DMF) δ 155.34, 150.62, 144.33, 142.99, 127.06, 
123.12, 74.04, 36.56, 27.17, 25.33 ppm. ESI-MS: m/z 514.00 [M – NO3-]+, 225.90            
[M – 2NO3-]2+. Anal. calcd for C28H28N6O6S·5H2O: C, 50.44; H, 5.74; N, 12.61. Found: 
C, 50.46; H, 5.28; N, 12.63. 
 
1,6-Bis(pyrazinium)hexane nitrate (41) 
The title compound was prepared from 
1,6-bis(pyrazinium)hexane bromide (39)11 (99%, white 
powder). 
1H NMR (200 MHz, D2O) δ 9.49 (m, 4H, H3), 9.09 (m, 4H, H2), 4.74 (obscured by HOD 
peak, m, 4H, Hhexyleneα), 2.12 (m, 4H, Hhexyleneβ), 1.51 (m, 4H, Hhexyleneγ) ppm. 13C{1H} NMR 
(D2O) δ 151.38, 137.61 (t, 1JC,N = 7.8 Hz), 63.32, 30.56, 25.19 ppm. ESI-MS: m/z 122.13 
[M – 2NO3-]2+. Anal. calcd for C14H20N6O6·0.33H2O: C, 44.92; H, 5.56; N, 22.45. Found: 
C, 44.91; H, 5.35; N, 22.41. 
 
1-Methyl-3-aminopyrazinium nitrate (43) 
The title compound was prepared from 1-methyl-3-aminopyrazinium 
iodide (42)12 (99%, colourless crystals). Slow evaporation of an 
aqueous solution of the title compound afforded single crystals suitable for X-ray 
crystallographic analysis, details of which are given in the Appendices (Section A.3). 
1H NMR (D2O) δ 8.56 (m, 1H, H5), 8.11 (m, 1H, H6), 7.12 (s, 1H, H2), 4.28 
(s, 3H, CH3) ppm. 13C{1H} NMR (D2O) δ 158.97, 149.10, 126.55 (t, 1JC,N = 11.18 Hz), 
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124.52 (t, 1JC,N = 8.85 Hz) 48.83 (t, 1JC,N = 5.1 Hz) ppm. ESI-MS: m/z 110.00 [M – NO3-]+. 
Anal. calcd for C5H8O3N4: C, 34.17; H, 4.82; N, 31.88. Found: C, 34.10; H, 4.64; N, 31.77. 
 
1,6-Bis(3-aminopyrazinium)hexane nitrate (49) 
The title compound was prepared from 
1,6-bis(3-aminopyrazinium)hexane bromide (48) (96%, tan 
crystals). 
1H NMR (D2O) δ 8.58 (m, 2H, H5), 8.15 (s, 2H, H6), 7.95 (d, 2H, 3JH,H = 2.8 Hz, H2), 4.48 
(t, 4H, 3JH,H = 7.4 Hz, Hhexyleneα), 2.03 (m, 4H, Hhexyleneβ), 1.45 (m, 4H, Hhexyleneγ) ppm. 
13C{1H} NMR (D2O) δ 159.09, 149.38, 125.52, 123.56, 62.65, 30.22, 25.19 ppm. ESI-MS: 
m/z 336.1 [M – NO3-]+, 273.0 [M – H+ – 2NO3-]+, 137.2 [M – 2NO3-]2+. Anal. calcd for 
C14H22N8O6: C, 42.21; H, 5.57; N, 28.13. Found: C, 42.28; H, 5.57; N, 27.86.  
 
1,3,5-Tris(3-aminopyraziniummethyl)-2,4,6-trimethylbenzene nitrate (54) 
The title compound was prepared from 
1,3,5-tris(4-aminopyraziniummethyl)-2,4,6-
trimethylbenzene bromide (53) (97%, white powder). 
1H NMR (D2O) δ 8.59 (m, 3H, H5), 7.96 (m, 3H, H6), 7.82 
(s, 3H, H2), 5.87 (s, 6H, CH2), 2.35 (s, 9H, CH3) ppm. 
13C{1H} NMR (D2O) δ 159.43, 149.85, 145.41, 127.74, 
124.34, 122.48, 59.70, 16.65 ppm. ESI-MS: m/z 567.47 
[M – NO3-]+, 504.63 [M – 2NO3- – H+]+, 441.60 [M – 3NO3- – 2H+]+, 409.53                     
[M – 2NO3- – H+ – apyz]+, 346.60 [M – 3NO3- – 2H+ – apyz]+, 252.53 [M – 2NO3-]2+, 
173.47 [M – 3NO3- – H+ – apyz]2+, 147.60 [M – 3NO3-]3+. Anal. calcd for 
C24H30O9N12·1.5H2O: C, 43.84; H, 5.05; N, 25.56. Found: C, 43.91; H, 4.87; N, 25.52. 
 
1-Methyl-2-aminopyrinidinium nitrate (57) 
The title compound was prepared from 1-methyl-2-aminopyrinidinium 
iodide (56)13 (97%, colourless crystals). 
1H NMR (D2O) δ 8.82 (dd, 1H, 3JH,H = 4.49 Hz, 4JH,H = 2.00 Hz, H4), 
8.39 (dd, 1H, 3JH,H = 6.59 Hz, 4JH,H = 2.00 Hz, H6), 7.12 (dd, 1H, 3JH,H = 6.59 Hz, 
3JH,H = 4.49 Hz, H5) 3.86 (s, 3H, CH3) ppm. 13C{1H} NMR (D2O) δ 166.37, 156.67, 151.19, 
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111.50, 42.06 ppm. ESI-MS: m/z 110.00 [M – NO3-]+. Anal. calcd for C5H8O3N4·0.2H2O: 
C, 34.17; H, 4.82; N, 31.88. Found: C, 34.33; H, 4.68; N, 31.87. 
 
1,4-Bis(2-aminopyrimidinium)butane nitrate (64) 
The title compound was prepared from 
1,4-bis(2-aminopyrimidinium)butane bromide  (63) (91%, white 
powder). 
1H NMR (D2O) δ 8.82 (dd, 2H, 3JH,H = 3.3 Hz, 4JH,H = 1.5 Hz, 
H4), 8.38 (dd, 2H, 3JH,H = 5.0 Hz, 4JH,H = 1.6 Hz, H6), 7.13 (dd, 2H, 3JH,H = 5.0 Hz, 
3JH,H = 3.4 Hz, H5), 4.26 (m, 4H, Hbutyleneα), 2.03 (m, 4H, Hbutyleneβ) ppm. 13C{1H} NMR 
(D2O) δ 166.3, 155.5, 149.8, 111.4, 53.8, 23.0 ppm. ESI-MS: m/z 245.07 [M – 2NO3-          
– H+]+, 123.13 [M – 2NO3-]2+. 
 
1,5-Bis(2-aminopyrimidinium)pentane nitrate (67) 
The title compound was prepared from 
1,5-bis(2-aminopyrimidinium)pentane bromide (66) (78%, white 
powder). 
1H NMR (300 MHz, D2O) δ 8.81 (dd, 2H, 3JH,H = 4.32 Hz, 
4JH,H = 1.75 Hz, H4), 8.37 (dd, 2H, 3JH,H = 6.58 Hz, 4JH,H = 1.66 Hz, H6), 
7.13 (dd, 2H, 3JH,H = 6.42 Hz, 3JH,H = 4.76 Hz, H4), 4.21 (t, 4H, 3JH,H = 7.34 Hz, Hpentyleneα), 
1.97 (m, 4H, Hpentyleneβ), 1.51 (qu, 2H, 3JH,H = 7.18 Hz, Hpentyleneγ) ppm. 13C{1H} NMR (D2O) 
δ 166.50, 155.94, 150.21, 111.77, 54.67, 26.20, 22.57 ppm. ESI-MS: m/z 259.07               
[M – 2NO3- – H+]+, 130.20 [M – 2NO3-]+. Anal. calcd for C13H20O6N8·1.66H2O: C, 37.69; 
H, 5.67; N, 27.05. Found: C, 37.38; H, 5.40; N, 27.16. 
 
1,6-Bis(2-aminopyrimidinium)hexane nitrate (70) 
The title compound was prepared from 
1,6-bis(2-aminopyrimidinium)hexane bromide (69) (95%, white 
powder). 
1H NMR (200 MHz, D2O) δ 8.79 (dd, 2H, 3JH,H = 4.4 Hz, 4JH,H = 1.9 Hz, H4), 8.37 (dd, 2H, 
3JH,H = 6.6 Hz, 4JH,H = 1.9 Hz, H6), 7.11 (dd, 2H, 3JH,H = 6.6 Hz, 3JH,H = 4.4 Hz, H5), 4.19 
(t, 4H, 3JH,H = 7.3 Hz, Hhexyleneα), 1.91 (m, 4H, Hhexyleneβ), 1.48 (m, 4H, Hhexyleneγ) ppm. 
13C{1H} NMR (D2O) δ 167.41, 156.95, 151.27, 112.75, 55.97, 27.39, 26.42 ppm. ESI-MS: 
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m/z 273.20 [M – 2NO3- – H+]+, 178.13 [M – apym – 2NO3- – H+]+, 137.20 [M – 2NO3-]2+. 
Anal. calcd for C14H22N8O6·H2O: C, 40.38; H, 5.81; N, 26.91. Found: C, 40.61; H, 5.72; 
N, 27.01. 
 
1,8-Bis(2-aminopyrimidinium)octane nitrate (73) 
The title compound was prepared from 
1,8-bis(2-aminopyrimidinium)octane bromide (72) (97%, white 
powder). 
1H NMR (D2O) δ 8.79 (m, 2H, H4), 8.36 (m 2H, H6), 7.11 (m, 2H, H5), 4.17 (t, 4H, 
3JH,H = 7.65 Hz, Hoctyleneα), 1.89 (m, 4H, Hoctyleneβ), 1.38 (m, 8H, Hoctyleneγ,δ) ppm. 13C{1H} 
NMR (D2O) δ 166.19, 155.91, 150.29, 111.67, 55.12, 28.42, 26.57, 25.59 ppm. ESI-MS: 
m/z 363.80 [M – NO3-]+, 301.27 [M – 2NO3- – H+]+, 151.00 [M – 2NO3-]2+. Anal. calcd for 
C16H26N8O6·H2O: C, 43.24; H, 6.35; N, 25.21. Found: C, 43.14; H, 6.17; N, 24.95. 
 
1,2-Bis(1-methyl-2-aminopyrimidinium)benzene nitrate (76) 
The title compound was prepared from 
1,2-bis(1-methyl-2-aminopyrimidinium)benzene bromide (75) 
(60%, colourless needles). 
1H NMR (400 MHz, D2O) δ 9.08 (dd, 2H, 3JH,H = 4.4 Hz, 
4JH,H = 2.0 Hz, H4), 8.37 (dd, 2H, 3JH,H = 6.7 Hz, 4JH,H = 2.0 Hz, H6), 7.76 (dd, 2H, 
3JH,H = 3.3 Hz, 3JH,H = 5.7 Hz, H3xylylene), 7.37 (dd, 2H, 3JH,H = 3.3 Hz, 3JH,H = 5.7 Hz, 
H4xylylene), 7.34 (dd, 2H, 3JH,H = 6.7 Hz, 3JH,H = 4.4 Hz, H5), 5.63 (s, 4H, CH2) ppm. 
13C{1H} NMR (100 MHz, D2O) δ 167.11, 156.27, 149.19, 130.62, 129.06, 128.52, 112.01, 
54.31 ppm. For 2-D COSY, see Section A.1. ESI-MS: m/z 293.00 [M – 2NO3- – H+]+, 
198.20 [M – 2NO3- – apym – H+]+. Anal. calcd for C16H18N8O6: C, 45.93; H, 4.34; N, 26.78. 
Found: C, 45.94; H, 4.350; N, 26.61. 
 
1,3-Bis(1-methyl-2-aminopyrimidinium)benzene nitrate (79) 
The title compound was prepared from 
1,3-bis(1-methyl-2-aminopyrimidinium)benzene bromide (78) 
(96%, white powder). 
1H NMR (D2O) δ 8.88 (m, 2H, H4apym), 8.34 (m, 2H, H6apym), 7.64 (t, 1H, 3JH,H = 7.59 Hz, 
H5xylylene), 7.46 (d, 4H, 3JH,H = 7.59 Hz, H4xylylene), 7.21 (s, 1H, H2xylylene), 7.16 
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(m, 2H, H5apym), 5.46 (s, 4H, CH2) ppm. Traces of DMF present. 13C{1H} NMR (D2O) 
δ 167.15, 156.30, 150.05, 132.50, 131.25, 129.59, 127.62, 112.12, 57.19 ppm. ESI-MS: m/z 
584.93 [2M – 4NO3- – H+]+, 293.13 [M – 2NO3- – H+]+, 198.27 [M – apym – 2NO3- – H+]+, 
147.13 [M – 2NO3-]2+. Anal. calcd for C16H18O6N8: C, 44.97; H, 4.48; N, 26.22. Found: 
C, 45.09; H, 4.43; N, 26.22. 
 
2,6-Bis(1-methyl-2-aminopyrimidinium)pyridine nitrate (84) 
The title compound was prepared from 
2,6-bis(1-methyl-2-aminopyrimidinium)pyridine chloride (83) 
(93%, white powder). 
1H NMR (D2O) δ 8.87 (dd, 2H, 3JH,H = 4.46 Hz, 4JH,H = 1.99 Hz, H4), 8.28 
(dd, 2H, 3JH,H = 6.59 Hz, 4JH,H = 1.99 Hz, H6), 8.02 (t, 1H, 3JH,H = 7.82 Hz, H4lut), 7.57 
(d, 2H, 3JH,H = 7.82 Hz, H3lut), 7.10 (dd, 2H, 3JH,H = 6.59 Hz, 3JH,H = 4.46 Hz, H5), 5.56 
(s, 4H, CH2) ppm. 13C{1H} NMR (D2O) δ 167.24, 156.65, 151.41, 150.94, 139.58, 122.77, 
111.704, 57.68 ppm. ESI-MS: m/z 294.13 [M – 2NO3- – H+]+, 199.2 [M – 2NO3- – H+ – 
apym]+, 147.73 [M – 2NO3-]2+. Anal. calcd for C15H17N9O6·0.33H2O: C, 42.36; H, 4.19; 
N, 29.64. Found: C, 42.35; H, 4.07; N, 29.62. 
 
1,3,5-Tris[1-(2-pyrimidiniummethyl)]-2,4,6-trimethylbenzene nitrate (86) 
The title compound was prepared from 
1,3,5-tris[1-(2-pyrimidiniummethyl)]-2,4,6-trimethylbenzene 
bromide (85) (95%, white powder) 
1H NMR (D2O) δ 8.85 (m, 3H, H4), 7.83 (m, 3H, H6), 7.06 
(m, 3H, H5), 5.38 (s, 6H, CH2), 2.29 (s, 9H, CH3) ppm. 
13C{1H} NMR (D2O) δ 166.22, 156.75, 145.69, 144.99, 
127.40, 112.13, 51.85, 16.33 ppm. ESI-MS: m/z 442.00 [M – 3NO3- – 2H+]+, 347.13         
[M – 3NO3- – 2H+ – apym]+, 284.07 [M – 2NO3-]2+, 252.20 [M – 3NO3- – 2H+ – 2apym]+, 
221.47 [M – 3NO3- – H+]2+, 174.07 [M – 3NO3- – H+ – apym]2+. Anal. calcd for 
C24H30O9N12·3H2O: C, 42.10; H, 5.30; N, 24.55. Found: C, 41.73; H, 4.74; N, 24.30. 
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1-(2-Pyrimidylaminomethyl)-2-(pyrimidiniummethyl)benzene nitrate (90) 
The title compound was prepared from 
1,2-bis(1-methyl-2-aminopyrimidinium)benzene bromide (75) 
(60%, colourless prismatic crystals). The mixture was warmed at 
70°C for 10 min in order to effect the rearrangement. Slow 
evaporation of the resulting solution afforded single crystals suitable for X-ray 
crystallographic analysis, details of which are given in the Appendices (Section A.3). 
1H NMR (D2O) δ 8.64 (dd, 1H, 3JH,H = 4.35Hz, 4JH,H = 1.97 Hz, H4aminopyridinium), 8.24 (d, 
2H, 3JH,H = 4.93Hz, H3aminopyridine), 7.82 (dd, 1H, 3JH,H = 6.80 Hz, 4JH,H = 1.97 Hz, 
H6aminopyridinium), 7.63-7.42 (m, 4H, Hphenylene), 6.93 (dd, 1H, 3JH,H = 6.80 Hz, 3JH,H = 4.35 Hz, 
H5aminopyridinium), 6.76 (t, 1H, 3JH,H = 4.93Hz, H4aminopyridine), 5.27 (s, 2H, aminopyridiniumCH2), 
4.66 (s, 2H, aminopyridineCH2) ppm. For 2-D COSY, see Section A.1. ESI-MS: m/z 293.07 
[M – NO3-]+, 198.27 [M – NO3- – apym]+. Anal. calcd for C16H17O3N7·1.8H2O: C, 49.56; 
H, 5.35; N, 25.28. Found: C, 49.42; H, 5.25; N, 25.49. 
 
1,1′-Bis[4-(4,4′-bipyridinium)butyl]-4,4′-bipyridinium nitrate (102) 
 
The title compound was prepared from 1,1′-bis[4-(4,4′-bipyridinium)butyl]-4,4′-
bipyridinium bromide (100) (72%, colourless crystals). 
1H NMR (D2O) δ 9.15 (d, 4H, 3JH,H = 6.7 Hz, H2′′), 9.01 (d, 4H, 3JH,H = 6.8 Hz, H2′′′), 
8.81 (m, 4H, H2′), 8.58 (d, 4H, 3JH,H = 6.7 Hz, H3′′), 8.44 (d, 4H, 3JH,H = 6.7 Hz, H3′′′), 
7.94 (d, 4H, 3JH,H = 5.6 Hz, H3′), 4.85 (m, 4H, H1), 4.83 (obscured by HOD peak, 4H, H4), 
2.26 (m, 8H, H2,3) ppm. 13C{1H} NMR (D2O) δ 154.50, 150.64 (2 resonances), 145.93, 
145.21, 143.07, 127.53, 126.62, 123.02, 61.54, 60.94, 27.75, 27.69 ppm. ESI-MS: m/z 
766.13 [M – NO3-]+, 352.07 [M – 2NO3-]2+, 214.00 [M – 3NO3-]3+. Anal. calcd for 
C38H40O12N10·6H2O: C, 48.72; H, 5.59; N, 14.95. Found: C, 48.49; H, 5.23; N, 15.18. 
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1,1′-Bis[6-(4,4′-bipyridinium)hexyl]-4,4′-bipyridinium nitrate (104) 
 
The title compound was prepared from 1,1′-bis[6-(4,4′-bipyridinium)hexyl]-4,4′-
bipyridinium bromide (101) (70%, white powder). 
1H NMR (D2O) δ 9.13 (d, 4H, 3JH,H = 6.4 Hz, H2′′), 8.98 (d, 4H, 3JH,H = 6.5 Hz, H2′′′), 8.81 
(m, 4H, H2′), 8.56 (d, 4H, 3JH,H = 6.1 Hz, H3′′), 8.43 (d, 4H, 3JH,H = 6.3 Hz, H3′′′), 7.95 
(d, 4H, 3JH,H = 4.8 Hz, H3′), 4.76 – 4.68 (obscured by HOD peak, 8H, H1,6), 2.13 (m, 8H, 
H2,5), 1.51 (m, 8H, H3,4) ppm. 13C{1H} NMR (D2O) δ 154.11, 150.71, 150.44, 145.83, 
145.14, 143.17, 127.33, 126.45, 123.01, 62.41, 61.85, 30.79, 30.70, 25.27 ppm. For 2-D 
COSY, see Section A.1. ESI-MS: m/z 1707.87 [2M – NO3-]+, 1412.67 [5M – 3NO3-]3+, 
1265.00 [3M – 2NO3-]2+, 1117.67 [4M – 3NO3-]3+, 822.33 [M – NO3-]+, 380.13                 
[M – 2NO3-]2+. Anal. calcd for C42H48N10O12·9H2O: C, 48.18; H, 6.35; N, 13.38. Found: 
C, 47.97; H, 5.88; N, 13.27. 
 
6.7 Synthesis of PF6- salts 
Typically, a halide salt (0.5 mmol) was dissolved in the minimum amount of H2O and was 
treated with KPF6 (saturated aqueous solution, 50 mL). The mixture was allowed to stand 
overnight and the precipitate which formed was isolated by filtration, washed with H2O 
(2 mL) and dried in vacuo to give the PF6- salt as a white/off-white powder. 
 
1,4-Bis(4,4′-bipyridinium)butane hexafluorophosphate (23) 
The title compound was prepared 
from 1,4-bis(4,4′-bipyridinium)butane 
bromide (21)6 (51%, white powder). 
1H NMR (CD3CN) δ 8.86 (d, 4H, 3JH,H = 6.0 Hz, H2), 8.74 (d, 4H, 3JH,H = 7.2 Hz, H2′), 
8.33 (d, 4H, 3JH,H = 6.0 Hz, H3), 7.79 (d, 4H, 3JH,H = 7.2 Hz, H3′), 4.59 (m, 4H, Hbutyleneα), 
2.07 (m, 4H, Hbutyleneβ) ppm. 13C{1H} NMR (CD3CN) δ 154.73, 151.57, 145.65, 142.14, 
126.75, 122.65, 61.09, 27.85 ppm. ESI-MS: m/z 513.0 [M – PF6-]+, 184.2 [M – 2PF6-]2+. 
Anal. calcd for C24H24N4P2F12: C, 43.78; H, 3.67; N, 8.51. Found: C, 43.79; H, 3.87; 
N, 8.44. 
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1,4-Bis(pyrazinium)butane hexafluorophosphate (35) 
The title compound was prepared from 
1,4-bis(pyrazinium)butane bromide (34)11 (48%, white 
powder). 
1H NMR (CD3CN) δ 9.42 (m, 4H, H3), 8.68 (d, 4H, 3JH,H = 4.2 Hz, H2), 4.60 (m, 4H, 
Hbutyleneα), 2.06 (m, 4H, Hbutyleneβ) ppm. 13C{1H} NMR (CD3CN) δ 152.41, 137.61 
(t, 1JC,N = 8.8 Hz), 62.46, 27.69 ppm.  ESI-MS: m/z 867.00 [2M – PF6-]+, 361.00                
[M – PF6-]+, 108.2 [M – 2PF6-]2+. Anal. calcd for C12H16N4P2F12·0.5H2O: C, 27.97; H, 3.33; 
N, 10.87. Found: C, 27.85; H, 3.28; N, 10.59. 
 
1,6-Bis(pyrazinium)hexane hexafluorophosphate (41) 
The title compound was prepared from 
1,6-bis(pyrazinium)hexane bromide (39)11 (45%, white 
powder). 
1H NMR (CD3CN) δ 9.40 (m, 4H, H3), 8.68 (d, 4H, 3JH,H = 4.2 Hz, H2), 
4.54 (t, 4H, 3JH,H = 7.8 Hz, Hhexyleneα), 2.10 (obscured by HOD peak, m, 4H, Hhexyleneβ), 
1.36 (m, 4H, Hhexyleneγ) ppm. 13C{1H} NMR (CD3CN) δ 151.09, 136.35 (t, 1JC,N = 8.6 Hz), 
62.20, 29.85, 24.49 ppm. ESI-MS: m/z 922.93 [2M – PF6-]+, 389.07 [M – PF6-]+, 122.13 
[M – 2PF6-]2+. Anal. calcd for C14H20F12N4P2: C, 31.47; H, 3.77; N, 10.49. Found: C, 31.42; 
H, 3.64; N, 10.37. 
 
1,5-Bis(3-aminopyrazinium)pentane hexafluorophosphate (47) 
The title compound was prepared from 
1,5-bis(3-aminopyrazinium)pentane bromide (45) (69%, off-
white crystals). 
1H NMR (CD3CN) δ 8.52 (m, 2H, H5), 7.74 (s, 2H, H2), 7.70 (m, 2H, H6), 
6.34 (br, s, 4H, NH2), 4.27 (t, 4H, 3JH,H = 7.38 Hz, Hpentyleneα), 1.90 (m, 4H, Hpentyleneβ), 1.33 
(q, 2H, 3JH,H = 8.09 Hz, Hpentyleneγ) ppm. 13C{1H} NMR (CD3CN) δ 159.95, 150.62, 124.59, 
118.38, 62.71, 30.43, 23.00 ppm. ESI-MS: m/z 405.13 [M – PF6-]+, 259.20 [M – 2PF6- – 
H+]+, 130.20 [M – 2PF6-]+. Anal. calcd for C13H20P2F12N6: C, 28.38; H, 3.66; N, 15.27. 
Found: C, 28.47; H, 3.59; N, 15.09. 
 
Chapter Six: Experimental 
122 
1,4-Bis(1-methyl-3-aminopyrazinium)benzene hexafluorophosphate (52) 
The title compound was prepared from 
1,4-bis(1-methyl-3-aminopyrazinium)benzene 
bromide (51) (65%, off-white powder). 
1H NMR (CD3CN) δ 8.76 (m, 2H, H5), 7.86 (m, 2H, H6), 7.77 (m, 2H, H2), 7.55 (s, 4H, 
HxylyleneCH), 6.46 (br, s, 4H, NH2), 5.55 (s, 4H, CH2) ppm. 13C{1H} NMR (CD3CN) δ 159.84, 
150.77, 134.44, 131.40, 124.64, 124.15, 64.93 ppm. ESI-MS: m/z 438.93 [M – PF6-]+, 
292.87 [M – 2PF6- – H+]+ , 146.93 [M – 2PF6-]2+. Anal. calcd for C16H18N6F12P2: C, 32.89; 
H, 3.11; N, 14.34. Found: C, 32.95; H, 3.28; N, 14.19. 
 
1,3,5-Tris(3-aminopyraziniummethyl)-2,4,6-trimethylbenzene 
hexafluorophosphate (55) 
The title compound was prepared from 
1,3,5-tris(4-aminopyraziniummethyl)-2,4,6-
trimethylbenzene bromide (53) (75%, white powder). 
1H NMR (CD3CN) δ 8.58 (m, 3H, H5) 7.67 (m, 3H, H6), 
7.54 (s, 3H, H2), 6.35 (br, s, 6H, NH2), 5.75 (s, 6H, CH2), 
2.25 (s, 9H, CH3) ppm. 13C{1H} NMR (CD3CN) δ 160.20, 
150.86, 146.14, 128.24, 123.58, 123.44, 60.16, 17.52 ppm. 
ESI-MS: m/z 733.60 [M – PF6-]+, 587.47 [M – 2PF6- – H+]+, 492.40 [M – 2PF6- – apyz – 
H+]+, 441.47 [M – 3PF6- – 2H+]+, 346.60 [M – 3PF6- – 2H+ – apyz]+, 294.00 [M – 2PF6-]2+, 
173.47 [M – 3PF6- – H+ – apyz]2+, 147.60 [M – 3PF6-]3+. Anal. calcd for C24H30F18P3N9: 
C, 32.78; H, 3.44; N, 14.33. Found: C, 32.85; H, 3.28; N, 14.12. 
 
1-Benzyl-2-aminopyrazinium hexafluorophosphate (61) 
The title compound was prepared from 1-benzyl-
2-aminopyrazinium bromide (59) (38%, colourless crystals). One 
crystal was selected for X-ray analysis crystallographic analysis, 
details of which are given in the Appendices (Section A.3). 
1H NMR (CD3CN) δ 8.77 (dd, 1H, 3JH,H = 4.3 Hz, 4JH,H = 1.8 Hz, H4), 8.05 
(dd, 1H, 3JH,H = 6.6 Hz, 4JH,H = 1.8 Hz, H6), 7.43 (m, 3H, Bn), 7.27 (m, 2H, Bn), 
7.19 (br, s, 2H, NH2), 7.03 (dd, 1H, 3JH,H = 6.6 Hz, 3JH,H = 4.3 Hz, H5) ppm. 
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13C{1H} NMR (CD3CN) δ 167.57, 156.88, 149.95, 131.14, 130.52, 130.43, 129.38, 113.03, 
58.05 ppm. ESI-MS: m/z 516.73 [2M – PF6-]+, 185.80 [M – 2PF6-]2+. Anal. calcd for 
C11H12N3PF6: C, 39.89; H, 3.65; N, 12.69. Found: C, 40.10; H, 3.74; N, 12.90. 
 
1,4-Bis(2-aminopyrimidinium)butane hexafluorophosphate (65) 
The title compound was prepared from 
1,4-bis(2-aminopyrimidinium)butane bromide (63) (64%, white 
powder). 
1H NMR (400 MHz, CD3CN) δ 8.67 (dd, 2H, 3JH,H = 4.4 Hz, 4JH,H = 2.0 Hz, H4), 8.01 (dd, 
2H, 3JH,H = 6.8 Hz, 4JH,H = 2.0 Hz, H6), 7.17 (br, s, 4H, NH2), 6.97 (dd, 2H, 3JH,H = 6.8 Hz, 
3JH,H = 4.4 Hz, H5), 3.95 (m, 4H, Hbutyleneα), 1.76 (m, 4H, Hbutyleneβ) ppm. 13C{1H} NMR 
(100 MHz, CD3CN) δ 167.6, 156.7, 150.6, 113.0, 54.9, 24.1 ppm. ESI-MS: m/z 235.00     
[M – 2PF6- – H+]+, 123.07 [M – 2PF6-]2+. Anal. calcd for C12H18N6P2F12: C, 26.88; H, 3.38; 
N, 15.67. Found: C, 26.91; H, 3.40; N, 15.62. 
 
1,5-Bis(2-aminopyrimidinium)pentane hexafluorophosphate (69) 
The title compound was prepared from 
1,5-bis(2-aminopyrimidinium)pentane bromide (67) (71%, 
colourless crystals). 
1H NMR (300 MHz, CD3CN) δ 8.75 (dd, 2H, 3JH,H = 4.36 Hz, 4JH,H = 2.03 Hz, H4), 8.12 
(dd, 2H, 3JH,H = 6.59 Hz, 4JH,H = 1.83 Hz, H6), 7.21 (br, s, 4H, NH2), 7.05 (dd, 2H, 
3JH,H = 6.56 Hz, 3JH,H = 4.45 Hz, H4), 3.98 (t, 4H, 3JH,H = 7.45 Hz, Hpentyleneα), 1.81 (m, 4H, 
Hpentyleneβ), 1.41 (m, 2H, Hpentyleneγ) ppm. 13C{1H} NMR (CD3CN) δ 167.33, 156.62, 150.46, 
112.88, 55.26, 26.77, 23.09 ppm. ESI-MS: m/z 1504.93 [3M – PF6-]+, 954.93 [2M – PF6-]+, 
404.73 [M – PF6-]+, 259.13 [M – 2PF6- – H+]+, 130.20 [M – 2PF6-]2+. Anal. calcd for 
C13H20N6P2F12: C, 28.38; H, 3.66; N, 15.27. Found: C, 28.42; H, 3.86; N, 15.32. 
 
1,6-Bis(3-aminopyrazinium)hexane hexafluorophosphate (71) 
The title compound was prepared from 
1,6-bis(3-aminopyrazinium)hexane bromide (69) (43%, off-
white fibres). 
1H NMR (CD3CN) δ 8.57 (m, 2H, H5), 7.79 (m, 2H, H6), 7.73 (m, 2H, H2), 6.43 (br, s, 4H, 
NH2), 4.29 (t, 4H, 3JH,H = 7.5 Hz, Hhexyleneα), 2.11 (overlapping HOD peak, m, 4H, Hhexyleneβ), 
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1.36 (m, 4H, Hhexyleneγ) ppm. 13C{1H} NMR (CD3CN) δ 159.87, 150.52, 125.52, 124.53, 
62.90, 30.80, 25.76 ppm. ESI-MS: m/z 137.2 [M – 2PF6-]2+. Anal. calcd for 
C14H22F12N6P2·0.33H2O: C, 29.49; H, 4.01; N, 14.74. Found: C, 29.99; H, 4.35; N, 14.79. 
 
1,8-Bis(2-aminopyrimidinium)octane hexafluorophosphate (74) 
The title compound was prepared from 
1,8-bis(2-aminopyrimidinium)octane bromide (70) (79%, white 
powder). 
1H NMR (CD3CN) δ 8.77 (dd, 2H, 3JH,H = 4.38 Hz, 4JH,H = 2.06 Hz, H4), 8.16 (dd, 2H, 
3JH,H = 6.60 Hz, 4JH,H = 2.06 Hz, H6), 7.24 (br, s, 4H, NH2), 7.07 (dd, 2H, 3JH,H = 6.60 Hz, 
3JH,H = 4.38 Hz, H4), 4.01 (t, 4H, 3JH,H = 7.60 Hz, Hoctyleneα), 1.80 (m, 4H, Hoctyleneβ), 1.37 
(m, 8H, Hoctyleneγδ) ppm. 13C{1H} NMR (CD3CN) δ 167.17, 156.58, 150.41, 112.83, 55.63, 
29.44, 27.37, 26.47 ppm. ESI-MS: m/z 446.87 [M – PF6-]+, 301.07 [M – 2PF6- – H+]+, 
151.93 [M – 2PF6-]2+. Anal. calcd for C16H26F12N6P2: C, 32.44; H, 4.42; N, 14.19. Found: 
C, 32.44; H, 4.30; N, 13.94. 
 
1,2-Bis(1-methyl-2-aminopyrimidinium)benzene hexafluorophosphate 
(77) 
The title compound was prepared from 
1,2-bis(1-methyl-2-aminopyrimidinium)benzene bromide (75) 
(70%, white powder). 
1H NMR (400 MHz, CD3CN) δ 8.79 (dd, 2H, 3JH,H = 4.4 Hz, 
4JH,H = 2.0 Hz, H4), 7.81 (dd, 2H, 3JH,H = 6.4 Hz, 4JH,H = 2.0 Hz, H6), 7.47 (m, 2H, H3xylyl), 
7.23 (br, s, 4H, NH2), 7.09 (m, 2H, H4xylyl), 7.03 (dd, 2H, 3JH,H = 6.4 Hz, 3JH,H = 4.4 Hz, 
H5), 5.08 (s, 4H, CH2) ppm. 13C{1H} NMR (100 MHz, CD3CN) δ 168.1, 157.2, 149.5, 
131.8, 130.2, 129.9, 113.5, 55.1 ppm. ESI-MS: m/z 293.0 [M – 2PF6- – H+]+, 198.2           
[M – 2PF6- – apym – H+]+ 123.1 [M – 2PF6-]2+. Anal. calcd for C16H18N6P2F12: C, 32.89; 
H, 3.11; N, 14.38. Found: C, 33.05; H, 3.33; N, 14.54. 
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1,3-Bis(1-methyl-2-aminopyrimidinium)benzene hexafluorophosphate 
(80) 
The title compound was prepared from 
1,3-bis(1-methyl-2-aminopyrimidinium)benzene bromide 
(78) (51%, colourless crystals). 
1H NMR (CD3CN) δ 8.85 (dd, 2H, 3JH,H = 4.33 Hz, 4JH,H = 1.95 Hz, H4), 8.10 
(dd, 2H, 3JH,H = 6.66 Hz, 4JH,H = 1.95 Hz, H6), 7.58 (t, 1H, 3JH,H = 7.65 Hz, H5xylylene), 7.41 
(d, 4H, 3JH,H = 7.65 Hz, H4xylylene), 7.22 (br, s, 4H, NH2), 7.14 (s, 1H, H2xylylene), 7.12 (dd, 
2H, 3JH,H = 6.66 Hz, 3JH,H = 4.33 Hz, H5), 5.25 (s, 4H, CH2) ppm. 13C{1H} NMR (CD3CN) 
δ 167.88, 156.97, 150.23, 132.75, 131.57, 130.5, 129.00, 113.20, 57.36 ppm. ESI-MS: 
m/z 439.00 [M – PF6-]+, 293.20 [M – 2PF6- – H+]+, 198.27 [M – apym – 2PF6- – H+]+, 
147.12 [M – 2PF6-]2+. Anal. calcd for C16H18P2F12N6: C, 32.89; H, 3.11; N, 14.38. Found: 
C, 32.99; H, 2.89; N, 14.28. 
 
1,4-Bis(1-methyl-2-aminopyrimidinium)benzene hexafluorophosphate 
(82) 
The title compound was prepared from 
1,4-bis(1-methyl-2-aminopyrimidinium)benzene bromide 
(81)11 (62%, white powder). 
1H NMR (CD3CN) δ 8.80 (dd, 2H, 3JH,H = 4.2 Hz, 
4JH,H = 1.8 Hz, H4), 8.08 (dd, 2H, 3JH,H = 6.6 Hz, 4JH,H = 1.8 Hz, H6), 7.33 (s, 4H, Hxylylene), 
7.22 (br, s, 4H, NH2), 7.07 (dd, 2H, 3JH,H = 6.6 Hz, 3JH,H = 4.2 Hz, H5), 5.23 
(s, 4H, CH2) ppm. 13C{1H} NMR (CD3CN) δ 167.81, 156.91, 150.08, 132.71, 130.17, 
113.10, 57.51 ppm. ESI-MS: m/z 438.60 [M – PF6-]+, 292.73 [M – 2PF6- – H+]+, 197.93 
[M – apym – 2PF6- – H+]+, 146.87 [M – 2PF6-]2+. Anal. calcd for C16H18PF6N6·H2O: 
C, 42.11; H, 4.20; N, 18.42. Found: C, 42.04; H, 4.40; N, 18.32 (this suggests loss of HPF6). 
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1,3,5-Tris[1-(2-aminopyrimidiniummethyl)]-2,4,6-trimethylbenzene 
hexafluorophosphate (87) 
The title compound was prepared from 1,3,5-tris[1-(2-
aminopyrimidiniummethyl)]-2,4,6-trimethylbenzene bromide 
(85) (48%, white powder). 
1H NMR (CD3CN) δ 8.80 (m, 3H, H4), 7.66 (m, 3H, H6), 
7.51 (br, s, 6H, NH2), 7.02 (m, 3H, H5), 5.12 (s, 6H, CH2), 
2.17 (s, 9H, CH3) ppm. 13C{1H} NMR (CD3CN) δ 167.02, 
156.40, 146.26, 145.85, 127.85, 113.28, 52.56, 17.30 ppm. ESI-MS: m/z 734.07 [M – PF6-]+, 
587.93 [M – 2PF6- – H+]+, 442.13 [M – 3PF6- – 2H+]+, 347.00 [M – 3PF6- – 2H+ – apym]+, 
294.47 [M – 2PF6-]2+, 221.47 [M – 3PF6- – H+]2+, 174.07 [M – 3PF6- – H+ – apym]2+. Anal. 
calcd for C24H30F18P3N9·1.80H2O: C, 31.61; H, 3.71; N, 13.82. Found: C, 31.42; H, 3.43; 
N, 13.57. 
 
1,1′-Bis[4-(4,4′-bipyridinium)butyl]-4,4′-bipyridinium 
hexafluorophosphate (103) 
 
The title compound was prepared from 1,1′-bis[4-(4,4′-bipyridinium)butyl]-4,4′-
bipyridinium bromide (100) (89%, brown powder). 
1H NMR (CD3CN) δ 8.93 (d, 4H, 3JH,H = 5.9 Hz, H2′′), 8.82 (d, 4H, 3JH,H = 5.9 Hz, H2′), 
8.79 (d, 4H, 3JH,H = 6.8 Hz, H2′′′), 8.41 (d, 4H, 3JH,H = 6.0 Hz, H3′′), 8.33 (d, 4H, 
3JH,H = 6.7 Hz, H3′′′), 7.81 (dd, 4H, 3JH,H = 4.6 Hz, 5JH,H = 1.4 Hz, H3′), 4.68 (m, 4H, H1), 
4.62 (m, 4H, H4), 2.11 (m, 8H, H2,3) ppm. 13C{1H} NMR (CD3CN) δ 154.95, 151.76, 
150.88, 146.42, 145.74, 142.16, 128.02, 126.88, 122.69, 61.80, 61.18, 27.99, 27.93 ppm. 
For 2-D COSY, see Section A.1. ESI-MS: m/z 1015.13 [M – PF6-]+, 435.07 [M – 2PF6-]2+, 
241.73 [M – 3PF6-]3+. Anal. calcd for C38H40P4F24N6·3H2O: C, 37.57; H, 3.82; N, 6.92. 
Found: C, 37.38; H, 3.59; N, 6.70. 
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1,1′-Bis[6-(4,4′-bipyridinium)hexyl]-4,4′-bipyridinium 
hexafluorophosphate (105) 
 
The title compound was prepared from 1,1′-bis[6-(4,4′-bipyridinium)hexyl]-4,4′-
bipyridinium bromide (101) (45%, off-white powder). 
1H NMR (acetone-d6) δ 9.35 (d, 4H, 3JH,H = 6.6 Hz, H2′′), 9.20 (d, 4H, 3JH,H = 6.5 Hz, H2′), 
9.03 (m, 4H, H2′′′), 8.75 (d, 4H, 3JH,H = 6.3 Hz, H3′′), 8.62 (d, 4H, 3JH,H = 6.4 Hz, H3′′′), 
8.12 (m, 4H, H3′), 4.94 (t, 4H, 3JH,H = 7.9 Hz, H1), 4.86 (t, 4H, 3JH,H = 7.5 Hz, H6), 
2.23 - 2.21 (m, 8H, H2,5), 1.60 (m, 8H, H3,4) ppm. 13C{1H} NMR (CD3CN) δ 155.03, 
151.95, 150.91, 146.47, 145.80, 142.28, 128.12, 126.97, 122.78, 62.80, 62.19, 31.44, 31.36, 
25.79 (2 resonances) ppm. ESI-MS: m/z 1071.33 [M – PF6-]+, 463.40 [M – 2PF6-]2+. 
 
(±)-2,6-Bis(4,4′-bipyridinium)-9-thiabicyclo[3.3.1]nonane perchlorate (33) 
A solution of (±)-2,6-bis(4,4′-
bipyridinium)-9-
thiabicyclo[3.3.1]nonane chloride 
(30, 0.50 g, 0.96 mmol) in warm H2O (5 mL) was treated with LiClO4 (saturated aqueous 
solution, 5 mL) and the mixture allowed to stand overnight, over which time a precipitate 
formed. This was isolated by filtration, washed with H2O (2 mL) and dried in vacuo to give 
the product as a white powder (0.31 g, 50%). 
1H NMR (D2O) δ 9.18 (d, 4H, 3JH,H = 10.34 Hz, H2), 8.78 (d, 4H, 3JH,H = 6.63 Hz, H2′), 
8.51 (d, 4H, 3JH,H = 10.34 Hz, H3), 7.94 (d, 4H, 3JH,H = 6.63 Hz, H3′), 5.83 (m, 2H, 
Haliphatic), 3.45 (m, 2H, Haliphatic), 3.21 (m, 2H, Haliphatic), 2.52 (m, 6H, Haliphatic) ppm. 13C{1H} 
NMR (DMSO-d6) δ 153.5, 151.24, 144.60, 141.05, 126.16, 122.40, 72.51, 35.70, 27.05, 
23.63 ppm. ESI-MS: m/z 550.87 [M – ClO4-]+, 225.80 [M – 2ClO4-]2+. Anal. calcd for 
C28H28Cl2N4O8S·3.2H2O: C, 47.42; H, 4.94; N, 7.90. Found: C, 47.13; H, 4.20; N, 7.81. 
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6.8 Dimroth rearrangements 
1,2-Bis[(2-pyrimidylamino)methyl]benzene (91) 
1,2-Bis(1-methyl-2-aminopyrimidinium)benzene bromide 
(75, 182 mg, 0.400 mmol) was suspended in NaOH (1 M aqueous 
solution, 10 mL) and the mixture stirred at 60°C for 2 h, before 
being allowed to cool. The precipitate was isolated by centrifugation, washed with H2O 
(2 × 1 mL) and dried in vacuo to give the product as a yellow powder (109 mg, 93%). 
1H NMR (DMSO-d6) δ 8.20 (d, 4H, 3JH,H = 4.7 Hz, H4), 7.28 (dd, 2H, 3JH,H = 5.3 Hz, 
4JH,H = 3.5 Hz, H3xylylene), 7.13 (dd, 2H, 3JH,H = 5.5 Hz, 4JH,H = 3.5 Hz, H4xylylene), 6.41 
(t, 2H, 3JH,H = 4.3 Hz, H5), 4.53 (s, 4H, CH2) ppm. 13C{1H} NMR (DMSO-d6) δ 162.46, 
157.88, 137.94, 127.43, 126.31, 109.09, 42.13 ppm. ESI-MS: m/z 804.07 [3M – apym + 
Na+]+, 781.87 [3M – apym + Na+]+, 607.13 [2M + Na+]+, 584.87 [2M + H+]+, 512.13      
[2M – apym + H+]+, 490.20 [2M – apym + H+]+, 293.00 [M + H+]+. 
 
1,4-Bis[(2-pyrimidylamino)methyl]benzene (92) 
A method for the synthesis of this compound, from 
1,4-bis(aminomethyl)benzene and 2-chloropyrimidine, 
has been reported previously.14 However, this 
compound was instead prepared using a procedure similar to that described for 91, starting 
from 1,4-bis(1-methyl-2-aminopyrimidinium)benzene bromide (81) and heating the mixture 
for 24 h (84%, yellow powder). 
 
1H NMR (DMSO-d6) δ 8.24 (d, 4H, 3JH,H = 4.7 Hz, H4), 7.62 (br, s, 2H, NH, exchanges 
with D2O), 7.21 (s, 4H, Hxylylene), 6.54 (t, 2H, 3JH,H = 4.7 Hz, H5), 4.44 (s, 4H, CH2) ppm. 
ESI-MS: m/z 804.20 [3M – apym + Na+]+, 782.87 [3M – apym + Na+]+, 607.13               
[2M + Na+]+, 584.67 [2M + H+]+, 490.27 [2M – apym + H+]+, 293.07 [M + H+]+, 198.20   
[M – apym + H+]+. 
 
1,8-Bis(2-pyrimidylamino)octane (93) 
The title compound was prepared using a procedure similar to that 
for 91, instead starting from 1,8-bis(2-aminopyrimidinium)octane 
bromide (72) and heating the mixture for 24 h (64%, off-white 
powder). 
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1H NMR (DMSO-d6) δ 8.22 (d, 4H, 3JH,H = 4.7 Hz, H4), 7.05 (t, 2H, 3JH,H = 5.3 Hz, NH), 
6.50 (t, 2H, 3JH,H = 4.7 Hz, H5), 3.23 (m, 4H, Hoctyleneα), 1.49 (m, 4H, Hoctyleneβ), 1.27 
(m, 8H, Hoctyleneγ,δ) ppm. 13C{1H} NMR (DMSO-d6) δ 162.34, 157.85, 109.62, 40.57, 28.93, 
28.85, 26.45 ppm. ESI-MS: m/z 301.40 [M + H+]+. 
 
2,6-Bis[(2-pyrimidylamino)methyl]pyridine (94) 
This compound was prepared using a procedure similar to 
that for 91, instead starting from 2,6-bis(1-methyl-2-
aminopyrimidinium)pyridine chloride (83) and heating for 
24 h (85%, off-white powder). 
1H NMR (DMSO-d6) δ 8.27 (d, 4H, 3JH,H = 4.7 Hz, H4apym), 7.69 (t, 2H, 3JH,H = 6.0 Hz, 
NH), 7.63 (t, 1H, 3JH,H = 7.8 Hz, H4py), 7.10 (d, 2H, 3JH,H = 7.7 Hz, H3py), 6.59 (t, 2H, 
3JH,H = 4.7 Hz, H5apym), 4.56 (d, 4H, 3JH,H = 6.2 Hz, CH2) ppm. 13C{1H} NMR (DMSO-d6) 
δ 162.23, 158.87, 158.01, 136.99, 118.33, 110.44, 45.98 ppm. ESI-MS: m/z 609.00         
[2M + Na+]+, 294.27 [M + H+]+. 
 
1,3,5-Tris[(2-pyrimidylamino)methyl]-2,4,6-trimethylbenzene (95) 
1,3,5-Tris(1-(2-aminopyridiniummethyl)benzene bromide 
(85, 73.5 mg, 0.100 mmol) was suspended in NaOH (1 M 
aqueous solution, 4 mL) and the mixture was stirred at 60°C 
for 24 h, before being allowed to cool. The precipitate was 
isolated by centrifugation, washed with H2O (2 × 0.5 mL) 
and dried in vacuo to give the product as a yellow powder 
(40 mg, 81%). 
1H NMR (DMF-d7) δ 8.35 (d, 6H, 3JH,H = 4.5 Hz, H4), 6.75 (br, s, 3H, NH), 6.63 (d, 3H, 
3JH,H = 4.6 Hz, H5), 4.64 (s, 6H, CH2), 2.46 (s, 9H, CH3) ppm. ESI-MS: m/z 1765.07      
[4M + H+]+, 1324.93 [3M + H+]+, 905.33 [2M + Na+]+, 883.07 [2M + H+]+,                  
464.20 [M + Na+]+, 442.07 [M + H+]+, 347.13 [M – apym + H+]+. 
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1,2,4,5-Tetrakis[(2-pyrimidylamino)methyl]benzene (96) 
1,2,4,5-Tetrakis[1-(2-aminopyrimidiniummethyl)]benzene 
bromide (88) (24.9 mg, 30.0 µmol) was suspended in NaOH 
(1 M aqueous solution, 2 mL) and the mixture stirred at 60°C for 
48 h, before being allowed to cool. The precipitate was isolated 
by centrifugation, washed with H2O (2 × 0.5 mL) and dried in 
vacuo to give the product as a yellow powder (11.2 mg, 74%). 
1H NMR (DMSO-d6) δ 8.21 (d, 8H, 3JH,H = 4.7 Hz, H4), 7.66 
(t, 4H, 3JH,H = 5.6 Hz, NH), 7.28 (s, 2H, CH), 4.47 (d, 8H, 3JH,H = 5.8 Hz, CH2) ppm. Traces 
of DMF present. ESI-MS: m/z 507.20 [M + H+]+. 
 
6.9 Synthesis of palladium(II) and platinum(II) complexes of 
N-heterocyclic ligands 
[Pd2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2](PF6)8 (107) 
A solution of 1,4-bis(4,4′-
bipyridinium)butane nitrate (22, 
9.85 mg, 20.0 µmol) in H2O (1 mL) 
was treated with 
[Pd(2,2′-bipy)(NO3)2]15 (7.73 mg, 
20.0 µmol) and the suspension 
stirred for 24 h at 80°C. The mixture 
was filtered through cellulose, and 
the yellow solution treated with KPF6 (saturated aqueous solution, 20 mL). The precipitate 
was isolated by filtration, washed with cold H2O (0.5 mL) and dried in vacuo to give the 
product as an off-white solid (17.7 mg, 73%). 
1H NMR (CD3CN) δ 9.22 (d, 8H, 3JH,H = 6.6 Hz, H2), 8.81 (d, 8H, 3JH,H = 6.7 Hz, H2′), 
8.43 (m, 8H, H4bipy,H6bipy), 8.29 (d, 8H, 3JH,H = 6.7 Hz, H3′), 8.29 (d, 8H, 3JH,H = 6.7 Hz, 
H3), 7.63 (dd, 4H, 3JH,H = 6.5 Hz, 4JH,H = 1.4 Hz, H5bipy), 7.41 (d, 4H, 3JH,H = 5.4 Hz, 
H3bipy), 4.67 (m, 8H, Hbutyleneα), 2.11 (m, 8H, Hbutyleneβ) ppm. Anal. calcd for 
C68H64F48N12P8Pd2·3H2O: C, 32.99; H, 2.85; N, 6.79. Found: C, 32.70; H, 2.81; N, 6.65. 
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[Pt2(2,2′-bipy)2{4,4′-bipy(CH2)44,4′-bipy}2](PF6)8 (108) 
The title compound was prepared 
analogously to 107, using 
[Pt(2,2′-bipy)(NO3)2]15 instead of 
[Pd(2,2′-bipy)(NO3)2] and heating for 
48 h (white powder, 19.4 mg, 74%). 
1H NMR (CD3CN) δ 9.18 
(d, 8H, 3JH,H = 5.1 Hz, H2), 8.79 
(d, 8H, 3JH,H = 6.9 Hz, H2′), 8.46 
(m, 8H, H4bipy,H6bipy), 8.29 (d, 8H, 3JH,H = 6.9 Hz, H3′), 8.28 (d, 8H, 3JH,H = 5.1 Hz, H3), 
7.65 (m, 8H, H3bipy,H5bipy), 4.65 (m, 8H, Hbutyleneα), 2.09 (m, 8H, Hbutyleneβ) ppm. 1H NMR 
(D2O, of NO3- salt) δ 9.40 (d, 8H, 3JH,H = 6.6 Hz, H2) 9.05 (d, 8H, 3JH,H = 6.6 Hz, H2′) 8.54 
(m, 8H, H2bipy,H6bipy) 8.46 (d, 8H, 3JH,H = 6.6 Hz, H3′) 8.23 (d, 8H, 3JH,H = 6.6 Hz, H3) 7.71 
(m, 8H, H3bipy,H5bipy) 4.65 (m, 8H, Hbutyleneα) 2.09 (m, 8H, Hbutyleneβ) ppm. For 2D COSY, 
see Section A.1. Anal. calcd for C68H64F48N12P8Pt2·0.5H2O: C, 31.31; H, 2.51; N, 6.44. 
Found: C, 31.85; H, 2.81; N, 6.45. 
 
[Pd2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2](PF6)8 (109) 
The title compound was prepared 
analogously to 107, using 
1,6-bis(4,4′-bipyridinium)hexane 
nitrate (25) instead of the butane 
derivative (white powder, 17.2 mg, 
69%). 
1H NMR (CD3CN) δ 9.17 
(d, 8H, 3JH,H = 6.3 Hz, H2), 8.79 
(d, 8H, 3JH,H = 6.6 Hz, H2′), 8.35 (m, 8H, H4bipy,H6bipy), 8.24 (d, 8H, 3JH,H = 6.6 Hz, H3′), 
8.29 (d, 8H, 3JH,H = 6.3 Hz, H3), 7.58 (m, 4H, H5bipy), 7.39 (d, 4H, 3JH,H = 5.1 Hz, H3bipy), 
4.54 (t, 8H, 3JH,H = 7.2 Hz, Hhexyleneα), 1.97 (m, 8H, Hhexyleneβ), 1.40 (m, 8H, Hhexyleneγ) ppm. 
ESI-FT-ICR-MS: m/z calcd for C72H72F36N12P6Pt22+, [M – 2PF6-]2+: 1182.6561. Found: 
1182.6558, calcd for C72H72F30N12P5Pt23+, [M – 3PF6-]3+: 739.782983. Found: 739.781613. 
Anal. calcd for C72H72F48N12P8Pd2·H2O: C, 34.65; H, 2.99; N, 6.73. Found: C, 34.67; 
H, 3.22; N, 6.65. 
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[Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2](PF6)8 (110) 
The title compound was prepared 
analogously to 108, using 
1,6-bis(4,4′-bipyridinium)hexane 
nitrate (25) instead of the butane 
derivative (white powder, 20.9 mg, 
79%). 
1H NMR (CD3CN) δ 9.17 
(d, 8H, 3JH,H = 6.4 Hz, H2), 8.78 
(d, 8H, 3JH,H = 6.6 Hz, H2′), 8.38 (m, 8H, H4bipy,H6bipy), 8.24 (d, 8H, 3JH,H = 6.6 Hz, H3′), 
8.06 (d, 8H, 3JH,H = 6.4 Hz, H3), 7.58 (m, 4H, H5bipy), 7.39 (d, 4H, 3JH,H = 5.4 Hz, H3bipy), 
4.54 (t, 8H, 3JH,H = 4.5 Hz, Hhexyleneα), 1.97 (m, 8H, Hhexyleneβ), 1.40 (m, 8H, Hhexyleneγ) ppm. 
ESI-FT-ICR-MS: m/z calcd for C72H72F36N12P6Pt22+, [M – 2PF6-]2+: 1182.156840. Found: 
1182.153886, calcd for C72H72F30N12P5Pt23+, [M – 3PF6-]3+: 739.782983. Found: 
739.781613. Anal. calcd for C72H72F48N12P8Pt2: C, 32.57; H, 2.73; N, 6.33. Found: C, 32.53; 
H, 2.99; N, 6.29. 
 
[Pt2(dppp)2{4,4′-bipy(o-xylylene) 4,4′-bipy}2](PF6)4(OTf)4 (111) 
1,2-Bis(4,4′-bipyridiniummethyl)benzene 
hexafluorophosphate16 (29, 7.07 mg, 
10.0 µmol) and [Pt(dppp)(OTf)2]17 
(9.06 mg, 10.0 µmol) were dissolved in 
CH3CN (1 mL) and the solution was 
stirred for 24 h at 60°C. The solvent was 
allowed to evaporate slowly, and the 
residue dried in vacuo to give the product 
as a white solid (16.41 mg, 99%). 
1H NMR (CD3CN) δ 8.79 (m, 8H), 8.08 
(m, 4H), 7.58 (m, 16H), 7.44 (m, 6H), 
7.38 (m, 8H), 7.21 (m, 2H), 5.86 (m, 4H, NCH2), 5.66 (m, 4H, NCH2′),§§ 3.19 (m, 8H, 
PCH2), 2.23 (m, 4H, PCH2CH2) ppm. 31P{1H} NMR (121 MHz, CD3CN) δ –13.61 (s, PPt),  
–13.61 (d, 1JP,Pt = 3028 Hz, PPt), –143.40 (septet, 1JP,F = 707 Hz, PF6-) ppm. ESI-FT-ICR-
                                               
§§
 These protons become diastereotopic upon complexation due to restricted rotation of the bound ligand. 
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MS: m/z calcd for C111H100Pt2F27N8O3P8S3+,          [M – 3OTf-]3+: 928.48171. Found: 
928.48223. Anal. calcd for C114H100F36N8O12P8Pt2S4·5H2O: C, 41.32; H, 3.35; N, 3.38. 
Found: C, 41.20; H, 3.33; N, 3.39. 
 
cis-[Pt2Cl4{4,4′-bipy(o-xylylene) 4,4′-bipy}2](PF6)4 (112) 
A solution of 1,2-bis(4,4′-
bipyridiniummethyl)benzene 
hexafluorophosphate16 (29, 7.07 mg, 
10.0 µmol) in CH3CN (1 mL) was treated with 
cis-[Pt(PhCN)2Cl2] (4.72 mg, 10.0 µmol) and 
the suspension was stirred for 24 h at 60°C. 
The solvent was allowed to evaporate slowly, 
and the solid washed with Et2O (0.5 mL) and 
dried in vacuo to give the product as a yellow 
solid (9.94 mg, 97%). 
ESI-FT-ICR-MS: m/z calcd for C56H48N8PF6Cl4Pt23+, [M – 3PF6-]3+: 503.05527. Found: 
503.05560. Anal. calcd for C56H48N8P4F24Cl4Pt2·PhCN: C, 35.80; H, 2.55; N, 5.96. Found: 
C, 35.99; H, 2.86; N, 5.99. 
 
cis-[Pd2Cl4{4,4′-bipy(CH2)34,4′-bipy}2](PF6)4 (113) 
A solution of 1,3-bis(4,4′-bipyridinium)propane 
hexafluorophosphate (20, 6.44 mg, 10.0 µmol) 
in CH3CN (1 mL) was treated with 
[Pd(PhCN)2Cl2] (3.83 mg, 10.0 µmol) and the 
suspension stirred for 24 h at 60°C. The 
solution was allowed to evaporate slowly, and 
the solid was washed with Et2O (0.5 mL) and 
dried in vacuo to give the product as a yellow 
solid (8.29 mg, 94%). 
1H NMR (CD3CN) δ 9.04 (d, 8H, 3JH,H = 5.9 Hz, H2), 8.82 (d, 8H, 3JH,H = 6.1 Hz, H2′), 8.34 
(d, 8H, 3JH,H = 6.1 Hz, H3′), 7.86 (d, 8H, 3JH,H = 5.9 Hz, H3), 7.67 (m, 12H, H2,4benzonitrile), 
7.50 (m, 8H, H3benzonitrile), 4.70 (m, 8H, Hpropyleneα), 2.70 (m, 4H, Hpropyleneβ) ppm. 
ESI-FT-ICR-MS: m/z 677.97932 [M – 2PF6-]2+. Anal. calcd for 
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C46H44Cl4F24N8P4Pd2·PhCN·H2O: C, 36.08; H, 2.91; N, 7.14. Found: C, 35.74; H, 3.02; 
N, 7.03. 
 
[Pt4(2,2′-bipy)4{apyz(CH2)6apyz–2H}2](PF6)8 (119) 
A solution of  1,6-bis(3-
aminopyrazinium)hexane nitrate (49, 7.96 mg, 
20.0 µmol) in H2O (1 mL) was treated with 
[Pt(2,2′-bipy)(NO3)2] (19.01 mg, 40.0 µmol) 
and the suspension was stirred for 72 h at 
80°C. The red solution was treated with KPF6 (saturated aqueous solution, 15 mL) and 
allowed to stand for 30 min. The precipitate was isolated by filtration, washed with cold 
H2O (1 mL) and dried in vacuo to give the product as an orange-red solid (19.63 mg, 61%). 
1H NMR (D2O, of NO3- salt) δ 8.80–7.20 (m, 44H, Hbipy,apyz), 4.36 (m, 8H, Hhexyleneα), 1.92 
(m, 8H, Hhexyleneβ), 1.42 (m, 8H, Hhexyleneγ) ppm. 195Pt NMR (D2O, of NO3- salt)                     
δ –2360.8 ppm. ESI-FT-ICR-MS: m/z calcd for C68H72F30N20P5Pt43+, [M – 3PF6-]3+: 
891.768257. Found: 891.768992. Anal. calcd for C68H72F48N20P8Pt4·6H2O: C, 25.38; 
H, 2.63; N, 8.71. Found: C, 25.57; H, 2.66; N, 8.49. UV-vis (0.014 mM in H2O): 
λ = 305 nm, ε = 6.82×104 M-1cm-1; λ = 428 nm, ε = 8.36×103 M-1cm-1. 
 
[Pt2(2,2′-bipy)2(Meapyz–H)2](PF6)4 (122) 
A solution of 1-methyl-3-aminopyrazinium nitrate 
(43, 6.88 mg, 40.0 µmol) in H2O (1 mL) was treated with 
[Pt(2,2′-bipy)(NO3)2] (19.01 mg, 40.0 µmol) and the 
suspension was stirred for 72 h at 80°C. The red solution was 
treated with KPF6 (saturated aqueous solution, 15 mL) and 
allowed to stand for 30 min. The precipitate was isolated by filtration, washed with cold 
H2O (1 mL) and dried in vacuo to give the product as an orange-red solid (19.44 mg, 64%). 
1H NMR (D2O, of NO3- salt) δ 8.70-7.30 (m, 22H, Hbipy,apyz), 4.20 (m, 6H, CH3) ppm. 
195Pt NMR (D2O, of NO3- salt) δ –2358 ppm. Anal. calcd for C30H30F24N10P4Pt2·H2O: 
C, 23.73; H, 2.12; N, 9.22. Found: C, 23.77; H, 2.42; N, 9.03. UV-vis (0.031 mM in H2O): 
λ = 305 nm, ε = 2.22×104 M-1cm-1; λ = 428 nm, ε = 2.90×103 M-1cm-1. 
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[Pt4(2,2′-bipy)4{apym(CH2)5apym–2H}2](PF6)8 (124) 
A solution of  1,5-bis(3-
aminopyrimidinium)pentane nitrate (67, 9.00 mg, 
20.0 µmol) in H2O (1 mL) was treated with 
[Pt(2,2′-bipy)(NO3)2] (19.01 mg, 40.0 µmol) and 
the suspension was stirred for 72 h at 80°C. The 
orange solution was treated with KPF6 (saturated aqueous solution, 15 mL) and allowed to 
stand for 30 min. The precipitate was isolated by filtration, washed with cold H2O (1 mL) 
and dried in vacuo to give the product as an orange solid (21.57 mg, 70%). 
1H NMR (D2O, of NO3- salt) δ 9.48 (d, 4H, 3JH,H = 5.3 Hz, H6apym), 8.74 (d, 4H, 
3JH,H =  6.1 Hz, H4apym), 8.70 (d, 4H, 3JH,H = 5.7 Hz, Hbipy), 8.4–8.15 (m, 12H, Hbipy), 8.13 
(d, 4H, 3JH,H = 8.1 Hz, Hbipy), 7.67 (t, 4H, 3JH,H = 6.6 Hz, Hbipy), 7.28 (t, 4H, 3JH,H = 6.6 Hz, 
Hbipy), 7.12 (t, 4H, 3JH,H = 5.9 Hz, H5apym), 4.75 (m, 4H, Hpentyleneα), 4.33 (m, 4H, 
Hpentyleneα′),*** 2.0–1.2 (m, 12H, Hpentyleneβ,Hpentyleneγ) ppm. 195Pt NMR (D2O, of NO3- salt)      
δ –2253.7 ppm. ESI-FT-ICR-MS: m/z calcd for C66H68F36N20P6Pt42+, [M – 2PF6-]2+: 
1395.61755. Found: 1395.61458, calcd for C33H34F18N10P3Pt2+, [½M – PF6-]+: 1395.11721. 
Found: 1395.11783 (the intensities of both ions are comparable). Anal. calcd for 
C66H68F48N20P8Pt4·6H2O: C, 25.73; H, 2.22; N, 9.09. Found: C, 25.97; H, 2.36; N, 9.16. 
UV-vis (0.120 mM in H2O): λ = 358 nm, ε = 1.72×104 M-1cm-1; λ = 433 nm, 
ε = 4.91×103 M-1cm-1. For 2D COSY and UV-vis spectrum, see Sections A.1 and A.2. 
 
6.10 Synthesis of palladium(II) and platinum(II) complexes of 
PEGda 
[Pd(2,2′-bipy)(PEGda)](NO3)2 (125) 
[Pd(2,2′-bipy)(NO3)2] (7.73 mg, 20.0 µmol) was added to 
PEGda (6.94 mg, 20.0 µmol) in H2O (5 mL) and the 
suspension was stirred for 6 h at 60°C, over which time 
[Pd(2,2′-bipy)(NO3)2] had dissolved. The pale-yellow 
solution was then filtered through cellulose to afford a stock solution of the title complex 
(assumed to be quantitative). 
                                               
***
 These protons become diastereotopic upon complexation due to the restricted rotation of the bound ligands. 
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1H NMR (D2O) δ 9.1-8.0 (m, 6H, H6bipy,H3bipy,H4bipy), 7.7 (m, 2H, H5bipy), 6.46 (br, s, 4H, 
NH2), 4.00-3.40 (m, 76H, (CH2OCH2)19), 3.25 (t, 4H, 3JH,H = 5.77 Hz, CH2NH2) ppm. 
ESI-FT-ICR-MS: m/z calcd for C50H92N4O19Pd2+, [M – 2NO3-]2+: 579.27006. Found: 
579.27153. 
 
[Pt(2,2′-bipy)(PEGda)](NO3)2 (126) 
 [Pt(2,2′-bipy)(NO3)2] (10.6 mg, 22.4 µmol) and PEGda 
(20.1 mg, 22.4 µmol) were dissolved in DMF (5 mL) and 
stirred for 48 h at 60°C after which the yellow solution was 
evaporated to dryness. The residue was dissolved in H2O 
(1 mL) and the mixture filtered through cellulose to afford a stock solution of the title 
complex (assumed to be quantitative). 
1H NMR (DMF-d7) δ 9.11 (d, 2H, 3JH,H = 5.63 Hz, H6bipy), 8.90 (d, 2H, 3JH,H = 7.55 Hz, 
H3bipy), 8.66 (m, 2H, H4bipy), 8.07 (m, 2H, H5bipy), 6.46 (br, s, 4H, NH2), 4.00-3.40 
(m, 76H, (CH2OCH2)19), 3.36 (m, 4H, CH2NH2) ppm. 195Pt NMR (DMF-d7) δ –2660.6 ppm. 
ESI-FT-ICR-MS: m/z calcd for C50H92N4O19Pt2+, [M – 2NO3-]2+: 624.30133. Found: 
624.29932. 
 
[Pt(tmeda)(PEGda)](NO3)2 (127) 
[Pt(tmeda)I2]18 (15.9 mg, 28.2 µmol) was suspended in 
DMF (3 mL) and treated with AgNO3 (9.54 mg, 56.2 µmol) in 
DMF (3 mL). The mixture was stirred in the absence of light 
for 24 h at 55°C. AgI was removed by filtration, and the 
colourless filtrate was added to PEGda (25.3 mg, 28.2 µmol). The solution was stirred for 
72 h at 55°C, after which it was evaporated to dryness. This was dissolved in H2O (1 mL) 
and the mixture filtered through cellulose to afford a stock solution of the title complex 
(assumed to be quantitative). 
1H NMR (DMF-d7) δ 5.51 (br, s, 4H, NH2), 4.00-3.40 (m, 76H, (CH2OCH2)19), 3.30 (m, 4H, 
CH2NH2), 2.97 (s, 12H, CH3(tmeda)), 2.90 (s, 4H, CH2(tmeda)) ppm. 195Pt NMR (DMF-d7) 
δ –2695.5 ppm. ESI-FT-ICR-MS: m/z calcd for C46H100N5O22Pt+, [M – NO3-]+: 1269.65022. 
Found: 1269.64911. 
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[Pt(en)(PEGda)](NO3)2 (128) 
[Pt(en)I2]18 (13.40 mg, 26.33 µmol) was suspended in DMF 
(3 mL) and treated with AgNO3 (8.88 mg, 52.26 µmol) in DMF 
(3 mL). The mixture was stirred in the absence of light for 24 h 
at 55°C. AgI was removed by filtration, and the colourless filtrate was added to PEGda 
(23.61 mg, 26.33 µmol) in DMF (1 mL). The solution was stirred for 72 h at 55°C, after 
which it was evaporated to dryness to give a pale yellow oil which was used without further 
purification (assumed to be quantitative). 
1H NMR (DMF-d7) δ 5.72 (br, s, 4H, NH2), 5.44 (br, s, 4H, NH2), 3.90–3.40 (m, 76H, 
(CH2OCH2)19), 3.03 (m, 4H, CH2NH2), 2.75 (br, s, 4H, CH2(en)) ppm. 195Pt NMR 
(DMF-d7) δ –2870 ppm. ESI-FT-ICR-MS: m/z calcd for C42H92N5O22Pt+, [M – NO3-]+: 
1213.58762. Found: 1213.58575. 
 
6.11 Synthesis of palladium(II) and platinum(II) acyclic model 
complexes 
[Pt(2,2′-bipy)(NH3)2](NO3)2 (146) 
[Pt(2,2′-bipy)(NO3)2] (18.25 mg, 38.4 µmol) was suspended in 
H2O (0.3 mL) and treated with NH3 (28% aqueous solution, 
26 mg, ~430 µmol). The suspension was stirred for 4 h at 70°C 
and allowed to cool. The mixture was filtered through cellulose, 
and the resulting pale-yellow solution was allowed to evaporate 
slowly to give the product as a pale yellow powder (16.9 mg, 86%). 
1H NMR (DMSO-d6) δ 8.71 (m, 4H, H3, H6), 8.53 (m, 2H, H4), 7.96 (m, 2H, H5), 5.28 
(br, s, 6H, NH3) ppm. 13C{1H} NMR (DMSO-d6) δ 156.4, 149.5, 141.8, 127.8, 124.6 ppm. 
195Pt NMR (DMSO-d6) δ –2604 ppm. ESI-FT-ICR-MS: m/z calcd for C20H28N11O9Pt2+, 
[2M – NO3-]+: 956.13615. Found: 956.13360. Anal. calcd for C10H14N6O6Pt: C, 23.58; 
H, 2.77; N, 16.50. Found: C, 23.77; H, 2.91; N, 16.51. 
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[Pd(2,2′-bipy)(Mebipy)2](NO3)4 (147) 
[Pd(2,2′-bipy)(NO3)2] (15.0 mg, 38.8 µmol) was 
added to a solution of 1-methyl-4,4′-bipyridinium 
nitrate (15, 18.1 mg, 77.6 µmol) in H2O (0.5 mL) and 
the suspension was stirred for 2 h at 80°C, over which 
time [Pd(2,2′-bipy)(NO3)2] had dissolved. The pale-
yellow solution was filtered through cellulose, and 
slowly evaporated to give the product as a pale-
yellow powder (34.5 mg, 99%). 
1H NMR (D2O) δ 9.44 (d, 4H, 3JH,H = 6.01 Hz, H2Mebipy), 9.00 (d, 4H, 3JH,H = 6.47 Hz, 
H2′Mebipy), 8.51 (d, 2H, 3JH,H = 7.96 Hz, H6bipy), 8.45 (d, 4H, 3JH,H = 6.47 Hz H3′Mebipy), 8.42 
(obscured, 2H, H4bipy), 8.28 (d, 4H, 3JH,H = 6.01 Hz, H3Mebipy), 7.64 (t, 2H, 3JH,H = 6.19 Hz, 
H5bipy), 7.54 (dd, 2H, 3JH,H = 5.44 Hz, H3bipy), 4.50 (s, 3H, CH3) ppm. 13C{1H} NMR 
(100 MHz, D2O) δ 156.4, 152, 150.7, 149.5, 146.4, 145.7, 142.4, 127.7, 126.1, 125.9, 124.0, 
47.8 ppm. For 2D COSY, HSQC and HMBC see Section A.1. ESI-MS: m/z 789.52           
[M – NO3-]+. Anal. calcd for C32H30N10O12Pd·2.5H2O: C, 42.80; H, 3.93; N, 15.60. Found: 
C, 42.60; H, 3.90; N, 15.51. 
 
[Pt(2,2′-bipy)(Mebipy)2](NO3)4 (148) 
This complex has been reported previously as its ClO4- 
salt.19 The NO3- salt was prepared analogously to 147, 
using [Pt(2,2′-bipy)(NO3)2] instead of 
[Pd(2,2′-bipy)(NO3)2] and stirring overnight (97%, pale 
yellow powder). 
1H NMR (D2O) δ 9.44 (dd, 4H, 3JH,H = 5.51 Hz, 
4JH,H = 1.33 Hz, H2Mebipy), 9.02 (d, 4H, 3JH,H = 6.79 Hz, 
H2′Mebipy), 8.57 (d, 2H, 3JH,H = 7.44 Hz, H6bipy), 8.51 
(obscured, 2H, H4bipy), 8.48 (d, 4H, 3JH,H = 6.79 Hz H3′Mebipy), 8.28 (dd, 4H, 3JH,H = 5.51 Hz, 
4JH,H = 1.33 Hz, H3Mebipy), 7.82 (d, 2H, 3JH,H = 5.50 Hz, H5bipy), 7.70 (td, 2H, 
3JH,H = 7.40 Hz, 4JH,H = 1.33 Hz H5bipy), 4.52 (s, 3H, CH3) ppm. 13C{1H} NMR 
(100 MHz, D2O) δ 156.9, 153.3, 150.8, 149.5, 146.8, 146.1, 142.8, 128.2, 126.8, 126.2, 
124.4, 48.2 ppm. 195Pt NMR (D2O) δ –2522.6 ppm. For 2D COSY, HSQC and HMBC see 
Chapter Six: Experimental 
139 
Section A.1. ESI-MS: m/z 879.64 [M – NO3-]+; 1944 [2M + NO3-]-, 1003.02 [M + NO3-]-.††† 
Anal. calcd for C32H30N10O12Pt·3.5H2O: C, 38.25; H, 3.71; N, 13.94. Found: C, 38.09; 
H, 3.41; N, 13.77. 
 
[Pd(phen)(Mebipy)2](NO3)4 (149) 
The title compound was prepared analogously to 
147, using [Pd(phen)(NO3)2]15 instead of 
[Pd(2,2′-bipy)(NO3)2] (98%, pale yellow powder). 
1H NMR (D2O) δ 9.49 (d, 4H, 3JH,H = 6.37 Hz, 
H2Mebipy), 8.99 (d, 4H, 3JH,H = 6.53 Hz, H2′Mebipy), 
8.91 (dd, 2H, 3JH,H = 6.43 Hz, 3JH,H = 2.93 Hz, 
H3phen), 8.45 (d, 4H, 3JH,H = 6.53 Hz H3′Mebipy), 
8.29 (d, 2H, 3JH,H = 6.43 Hz, H3Mebipy), 8.29 
(s, 2H, H5phen), 7.92-7.88 (4H, H2,4phen), 4.50 (s, 3H, CH3) ppm. 13C{1H} NMR 
(100 MHz D2O) δ 152.59, 151.05, 150.45, 146.92, 146.82, 146.04, 141.70, 131.12, 128.04, 
126.41, 126.25, 126.09, 48.13 ppm. For 2-D COSY, HSQC and HMBC see Section A.1. 
Anal. calcd for C34H30N10O12Pd·2.5H2O: C, 44.29; H, 3.83; N, 15.19. Found: C, 44.54; 
H, 3.84; N, 15.16. 
 
6.12 Biomolecular mass spectrometry 
Freshly prepared stock solutions of DNA (1000 µM in 0.1 M NH4OAc) and metal 
complexes (200 µM in either 0.01 or 0.1 M NH4OAc) were prepared. These were combined 
and diluted with either 0.01 or 0.1 M NH4OAc to give mixtures in which the final 
concentration of DNA was 10 µM (pH ≈ 7.0 or 7.4 for 0.01 and 0.1 M NH4OAc, 
respectively). The solutions were mixed by vortex and left at room temperature for at least 
15 min before being analysed. Negative-ion ESI mass spectra were acquired using a Waters 
Micromass Q-ToF2 Ultima spectrometer equipped with a Z-spray probe, calibrated over the 
appropriate range with CsI (750 µM). Unless otherwise stated, the conditions used were: 
Vcapillary = 2.5 V, Vcone = 70 V, Tsource = 25ºC, Tdesolvation = 100ºC, collision energy = 2. 
Spectra were acquired by summing 20 scans (10 scans for the comparative binding studies 
of D2). 
 
                                               
†††
 Data for 147 and 148 were collected using a Micromass Q-ToF2 Ultima spectrometer. 
Chapter Six: Experimental 
140 
6.13 Thermal denaturation 
Thermal denaturation experiments of DNA in the presence of metal complexes were 
performed using a procedure similar to that employed by Cusumano and co-workers.20 
Mixtures of CT-DNA and complexes ([DNA base pairs] = 78 µM, [complex] = 7.8 µM) 
were prepared in phosphate-buffered saline solution (1 mM phosphate, 2 mM NaCl, pH 7.4) 
and their thermal denaturation monitored by recording absorbance values at 260 nm over the 
temperature range 37 – 100ºC. The solutions were held at 37ºC for 30 min prior to heating 
at 0.5ºC/min and absorbance readings were taken every 2 min (1ºC). Data were fitted to 
sigmoidal plots using origin 7.0®, and Tm values were estimated from the x-intercepts of 2nd 
derivative plots. All values are averaged over at least 2 runs for each mixture. These were 
compared to values obtained for CT-DNA in the absence of metal complex. 
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A.1 2-D NMR spectra 
 
Figure A.1: 1H-1H COSY (400 MHz, D2O) spectrum of 1,2-bis(1-methyl-2-aminopyrimidinium)benzene 
nitrate (76). 
 
 
Figure A.2: 1H-1H COSY (300 MHz, D2O) spectrum of 1,3-bis(1-methyl-2-aminopyrimidinium)benzene 
bromide (78). 
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Figure A.3: 1H-13C HSQC (300 MHz, D2O) spectrum of 1,3-bis(1-methyl-2-aminopyrimidinium)benzene 
bromide (78). 
 
 
Figure A.4: 1H-1H COSY (300 MHz, D2O) spectrum of 1,1′-bis[4-(4,4′-bipyridinium)butyl]-4,4′-
bipyridinium bromide (100). 
 
 
Appendices 
III 
 
Figure A.5: 1H-1H COSY (300 MHz, D2O) spectrum of 1,1′-bis[4-(4,4′-bipyridinium)butyl]-4,4′-
bipyridinium hexafluorophosphate (103). 
 
 
Figure A.6: 1H-1H COSY (300 MHz, D2O) spectrum of 1,1′-bis[6-(4,4′-bipyridinium)hexyl]-4,4′-
bipyridinium nitrate (104). 
 
 
Figure A.7: 1H-1H COSY (300 MHz, D2O) spectrum of [Pt4(2,2′-bipy)4{apym(CH2)5apym–2H}2](PF6)8 
(124). 
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Figure A.8: 1H-1H COSY (400 MHz, D2O) spectrum of [Pd(2,2′-bipy)(Mebipy)2](NO3)4 (147). 
 
  
Figure A.9: 1H-13C HSQC (400 MHz, D2O) spectrum of [Pd(2,2′-bipy)(Mebipy)2](NO3)4 (147). 
 
 
Figure A.10: 1H-13C HMBC (400 MHz, D2O) spectrum of [Pd(2,2′-bipy)(Mebipy)2](NO3)4 (147). 
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Figure A.11: 1H-1H COSY (400 MHz, D2O) spectrum of [Pt(2,2′-bipy)(Mebipy)2](NO3)4 (148). 
 
 
Figure A.12: 1H-13C HSQC (400 MHz, D2O) spectrum of [Pt(2,2′-bipy)(Mebipy)2](NO3)4 (148). 
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Figure A.13: 1H-13C HMBC (400 MHz, D2O) spectrum of [Pt(2,2′-bipy)(Mebipy)2](NO3)4 (148). 
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Figure A.14: 1H-1H COSY (400 MHz, D2O) spectrum of [Pd(phen)(Mebipy)2](NO3)4 (149). 
 
 
Figure A.15: 1H-13C HSQC (400 MHz, D2O) spectrum of [Pd(phen)(Mebipy)2](NO3)4 (149). 
 
 
Figure A.16: 1H-13C HMBC (400 MHz, D2O) spectrum of [Pd(phen)(Mebipy)2](NO3)4 (149). 
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Figure A.17: 1H-1H COSY (300 MHz, D2O) spectrum of [Pt2(2,2′-bipy)2(bipyC4H8bipy)2](NO3)8 (108 as 
NO3- salt). 
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Figure A.18: UV-visible spectrum of [Pt4(2,2′-bipy)4{apym(CH2)5apym–2H}2](NO3)8 (124 as NO3- salt, 
0.120 mM in H2O). 
 
A.3 X-ray crystallographic procedures and results 
(±)-2,6-Bis(4,4′-bipyridinium)-9-thiabicyclo[3.3.1]nonane chloride (30) 
A colourless needle-like crystal of the title compound was attached with Exxon Paratone N, 
to a short length of fibre supported on a thin piece of copper wire inserted in a copper 
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mounting pin.  The crystal was quenched in a cold N2 gas stream from an Oxford 
Cryosystems Cryostream. A Bruker-Nonius FR591 Kappa APEX II diffractometer 
employing graphite monochromated MoKα radiation generated from a fine-focus rotating 
anode was used for the data collection. Cell constants were obtained from a least squares 
refinement against 8715 reflections located between 5.28 and 59.92º 2θ. Data were collected 
at 150(2) K with φ and ω scans to 60.54º 2θ.  The data integration and reduction were 
undertaken with SAINT and XPREP,1 and subsequent computations were carried out with 
the X-Seed2 graphical user interface. An empirical absorption correction determined with 
SADABS3 was applied to the data. 
 
The structure was solved in the space group P212121 by direct methods with SHELXS-97,4 
and extended and refined with SHELXL-97.4 The non-H atoms in the asymmetric unit were 
modelled with anisotropic displacement parameters. A riding atom model with group 
displacement parameters was used for the H atoms. The absolute structure was established 
with the Flack parameter5 refining to 0.45(10). 
 
Formula C28H45.50Cl2N4O8.75S, M 681.14 Da, orthorhombic, space group P212121, 
a 6.9765(2), b 19.7846(5), c 24.6467(6) Å, V 3401.92(15) Å3, Dc 1.330 gcm-3, Z 4, crystal 
size  0.33×0.08×0.08 mm, colour colourless, habit needle, temperature 150(2) K, λ(MoKα) 
0.71073 Å, µ(MoKα) 0.306 mm-1, T(SADABS)min,max 0.894, 0.976, 2θmax  60.54, hkl range 
-9 9, -27 26, -34 34, N 89460, Nind 9994(Rmerge 0.0485), Nobs 9322(I > 2σ(I)), Nvar 440, 
residuals* R1(F) 0.0849, wR2(F3) 0.2352, GoF(all) 1.128, ∆ρ
 min,max -0.647, 1.119 e- Å-3.  
 
*R1 = Σ||Fo| – |Fc||/Σ|Fo| for Fo > 2σ(Fo); wR2 = (Σw(Fo2 – Fc2) 2/Σ(wFo2) 2)½ (all reflections) 
 w = 1/[σ2(Fo2)+(0.1261P)2 + 3.8131P]; P = (Fo2 +2Fc2)/3 
 
1-Methyl-3-aminopyrazinium nitrate (43) 
A colourless block-like crystal of the title compound was mounted on a Bruker SMART 
1000 CCD diffractometer employing graphite monochromated MoKα radiation generated 
from a sealed tube. Cell constants were obtained from a least squares refinement against 
4414 reflections located between 7.21 and 56.56º 2θ. Data were collected at 150(2) K with 
ω scans to 56.58º 2θ. The data integration and reduction were undertaken with SAINT and 
XPREP, and subsequent computations were carried out with the WinGX6 graphical user 
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interface. The intensities of 88 standard reflections recollected at the end of the experiment 
changed by 16 during the data collection and a correction was accordingly applied to the 
data. An empirical absorption correction determined with SADABS was applied to the data. 
 
The structure was solved in the space group P32 by direct methods with SIR97,7 and 
extended and refined with SHELXL-97. The non-H atoms in the asymmetric unit were 
modelled with anisotropic displacement parameters. Of the 8 H atoms included in the model 
2 were located and modelled with isotropic displacement parameters, and a riding atom 
model was used for the remainder. The absolute structure was established with the Flack 
parameter refining to 0.074(1). 
 
Formula C5H8N4O3, M 172.15 Da, trigonal, space group P32, a 6.1596(7), b 6.1596(7), 
c 16.966(4) Å, γ 120.00º, V 557.46(16) Å3, Dc 1.538 gcm-3, Z 3, crystal size 
0.600×0.570×0.560 mm, colour colourless, habit block, temperature 150(2) K, λ(MoKα) 
0.71073 Å, µ(MoKα) 0.128 mm-1, T(SADABS)min,max 0.834, 0.931, 2θmax 56.58, hkl range 
-8 8, -8 8, -22 21, N 5431, Nind 1771(Rmerge 0.0190), Nobs 1740(I > 2σ(I)), Nvar 116, residuals 
R1(F) 0.0266, wR2(F2) 0.0690, GoF(all) 0.983, ∆ρmin,max -0.270, 0.164 e-Å-3. 
 
w = 1/[σ2(Fo2)+(0.0509P)2 + 0.0552P]; P = (Fo2 +2Fc2)/3 
 
1-Benzyl-2-aminopyrazinium hexafluorophosphate (61) 
A colourless prism-like crystal of the title compound was mounted on a Bruker 
APEXII-FR591 diffractometer employing graphite monochromated MoKα radiation 
generated from a rotating anode. Cell constants were obtained from a least squares 
refinement against 574 reflections located between 7.98 and 59.32º 2θ. Data were collected 
at 150(2) K with ω+φ scans to 60.02º 2θ. The data integration and reduction were 
undertaken with SAINT and XPREP, and subsequent computations were carried out with 
the WinGX graphical user interface. An empirical absorption correction determined with 
SADABS was applied to the data. 
 
The structure was solved in the space group C2/c by direct methods with SIR97, and 
extended and refined with SHELXL-97. Of the 40 non-H atom sites in the asymmetric unit, 
16 were modelled with anisotropic displacement parameters and the rest were modelled 
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with isotropic displacement parameters. Of the 12 H atoms included in the model 2 were 
located and modelled with isotropic displacement parameters, and a riding atom model was 
used for the remainder. 
 
Formula C11H12F6N3P, M 331.21 Da, monoclinic, space group C2/c, a 19.106(4), 
b 8.6832(17), c 17.974(5) Å, β 117.261(6), V 2650.8(11) Å3, Dc 1.660 gcm-3, Z 8, crystal 
size 0.435×0.340×0.235 mm, colour colourless, habit prism, temperature 150(2) K, 
λ(MoKα) 0.71073 Å, µ(MoKα) 0.275 mm-1, T(SADABS)min,max 0.808, 0.937, 2θmax 60.02, 
hkl range -26 26, -12 12, -25 24, N 17110, Nind 3842 (Rmerge 0.0461), Nobs 2961(I > 2σ(I)), 
Nvar 218, residuals R1(F) 0.0633, wR2(F2) 0.1715, GoF(all) 1.036, ∆ρmin,max -0.838, 
0.697 e-Å-3. 
 
w = 1/[σ2(Fo2)+(0.0751P)2 + 7.7923P] 
 
1,3-Bis(1-methyl-2-aminopyrimidinium)benzene triflate 
hexafluorophosphate (80′) 
The mixed salt [apym(m-xylylene)apym](OTf)1.95(PF6)0.05 formed as colourless crystals on 
slow evaporation of a CD3CN solution containing equimolar amounts of [Pt(dppp)(OTf)2] 
and [apym(m-xylylene)apym](PF6)2 (80). 
 
One of the block-like crystals was mounted on a Bruker APEXII-FR591 diffractometer 
employing graphite monochromated MoKα radiation generated from a rotating anode. Cell 
constants were obtained from a least squares refinement against 7706 reflections located 
between 4.61 and 78.94º 2θ. Data were collected at 150(2) K with ω+φ scans to 80.10º 2θ. 
The data integration and reduction were undertaken with SAINT and XPREP, and 
subsequent computations were carried out with the WinGX graphical user interface. An 
empirical absorption correction determined with SADABS was applied to the data. 
 
The structure was solved in the space group P1 by direct methods with SIR97, and 
extended and refined with SHELXL-97. Of the 45 non-H atom sites in the asymmetric unit, 
38 were modelled with anisotropic displacement parameters and the rest were modelled 
with isotropic displacement parameters. A riding atom model with group displacement 
parameters was used for the H atoms. 
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Formula C17.95H18F6.15N6O5.85P0.05S1.95, M 592.32 Da, triclinic, space group P1, 
a 9.6224(4), b 11.2521(5), c 12.3853(5) Å, α 98.435(2), β 112.739(2), γ 100.330(2)º, 
V 1181.73(9) Å3, Dc 1.665 gcm-3, Z 2, crystal size 0.300×0.250×0.200 mm, colour 
colourless, habit block, temperature 150(2) K, λ(MoKα) 0.71073 Å, µ(MoKα) 0.322 mm-1, 
T(SADABS)min,max 0.859, 0.937, 2θmax 80.10, hkl range -17 17, -20 20, -22 22, N 79449, 
Nind 14574 (Rmerge 0.0305), Nobs 12323(I > 2σ(I)), Nvar 365, residuals R1(F) 0.0357, wR2(F2) 
0.0982, GoF(all) 1.025, ∆ρmin,max -0.384, 0.577 e-Å-3. 
 
w = 1/[σ2(Fo2)+(0.0496P)2 + 0.2401P] 
 
 
Figure A.19: ORTEP of 80′, with ellipsoids drawn at the 50% probability level. The OTf- and PF6- 
anions are omitted for clarity. 
 
 
Figure A. 20: The solid state packing of 80′, featuring 1-D chains held together by N–H···N and N–H···O 
H-bonds. In turn, these chains are linked by C–Hphenylene···O interactions to form 2-D sheets. The sheets 
are linked by anion-π interactions (rcentroid–O(4) = 3.02 Å, rcentroid–F(6) = 2.99 Å). 
 
1-(2-Pyrimidylaminomethyl)-2-(pyrimidiniummethyl)benzene nitrate (90) 
A colourless prism-like crystal of the title compound was mounted on a Bruker 
APEXII-FR591 diffractometer employing graphite monochromated MoKα radiation 
generated from a rotating anode. Cell constants were obtained from a least squares 
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refinement against 437 reflections located between 4.87 and 48.98º 2θ. Data were collected 
at 150(2) K with ω+φ scans to 63.48º 2θ. The data integration and reduction were 
undertaken with SAINT and XPREP, and subsequent computations were carried out with 
the WinGX graphical user interface. An empirical absorption correction determined with 
SADABS was applied to the data. 
 
The structure was solved in the space group P21/n by direct methods with SIR97, and 
extended and refined with SHELXL-97. Of the 32 non-H atom sites in the asymmetric unit, 
29 were modelled with anisotropic displacement parameters and the rest were modelled 
with isotropic displacement parameters. Of the 23 H atoms included in the model 9 were 
located and modelled with isotropic displacement parameters, and a riding atom model was 
used for the remainder. 
 
Formula C16H23N7O6, M 409.41 Da, monoclinic, space group P21/n, a 10.614(2), 
b 10.482(3), c 17.966(5) Å, β 100.303(9), V 1966.6(9) Å3, Dc 1.383 gcm-3, Z 4, crystal size 
0.190×0.119×0.099 mm, colour colourless, habit prism, temperature 150(2) K, λ(MoKα) 
0.71073 Å, µ(MoKα) 0.108 mm-1, T(SADABS)min,max 0.8539, 0.99, 2θmax 63.48, hkl range 
-15 15, -15 15, -26 26, N 31881, Nind 6621(Rmerge 0.0815), Nobs 3165(I > 2σ(I)), Nvar 299, 
residuals R1(F) 0.0642, wR2(F2) 0.1804, GoF(all) 1.029, ∆ρmin,max -0.560, 0.547 e-Å-3.  
 
w = 1/[σ2(Fo2)+(0.0707P)2 + 0.2567P] 
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A.4 Negative-ion ESI mass spectra of oligonucleotide solutions 
A.4.1 Spectra of mixtures containing D2/D2a and 
palladium(II)/platinum(II) complexes 
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Figure A.21: ESI-MS of D2 with [Pd(tmeda)(PEGda)]2+ (1 : 1) in (a) 0.01 M NH4OAc or (b) H2O; • [D2 – 
nH+]n– (n = 5, 6); ◦a [D2a – 3H+]3–; ◦b [D2b – 3H+]3–; •▪ [D2 + Pd(tmeda)(PEGda)2+ – 5H+]3–; 
•▫ [D2 + PEGda – 3H+]3–; •▫′ [D2 + Pd(tmeda)2+ – nH+](n–2)– (n = 7, 8); •▫′▫′ [D2 + 2Pd(tmeda)2+ – nH+](n–4)– 
(n = 9, 10); ◦a▫′ [D2a + Pd(tmeda)2+ – 5H+]3–; ◦b▫′ [D2b + Pd(tmeda)2+ – 5H+]3–. 
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◦a ◦b
•▪
•
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Figure A.22: ESI-MS of D2 with [Pt(en)(PEGda)]2+ (1 : 1 in 0.01 M NH4OAc); • [D2 – nH+]n– (n = 4, 5, 
6); ◦a [D2a – 3H+]3–; ◦b [D2b – 3H+]3–; •▪ [D2 + Pt(en)(PEGda)2+ – 7H+]5–. 
 
•
•
× ××
 
Figure A.23: ESI-MS of D2 with [Pt(2,2′-bipy)(PEGda)]2+ (1 : 1 in 0.01 M NH4OAc); • [D2 – nH+]n– 
(n = 5, 6); × ion present from previous acquisition. 
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Figure A.24: ESI-MS of D2a with [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ (1 : 1 in 0.01 M 
NH4OAc); ◦a [D2a – nH+]n– (n = 3, 4, 5, 6); ◦a▪ [D2a + Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}28+ – 
11H+]3–; ◦a▪▫′ [D2a + Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}28+ – 11H+]3–; ◦a▫▫′ [D2a + Pt(2,2′-bipy){4,4′-
bipy(CH2)64,4′-bipy}4+ – 7H+]3–. 
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A.4.2 Spectra obtained for comparison of binding affinities of 
platinum(II) complexes towards D2 
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Figure A.25: ESI-MS of D2 with daunomycin (1 : 5 in 0.1 M NH4OAc) with cone at (a) 150 V, (b) 130 V, 
(c) 110 V, (d) 90 V, (e) 70 V. 
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Figure A.26: D2-binding profile for daunomycin (1 : 5 in 0.1 M NH4OAc). 
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Figure A.27: ESI-MS of D2 with distamycin (1 : 5 in 0.1 M NH4OAc) with cone at (a) 70 V, (b) 90 V, 
(c) 110 V, (d) 130 V, (e) 150 V. 
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Figure A.28: D2-binding profile for distamycin (1 : 5 in 0.1 M NH4OAc). 
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Figure A.29: ESI-MS of D2 with [Pt(2,2′-bipy)(Mebipy)2]4+ (1 : 5 in 0.1 M NH4OAc) with cone at 
(a) 150 V, (b) 130 V, (c) 110 V, (d) 90 V, (e) 70 V. 
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Figure A.30: D2-binding profile for [Pt(2,2′-bipy)(Mebipy)2]4+ (1 : 5 in 0.1 M NH4OAc). 
Appendices 
XVIII 
(a)
(b)
(c)
(d)
(e)
•▪▪▪▪
•▪▪
•▪▪▪
•
•▪•
•▪▪ •▪▪▪•▪
•▪▪•▪
◦a ◦b
 
Figure A.31: ESI-MS of D2 with [Pt(2,2′-bipy)(NH3)2]2+ (1 : 5 in 0.1 M NH4OAc) with cone at (a) 150 V, 
(b) 130 V, (c) 110 V, (d) 90 V, (e) 70 V. 
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Figure A. 32: D2-binding profile for [Pt(2,2′-bipy)(NH3)2]2+ (1 : 5 in 0.1 M NH4OAc). 
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Figure A.33: ESI-MS of D2 with [Pt(en)(PEGda)]2+ (1 : 5 in 0.1 M NH4OAc) with cone at (a) 150 V, 
(b) 130 V, (c) 110 V, (d) 90 V, (e) 70 V. 
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Figure A.34: D2-binding profile for [Pt(en)(PEGda)]2+ (1 : 5 in 0.1 M NH4OAc). 
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Figure A.35: ESI-MS of D2 with [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ (1 : 2.5 in 0.1 M NH4OAc) 
with cone at (a) 150 V, (b) 130 V, (c) 110 V, (d) 90 V, (e) 70 V. 
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Figure A.36: D2-binding profile for [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′-bipy}2]8+ (1 : 5 in 0.1 M 
NH4OAc). 
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Figure A.37: ESI-MS of D2′a (in 0.05 M NH4OAc); ◦′a [D2′a – nH+]n– (n = 3, 4, 5, 6, 7). 
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Figure A.38: ESI-MS of D2′b (in 0.05 M NH4OAc); ◦′b [D2′b – nH+]n– (n = 3, 4, 5, 6, 7). 
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Figure A.39: ESI-MS of D2′ (in 0.05 M NH4OAc); •′ [D2′ – nH+]n– (n = 5, 6). 
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A.5 Thermal denaturation data 
Sample melting profiles of mixtures containing DNA and given below. Traces of raw data 
(black), sigmoidal fits (red) and their 1st (blue) and 2nd derivatives (green) are provided in 
each case. 
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Figure A.40: DNA melting profile for [Pt2(2,2′-bipy)2{4,4′-bipy(CH2)64,4′bipy}2](NO3)8 (110 as NO3- 
salt). 
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Figure A.41: DNA melting profile for [Pt(2,2′-bipy)(PEGda)](NO3)2 (126). 
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Figure A.42: DNA melting profile for [Pt(tmeda)(PEGda)](NO3)2 (127). 
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Figure A.43: DNA melting profile for [Pt(en)(PEGda)](NO3)2 (128). 
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Figure A.44: DNA melting profile for PEGda. 
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Figure A.45: DNA melting profile for [Pt(2,2′-bipy)(NH3)2](NO3)2 (146). 
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Figure A.46: DNA melting profile for [Pt(2,2′-bipy)(Mebipy)2](NO3)4 (148). 
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Figure A.47: DNA melting profile for EtdBr (152). 
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